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ABSTRACT 
In Leishmaniasis, the parasites undergo survival and 
multiplication within the host macrophages - the very cells 
which normally should have destroyed them. This adaptation on 
the part of parasites not only deranges host's defense system 
but even defeats man's ingenuity in directing and delivering 
drugs to kill them. Moreover, most of the potentially active 
leishmanicidal compounds are toxic, as also there are some 
indications of parasites developing resistance and insensiti-
vity to some of the compounds. 
Hamsters and Balb/c mice are generally found more 
suitable than other animals for maintenance of L. donovani 
parasites, in vivo, for routine screening of potential anti-
leishmanial compounds. Acquired resistance to pentavalent 
antimonials has been demonstrated both experimentally and 
clinically. 
Some of the recent approaches in the chemotherapeutic 
control of leishmaniasis include targeting of drug through 
liposomes, development of compounds based on metabolic 
peculiarities of the parasites and use of various drug 
combinations. More recently the use of adjuvants 
(immunomodulators) alone or in combination with parasite 
antigens has been widely studied with significant results. It 
has been reported that intravenous administration of glucan, 
before or after L. donovani infection, causes granulamatous 
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foci and hypertrophy of Kupffer cells in the liver along with 
significant reduction in the number of parasites. TDM in 
water oil emulsion or in aqueous suspension has been shown to 
confer a significant protective effect against different 
viral, bacterial and parasitic infections. Simialrly, it has 
been effectively used against tumors. 
Combined use of an immunomodulator and a specific drug 
for therapeutic purposes is a comparatively recent approach 
to control certain infections. Glucan in combination with 
ampicillin has been shown to exert a significant synergistic 
effect on the survival rate of rats with induced bacterial 
peritonitis. The combined use of sodium stibogluconate and 
Corynebacterium parvum was reported to stimulate R.E. system 
in the treatment of L. donovani infected mice. The above 
regime was found more effective than the administration of 
drug only, or C.. parvum alone. This study for the first 
time provides a documented evidence that the therapeutic 
modality involving simultaneous administration of drug and an 
immunoenhancer can be used to advantage in the treatment of 
experimental L. donovani infection. BHMARB medium was used 
for anaemic culture of L. donovani promasti gotes. It was 
found to adequately support the growth of the parasite. The 
rate of multiplication of promastigotes in BHMARB medium was 
about 77.83 times after 6 days of incubation. Parasites 
obtained from 6 days old cultures in BHMARB medium were 
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washed 6 t imes i n normal s a l i n e t o wh i ch Qentamyc in was 
added. The washed promast igotes were dispensed by shaking and 
osmolysed i n double d i s t i l l e d water . The osmolysed suspension 
represented the whole ant igen p repara t i on f rom L. donovani 
promast igotes. The so lub le and p a r t i c u l a t e an t igen f r a c t i o n s 
were s t a i n e d by c e n t r i f u g a t i o n o f t h e who le a n t i g e n a t 
105,000 X g f o r one hour . The s u p e r n a t a n t t h u s o b t a i n e d 
represented the so lub le ant igen f r a c t i o n , wh i l e the depos i t 
represented the p a r t i c u l a t e ant igen f r a c t i o n . 
The v a r i o u s a n t i g e n f r a c t i o n s were p a r t i a l l y 
c h a r a c t e r i z e d by e s t i m a t i n g p r o t e i n , c a r b o h y d r a t e , DNA 
c o n t e n t s and a n t i g e n i c i t y b e f o r e b e i n g used f o r 
immunological s t u d i e s . The a n t i g e n i c i t y of whole a n t i g e n , 
so lub le and p a r t i c u l a t e ant igen f r a c t i o n s was checked aga ins t 
a n t i s e r a o b t a i n e d f r o m cases o f K a l a - a z a r . I n d i r e c t 
h a e m a g g 1 u t i n a t i o n ( I H A ) and aga r d i f f u s i o n t e s t s were 
employed t o de tec t the an t i gen i c a c t i v i t y of whole a n t i g e n , 
s o l u b l e and p a r t i c u l a t e a n t i g e n f r a c t i o n s . An a n t i g e n 
d i l u t i o n of 1:16 was found t o be t h e opt imum w o r k i n g 
d i l u t i o n f o r use in IHA t e s t s . 
Golden hamsters which are h i g h l y s u s c e p t i b l e t o L. 
donovani i n f e c t i o n were used f o r t h i s s tudy . The animals were 
i n f ec ted w i th 1x10' promast igotes i n 0.1 m l / samples. Two 
weeks a f t e r the i n o c u l a t i o n t h e hamste rs were s p l i t i n t o 
d i f f e r e n t g r o u p s . Each g r o u p c o n t a i n e d 5 h a m s t e r s . L. 
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donovani infection appeared first in the liver followed by 
lymphoid organs such as spleen, bonemarrow, lymphnodes and 
thymus in golden hamsters. Gross pathological changes 
included hepatomegaly during L. donovani infection. 
Consequent to the administration of drugs, the response 
in the infected group was found to be varied depending upon 
the dosages alone. Drugs given in combination with a TDM dose 
of 10 mg / kg body weight caused the parasitic count to 
drop. There was a remarkable drop, when it was combined with 
500 ug of TDM per kg body weight. 
The haematological studies showed that the total 
leukocyte count was increased in the infected animals 
(7408.8) as well as in animals with smaller drug doses 
(6513.8). When the animals were treated with a combination of 
lower drug doses and TDM, the count was 5076.6. The mean 
haemoglobin concentration was found to be decreased in 
infected animals as well as in the animal groups which were 
treated with lower drug doses. But when a combined therapy of 
smaller drug doses and TDM were given, the anaemic condition 
was overcome and the haemoglobin concentration was increased. 
The differential leukocyte count was also found to be 
affected in the infected animals. The lymphocytes, monocytes 
and the eosionophils were increased in the infected and in 
smaller drug dose treated animal groups. The count obtained 
X I X 
by using a combination of smaller drug doses and TDM were 
comparable to those obtained by using higher doaea of drugs. 
Biochemical assays were carried out in the infected and 
treated experimental hamsters. Liver showed a significant 
increase in the level of total lipid, lipid peroxidation, and 
the total cholesterol content in the infected and in the 
animal groups which were treated with lesser concentration of 
drug. The combined therapy of lesser drug doses and TDM 
normalized the elevated values of the above contents. The 
level of total proteins, phospholipids, total carbohydrates, 
total glycogen, glucose and total DNA and RNA were found 
decreased in the infected and lesser drug dose-treated animal 
groups. This effect was overcome significantly by the 
combined therapy of drug and TDM. The altered level of serum 
transaminase and phosphatase contents indicated the liver 
dysfunction. The values were normalized by using a 
combination of drug and TDM and the values obtained by this 
combined therapy were comparable to the values obtained with 
higher drug doses alone. 
Detection of humoral immune response was carried out by 
indirect-haemagglutination tests and enzyme-linked immuno-
sorbent assays (ELISA). The highest reciprocal antibody titre 
was found to be maximum in the infected animal groups, these 
titre values were found normal after giving the combined 
therapy of drug and TDM. 
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The eel 1-mediated immune response in the experimental 
animal was demonstrated by the development of delayed type 
hypersensitivity response (DTH) and macrophage migration 
inhibition tests. The DTH manifested as footpad swelling 
following the administration of phenol suspended promas-
tigotes. The hypersensitivity was maximum in the infected and 
smaller drug dose-treated experimental groups. After the 
combined therapy and the administration of higher drug doses, 
the DTH was found to be negative. The maximum macrophage 
inhibition was found in the infected and in the lesser drug 
doses treated animal groups. The MMIT appeared to be 
negative in the higher drug dose treated experimental groups 
and in the animals which were treated with a combined therapy 
of drug and TDM. 
Further, histopathological studies revealed that the 
infected liver parenchyma shows patchy necrosis in centri-
lobular region, indicating hepato cellular damage with an 
alteration in the pattern of hepatic lobules. Sinusoides 
were dilated, filled with hypertrophied, kupffer cells 
containing phagocytosed parasites (L.D. bodies). The animals 
treated with combined therapy of drug and TDM did not ehow 
any parasitic infiltration in the infected liver. 
Hematoxylin and eosin stained tissue sections from animals 
given a combined therapy and those receiving higher drug 
doses, showed normal liver architecture. There was a very 
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s l i gh t inflammation seen but the ce l l s did not contain L.D. 
bodies. 
These f i n d i n g s o b t a i n e d f rom v a r i o u s expe r imen ts 
suggest that combined therapy can be ga in fu l l y employed in 
the treatment of L. donovani i n f ec t i on . The innate t o x i c i t y 
and the res is tance to ce r t a i n 1 e i shman ic ida l drugs i s an 
important cons iderat ion to use such an i mmunomodul a t o r , 
pa r t i cu la r l y for reducing (subs tan t ia l l y ) the ant i le ishmania l 
drug concentration in the treatment of leishmaniasis. 
1. INTRODUCTION 
1.1 Historical Review 
Leishmaniasis is one of the top ten parasitic diseases 
identified by World Health Organisation for causing an 
estimated 1.2 million cases of infection per year. 
The Leishmanias are the causative agents of a variety 
of human diseases termed "Leishmaniasis" (Stauber, 1970). A 
1985 report states that there were 150,000 cases of Kala-azar 
during 1977 to 1982 resulting in hundreds of deaths. About 
400,000 new cases of disseminated leishmaniasis are reported 
almost every year from endemic areas of the world (Lainson 
and Shaw, 1978). Although there is no quantitative evaluation 
at the moment but rough estimates based on extrapolation of 
the scarce data available, indicate that some 350 million 
people in the world are at risk of acquiring leishmaniasis 
and that approximately 12 million are currently influenced by 
it (W.H.O. Tech. Rep. Ser. 1990). 
The human leishmaniasis was first reported by 
Cunningham in 1885, when he observed, but misinterpreted, the 
parasites in the tissues of a Delhi boil in Calcutta. The 
organism was mistaken as Mycobacteria. Later, in 1898 
Borovsky established the protozoan nature of the parasite 
(Zukerman and Lainson, 1977). But in 1903, it was Leishman 
who first described this organism as a causative agent of 
' v i s c e r a l Le ishmanias is ' a f t e r having examined the spleen o f 
a B r i t i s h s o l d i e r w i t h k a l a - a z a r . The B r i t i s h m a n was 
s ta t i oned a t 'Dum Dum' near C a l c u t t a , hence the name 'Dum 
Dum f e v e r ' . Later i n the same year , Donovan a lso i d e n t i f i e d 
the p a r a s i t e i n s p l e n i c t i s s u e . The o r g a n i s m i s o f t e n 
c a l l e d Leishmania donovani or L .D. body. I n 1904, Roger 
observed the convers ion o f amast igotes t o promast igotes i n 
c u l t u r e . Promastigotes were a lso found i n s a n d f l i e s by Ad ler 
and Odor in 1925. Transmission of o r i e n t a l sore by i n f e c t e d 
sandf l y b i t e was observed by Wenyon in Baghdad (1977) and 
Sergent in A l g e r i a (1921). 
The Leishmania Skin Test was descr ibed by Montenegro i n 
1926 and i n 1942 . The B r i t i s h Commiss ion i n I n d i a 
e x p e r i m e n t a l l y t r a n s m i t t e d K a l a - a z a r t o human v o l u n t e e r s 
t h r o u g h sand f l y b i t e . Zuckerman and L a i n s o n ( 1 9 7 7 ) , 
d e s c r i b e d t h e c a u s a t i v e a g e n t o f J l o o n o t i c C u t a n e o u s 
Le ishman ias is as L. tropica major. Bray et al. , (1973) 
es tab l i shed the name L. aethiopica f o r the p a r a s i t e causing 
C u t a n e o u s , as w e l l as more d i f f u s e d l e i s h m a n i a s i s i n 
E th iop ia and Kenya. Guteremala and Yucatan held L. tropica 
brazi1ienses and L. tropica quvanesis respons ib le f o r causing 
mucocu taneous l e i s h m a n i a s i s i n B r a z i l and C u t a n e o u s 
Le ishman ias is i n Panama and Costa R i c a r e s p e c t i v e l y . 
Zuckerman & Lainson (1977) and La inson and Shaw (1972) 
c l a s s i f i e d l e i s h m a n i a s i s i n t o two ma jo r g r o u p s , t h e L. 
mexi carta and L. brazil iensis complexes. 
1.2 Taxonomy 
The various causal agents of leishmaniases belong to 
the genus Leishmania whose systematic position is as follows: 
(W.H.O. - TDR/ LEISH - SEM/ 80.3) 
Phylum - Protozoa 
Sub phylum - Sorcomastigophora 
Order - Kinetoplastida 
Sub order - Trypanosomatina 
Family - Trypanosomatidae 
Genus - Leishmania 
The genus Leishmania has a wide distribution in the tropics 
and subtropics but is apparently absent in South-East Asia 
and the Pacific. 
1.3 Life Cycle and Morphology 
Leishmanias have a relatively simple lifecycle. 
Promastigotes in the proboscis of a female sandfly are 
introduced into the skin of a vertebrate host during a blood 
meal. The promastigotes invade reticulo-endothelial cells, 
transform into amastigotes, multiply within macrophages and 
invade other reticulo endothelial cells. Further, sandflies 
feeding on infected individuals ingest parasitized cells and 
the amastigotes transform into promastigotes which multiply 
in the gut and migrate to the proboscis, thus completing the 
cycle. 
1.3.1 Amastigote Stage 
The amastigote found within reticuloendothelial cells 
in the vertebrate host, is a round or oval organism measuring 
2 to 5 urn in greatest diameter. In Wright or Giemsa - stained 
preparations, the pale blue cytoplasm is surrounded by a 
plasma membrane and contains a large dark-purple nucleus and 
a small purple kinetoplast. A delicate thread connects the 
kinetoplast to a dot like basal body from which an axoneme 
arises and extends to the anterior end of the organism. 
Multiplication is by binary fission and mitotically dividing 
forms may be seen in spleen smears. 
1.3.2 Promastigotes Stage 
The promastigote found in culture and in the sandfly 
digestive tracts measures 1.5 to 3.5 by 15 to 20 um and has 
a single free flagellum 15 to 28 um long. Old cultures may 
contain short, broad and rounded forms 4 to 5 um in diameter 
with long flagella centrally directed to form rosettes. Ultra 
structurally, the organism is surrounded by a trilaminar 
plasma membrane, beneath which is a row of microtubules. The 
cytoplasm contains a large central nucleus, ribosomes, rough 
and smooth endoplasmic reticulum, a golgi body, various 
vesicles and a single mitochondrion. The kinetoplast is a 
complex body and appears as an electron dense granular band 
with a distinct fibrillar pattern, lying within an extension 
of the mitochondrion. The axoneme, which arises from the 
basal body and a paraxial rod are contained within the 
flagellar sheath. 
1.4 Ultra Structure of Leishmania Parasite 
There are two developmental stages in leishmania, the 
promastigote in the sandfly host and the amastigote in 
various species of mammals and reptiles. 
The body and flagellum of the promastigotes are each 
approximately 20 um long, and their organelles have staining 
characteristics similar to those of amastigotes. Electron 
microscopy has revealed that both forms are surrounded by 
typical trilaminar unit membrane 10-12 um thick and have a 
sub-pellicular microtubular system. The microtubular system 
functions as a cytokeleton imparting shape and flexibility to 
the parasite and perhaps also serves to anchor intrinsic 
plasma membrane proteins. The flagellar pocket, although not 
a true cytoplasm, has coated vesicles which contain 
supercoiled DNA (kDNA) that exists as a network of catenated 
minicircles and maxicircles. The kDNA divides before nuclear 
DNA but the nature of the proteins encoded by kDNA are in 
general unknown. 
Attempts to identify the role of kDNA have utilized 
drug induced dyskinetoplastic parasitic forms. Comparison 
between normal and dyskinetoplastic forms have inferred that 
kDNA may encode for mitrochondrial proteins. Reproduction 
starts with the division of the kinetoplast and 
bTepharoplast. The kinetopTast lengthens, without change in 
structure, then divides, but the dividing cells have two 
blepharoplasts, one at the base of flagellum while the other 
develops later and apart from the flagellum. Division of the 
nucleus has been said to involve spindle formations. The 
structure of the nuclear membrane remains unchanged during 
the divisions. 
The ultra structure of amastigotes generally resemble 
that of promastigotes, except for the overall shape and the 
absence of a free flagellum. 
1.5 Geographical Distribution and Epidemiology 
The Leishmaniasis have an immense geographical 
distribution in the tropics and subtropics of the world. The 
world wide annual incidence of leishmaniasis varies from 0.4 
to 12 million cases (TDR, 1989). 
1.5.1 Visceral Leishmaniasis (VL, Kala azar) 
Visceral leishmaniasis or infantile kala-azar is 
widely distributed in Mediterranean Portugal, France, Italy, 
Greece, Yugoslovia, North Africa, Lebanan, Iraq, Iran, Saudi 
Arabia, Yemen, Southern Russia, Central Asia and North China. 
Indian Kala-azar occurs in several parts of India 
(Assam, Bengal, Bihar, Uttar Pradesh, Madras and Sikkim) and 
Bangladesh. African kala-azar is common in Kenya and Sudan 
but sporadic cases occur in Chad, Upper Volta, Central 
African Republics, Zambia and Ethiopia. 
Precise incidence f igures are not avai lable but i t is 
l i k e l y t h a t t ens of thousands of cases of V i s c e r a l 
Leishmaniasis occur each year throughout the wor ld. 
1.5.2 Mucocutaneous Leishmaniasis (MCL) 
It is primarily found in South America although cases 
have also been reported in Africa, notably from Ethiopia and 
Sudan. 
1.5.3 Cutaneous Leishmaniasis 
Cutaneous leishmaniasis is the most prevalent form of 
leishmaniasis found in Africa, Latin America, the Indian sub 
continent. South West Asia and parts of the Mediterranean 
Basin and Soviet Union. 
Cutaneous leishmaniasis infection is characterized by 
nodular and ulcerative skin lesions caused by Leishmania 
tropica, Leishmania major or Leishmania aethiopica. 
[A] Leishmania tropica infection 
Urban cutaneous leishmaniasis is a natural infection 
of dogs and mainly caused by L. tropica. The parasite has 
been demonstrated in cutaneous lesions on the ears, lips, 
nose and inner canthus of the eyes of dogs in Iran, Iraq and 
India, where it is transmitted by P. sergenti. The infection 
was formely common in many large cities of the Middle East, 
namely Baghdad, Tehran, Aleppo and Damascus, Southern Italy 
and Greece. Pakistan and North Western India are also 
affected. 
[B] Leishmania major infection 
The cutaneous leishmaniasis caused by L. jamor is found 
in a wide area of sub-Saharan Africa between the tenth and 
thirteen parallels north, from Senegal in the west to Sudan 
in the east. 
The Nile rat {Arvieanthis mitoficus) is the major host, 
although infection has also been demonstrated in other 
rodents. Human disease is also a rural zoonosis and the main 
vector is P. papatasi in Sudan. River et aT. , (1993) 
suggested that CBA mice were can be protected from virulent 
L. major challenge by subcutaneous administration of 
radioattenuated parasite. 
[C] Leishmania aethiopica infection 
Cutaneous leishmaniasis in Africa can also be caused by 
L. aethiopica. The parasite is found in mountain valleys of 
the rift in Ethiopia and Kenya. It infects the rock hyrax 
(Procasia Tebessirica) and the tree hyrase {Heterohyrax 
brucei) and man is infected when his house stands on rocks on 
deforested mountain slopes. 
The situation in Namibia superficially resembles to 
that in Ethopia and Kenya because sporadic cases of cutaneous 
leishmaniasis occur and leishmania have been isolated from 
hyrase and from P. rassi near hyrase borrows. However, the 
parasites from man and P. rassi are identical. 
1.6 Clinical Forms 
Leishmaniasis, the disease caused by the infection of 
flagellate protozoan parasite leishmania occurs in three 
major clinical forms, Visceral, Mucocutaneous and Cutaneous. 
1.6.1 Visceral Leishmaniasis 
Visceral leishmaniasis or kala-azar is a clinical 
condition manifesting itself due to the infection of reti-
culoendothelial cells by L. donovani parasites. The resultant 
disease is characterized by a lengthy incubation period an 
insidious onset and a chronic course attended by irregular 
fever, enlargment of spleen and liver, leucopenia, anaemia 
and progressive wasting. The mortality is high, death occurs 
in untreated cases in two months to two years. 
Post Kala-azar Dermal Leishmaniasis (PKDL) 
It is an important sequalae of Kala-azar found in 
India, China and Sudan. It develops when visceral infection 
persists for a year or so. The condition is characterized by 
hypopigmented or erythematous macules, papules and nodules. 
The skin lesions contain amastigotes of leishmania. A large 
number of L. donovani can be recovered from such skin 
lesions. 
1.6.2 Mucocutaneous Leishmaniasis (MCL) 
Mucocutaneous leishmaniasis or Espundia of South 
America is a clinical condition due to infection of 
reticuloendothelial cells, initially of the skin and 
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subsequently of the mucosae of the mouth smd nose following 
L. braziliensis infection. It is chareicteri zed by the 
appearance of a variety of skin lesions; a papular lesion 
commonly becomes nodular and then ulcerates. Sometimes 
metastatic lesions may develop in the mucosae of the upper 
respiratory tract and the mouth, which extensively erode the 
adjacent tissues. 
1.6.3 Cutaneous Leishmaniasis (CL) 
Cutaneous leishmaniasis can present as hard, indurated 
plaques, nodules, scabby papules or warty tumor like lesions. 
Characteristically however, a lesion on an exposed area of 
the body begins as a red papule; enlarges to form a shallow 
ulcer with raised red margins and then heals with scarring. A 
healed lesion has a flat border with a slightly depressed 
area in the center that is completely reepithel iazed with 
thin scar tissue. The infection may disappear spontaneously 
leaving disfiguring scars, or persist for a very long period 
causing multiplications. 
1.7 Leishmania Antigen 
Like the other protozoan parasites, leishmania 
consists of complex series of antigens (Crook et a/., 1969; 
Afchain et al., 1972; Clinton et al. , 1972). Some antigens 
are species specific (eg. Oelerich 1973); some genus-specific 
(eg Oelerich 1973); and some are shared with related 
Generas, such as trypanosomas (Goble 1970, Neal & Miles 1970, 
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Afchain et al., 1972; Kagan 1973) or Striogomonas (Ranque et 
al., 1969). 
In leishmaniasis, the antigens play a very important 
role pertaining to immunodiagnosis, immunopathology and 
protective immunity. Preston and Dumonde (1971), proposed 
that leishmania may contain two types of antigens; those 
which stimulate specific resistance to infection (particulate 
antigen) and those which depress specific resistance to 
infection (soluble antigen). Crook et al., (1969) reported 
that leishmania parasites constitute an antigen mosaic of 
eleven antigens in a lysate of L. mexicana. In a comparison 
between L. braziliensis and L. donovani, there was much 
antigenic overlapping among the organisms. 
Differences in the antigenic composition between 
amastigote and promastigote stages of the parasites are 
documented by earlier studies. Although the above two forms 
certainly share some common antigen (Dwyer, 1973, Chang, 
1981). Dwyer (1973) not only confirmed the presence of shared 
antigens in clones of amastigotes and promastigotes of the 
same strain but also found stage specific antigens in each 
form. 
Antibody cross-absorption experiments showed that both 
the amastigote and promastigote stages shared some cross 
reactive antigens (Dwyer, 1976) among which four antigens 
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were common to promastigote and amastigote forms. These 
antigens were detected in cell free extracts of L. donovani 
(Simpson, 1968, Ghatak et al., 1982). 
Previous studies have shown a cross reaction between 
leishmania and other protozoans in immunological tests 
(Martaresche et al., 1975; Roffi et a]., 1980). Such cross-
reactivity is also reported between leishmaniasis sera and 
mycobacterial antigens (Smrkovski and Larson, 1977). 
Infection with non-pathogenic or mildly psithogenic strains of 
Mycobacterium in normal human beings and laboratory animals 
can induce the formation of antibodies reactive with 
leishmania at low serum dilution (Allain and Kagan, 1975, 
Bardana et al., 1973). 
It was also reported that both promastigotes and 
amastigotes of L. donovani share antigens that cross-react 
with components of blood cells from normal individuals of all 
ABO system type (Decker - Jackson and Honigberg, 1978). Adler 
and Gunders, (1964) differentiated these antigens among L. 
tropica, L. donovani, L. brazi Tiensis and L. mexicana. There 
are also certain antigens shared between different species of 
Leishmania as shown in the immunoflurosecent and ELISA tests 
(Edrissian and Darabian, 1979). Strains of L. tropica, L. 
donovani and L. braziliensis possess common antigens as shown 
by positive reaction in Kala-azar. 
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Since cross-reactivity between 7". Cruzi and Leishmania 
species is well known in serological tests (Decker - Jackson 
and Honigberg, 1978), it was suggested that extracts from 
L. donovani chagasi promastigotes should be the antigen of 
choice for diagnosis of visceral leishmaniasis by means of 
IFA and IHA tests. These tests were considered more suitable 
for areas with known endemicity for trypanosomias is (Badarlo 
et al. , 1983). 
In an attempt to determine the role of T - lymphocytes 
and the nature of antigens that activate them, or antigen 
specific murine T - lymphocyte clone which proliferates in 
response to antigens present on the membrane of intact L. 
donovani promastigote were propagated. One such line cross 
reacts with membrane antigens on seven other species and to a 
lesser extent with antigens on African Procyclic Trypano-
somas. These antigens were found to contain both mannose and 
galactose ligands. The antigen activity was also absorbed 
using extensively cross reactive monoclonal antibodies to 
parasites (Sheppard et a7., 1983). 
In a preliminary investigation on the surface antigen 
profiles of promastigotes from L. donovani complex, isolated 
in Brazil and Africa, no difference was observed. In 
addition, a glycoprotein of 65,000 molecular weight 
recognized by human sera from different geographical areas 
was the main component in both subspecies (Lepay et al . , 
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1983). A polysaccharide rich antigen was also isolated from 
the parasite (Ghose and Roy; 1983, Majumder, 1992). In an 
early study, soluble antigenic substances liberated by 
amastigotes of L. donovani were shown to be present in the 
sera of infected dogs (Nattan - Larrier and Gremard Richard, 
1983). Adler and Gunders (1964) also demonstrated the release 
of exoantigens by L. tropica and L. mexicana amastigotes and 
promastigotes. These exoantigens were able to elicit skin 
response in ensitized persons (Sergevie and Shuikina, 1969). 
Clinton et al. , (1972) recognized, for the first time the 
existence of a soluble factor in the used medium from 
cultures of L. donovani promastigotes. This excreted factor 
(EF) was shown to be immunologically active in sensitized 
guinea pigs, as it produced a delayed skin reaction and was 
capable of precipitating anti-leishmania antibodies raised in 
rabbit against living homologous promastigotes (Schnur et 
al., 1972). It was demonstrated that antigenic determinants 
are shared by promastigotes. This EF and the EF from the 
homologous amastigotes, are serologically specific for 
individual leishmanial strains. It is therefore, possible to 
define leishmania serotypes with the aid of EF (Schnur et 
al., 1972). The EF of L. mexicana was used as an antigen for 
coating wells for modified ELISA and sheep red cell 
agglutination assays. The ELISA as tested against sera of LD 
positive patients, was found much more sensitive than tanned 
red cell haemagglutination tests (TRCH). 
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The EF also showed some cross reaction against sera of 
patients with malaria and amoebiasis. Thus the crude EF of L. 
mexicana which can be obtained in large quantities can serve 
as a suitable and convenient antigen for large scale 
epidemiological surveys (Arora et al. , 1985). The existence 
of leishmanial exoantigens was suggested by positive immune 
peroxidase staining in the cytoplasm of giant cells 
(infected with L. major) and non-parasitized epithial cells 
(Sells & Burton, 1981). 
Soluble immune complexes containing anti-leishmanial 
antibodies were demonstrated in human serum in visceral 
leishmania (Casali & Lambert, 1979). It was also found that 
there are other substance released by L. donovani living 
promastigotes into the tissue for example, blood of 
infected hamsters. These substances differ from the excretory 
factors in their antigenic and biochemical characteristics. 
They were given the name of Anti gen i cal 1 y Active 
Glycoproteins (AAGP). The AAGP were found to consist of 6-7 
antigenically distinct components, which give reaction of 
identity and partial identity with human red cells and 
Mycobacterium butyricum. They also share certain antigens 
with a carbohydrate rich extract of T. cruzi (Decker-Jackson 
and Honigberg, 1978). 
1.8 Antigen Preparation 
Killed promastigotes have been used by many workers as 
antigen (Holbrook et al. , 1981a; El-Amin et al., 1985). The 
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promast i gotes may be k i l l e d by f o r m a l i n t r e a t m e n t or by 
f r e e z i n g and t h a w i n g . For t he f o r m a l i n t r e a t m e n t , t h e 
p romast igo tes are harves ted d u r i n g l o g phase growth by 
c e n t r i f u g a t i o n (900 x g f o r 30 minu tes) , washed three t imes 
i n E a r l e ' s ba lanced s a l t s o l u t i o n (EBSS) and k i l l e d by 
s u s p e n d i n g i n 0.^% f o r m a l i n f o r 30 m i n u t e s a t room 
temperature. Formal in k i l l e d promast igotes (FKP) are kept a t 
4°C o v e r n i g h t , washed t h r e e t i m e s , c o u n t e d i n a 
haemocy tome te r and resuspended i n EBSS a t t h e d e s i r e d 
concent ra t ion (Holbrook et al., 1981a; Holbrook and Cook, 
1983; Cook & Holbrook; 1983). 
For p r e p a r i n g f r e e z e - thawed a n t i g e n , t h e proma-
s t i g o t e s are f i r s t suspended in EBSS and f rozen a t -70°C and 
thawed a t 37°C. Th is procedure i s repeated th ree t imes. The 
c r i t e r i o n f o r the de termina t ion of promast igoters death i s 
t he absence o f p a r a s i t e m o t i l i t y (Dwyer , 1976; Decker -
Jackson & Honigberg, 1978; Cook & Holbrook 1983). The o ther 
method of a n t i g e n p r e p a r a t i o n i n c l u d e s d i s i n t e g r a t i o n o f 
p r o m a s t i g o t e s t o g e t a c e l l f r e e e x t r a c t . For such 
prepara t ion the promast igotes are obta ined from 72 hour o l d 
c u l t u r e s , washed t w i c e , by c e n t r i f u g a t i o n and d i s i n t e g r a t e d 
i n M i c k l e ' s d i s i n t e g r a t o r f o r 30 m i n u t e s . The o b t a i n e d 
homogenate i s f u r t h e r c l a r i f i e d by c e n t r i f u g a t i o n (Ghatak e t 
al., 1982). The pa ras i t es may a lso be d i s rup ted by son i ca t i on 
a t 30 MHz f o r one minute burs t f o r f i v e t imes i n a Branson's 
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c e l l d i s r u p t i o n . A complete d i s r u p t i o n of c e l l u l a r i n t e g r i t y 
may be v e r i f i e d by l i g h t microscopic examinat ion (Rassam and 
Al -Mudhaf far , 1980, Cook and Holbrook, 1983). 
Soluble and p a r t i c u l a t e f r a c t i o n s are a lso separated by 
c e n t r i f u g a t i o n of the sonicated promast igote p repara t ion a t 
4000 X g f o r 20 minutes. The supernatant i s passed through 
0.2 urn m i l l i p o r e membrane f i l t e r s . The p a r t i c u l a t e p e l l e t i s 
washed three t imes w i t h BBSS and suspended t o the o r i g i n a l 
volume (Cook and Holbrook, 1983). 
Rassam and A l -Mudha f fa r (1980) p r e p a r e d t he s o l u b l e 
a n t i g e n by k e e p i n g t h e u l t r a s o n i c a t e d p r o m a s t i g o t e 
suspension a t 4°C f o r two hours and then c e n t r i f u g a t i n g i t 
a t 7000 X g f o r one hour in a r e f r i g e r a t e d c e n t r i f u g e . The 
supernatant f r a c t i o n represent ing the so lub le ant igen was 
d ia l yzed f o r 20 hours against d i s t i l l e d water a t 4°C and then 
f reeze d r i e d . 
The s o l u b l e and p a r t i c u l a t e f r a c t i o n s a r e a l s o 
p r e p a r e d by r e p e a t e d c e n t r i f u g a t i o n and w a s h i n g o f 
p romas t i go tes f o l l o w e d by o s m o l y s i s i n s t e r i l e d i s t i l l e d 
w a t e r a t room t e m p e r a t u r e . The l y s e d s u s p e n s i o n i s 
cen t r i f uged a t 12,000 x g f o r 30 minutes i n a r e f r i g e r a t e d 
c e n t r i f u g e (Ja lees et al., 1981). Another method reported by 
Obaid e t al., ( 1 9 8 5 ) , u t i l i z e s t h e osmolyzed p a r a s i t i c 
suspension which i s f u r t h e r c e n t r i f u g e d a t 105, 000 x g f o r 
one hour t o o b t a i n s o l u b l e and t h e p a r t i c u l a t e a n t i g e n 
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fractions. The supernatant left after the last centrifugation 
represents the soluble antigen fraction (Ghatak et al. , 
1982). 
1.9 Host Parasite Relationship 
In contrast to the situation in many other protozoan 
diseases most patients who overcome the first bout of 
cutaneous or visceral leishmaniasis do not harbour a latent 
infection (Neal et al., 1969). 
While, antibody is formed particularly in visceral 
leishmaniasis, it is not thought to be of critical value in 
protection and immunity in leishmaniasis. It is generally 
considered to be predominantly cell mediated (Zuckerman, 
1975). Leishmaniasis may indeed serve as a prototype for a 
disease whose immune mechanism is dominated by cell-mediated 
reactions (Dumonde, 1973). The basic leishmanial lesion is 
the proliferating infected macrophage; itself a cell 
associated with immunity. 
Intracellular symbiosis in leishmaniasis represents the 
ability of amastigotes to live in macrophages. For 
establishing such an intracellular symbiosis, the sequented 
events are important; recognition, intra-cellular entry, 
survival and multiplication (Moulder, 1979). Under certain 
conditions leishmaniasis may exert either synergistic or 
antagonistic effects on the host's reaction to the other 
organisms or their antigenicity. 
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Leishmania macrophage i n t e r a c t i o n has been s tud ied by 
i n f e c t i n g pe r i t onea l macrophages in- vivo and in-vitro w i t h 
L. donovani ( M i l l e r & Twhoy, 1967; Akiyama and M c q u i l l e n , 
1972; Ebert e t a / . , 1976; Change and Dwyer, 1978). 
At a c r i t i c a l p o i n t i n t he deve lopment o f a immune 
response, f o c i of i n fec ted macrophages become surrounded by 
lymphocytes and plasma c e l l s wh i ch a t t a c k and d e s t r o y 
e m e r g i n g p a r a s i t e s o r i n f e c t e d macrophages o r b o t h 
(Anonymous, 1968) . Ruskin e t a l . , (1969) summarized t h e 
fundamenta l c e l l - m e d i a t e d immune mechanism a g a i n s t i n t r a 
c e l l u l a r p a r a s i t e s as p r o b a b l y i n v o l v i n g t h e s p e c i f i c 
s e n s i t i z a t i o n of lymphoid c e l l by p a r a s i t i c ant igen and the 
d e l i v e r y of a p a r a s i t i c i d a l message of macrophages, which 
t he reby become a c t i v a t e d b o t h a g a i n s t t he s p e c i f i c 
homologous ant igen and in some cases, aga ins t nonspec i f i c 
he te ro l ogous an t i gens as w e l l . I n o r d e r f o r s e n s i t i z e d 
lymphocytes t o a r r e s t the development o f a le ishmania l f o c u s , 
they must t h e r e f o r e e s t a b l i s h i n t i m a t e c o n t a c t w i t h t h e 
sur face of i n f e c t e d macrophages (Garnham and Humphrey, 1969). 
Such c o n t a c t r e l e a s e s a g e n t s l e a d i n g t o t h e s e c o n d a r y 
accumulat ion and a c t i v a t i o n of macrophages (Frankenburg e t 
al., 1 9 9 3 ) . I n t e r a c t i o n in vivo, be tween s e n s i t i z e d 
lymphocytes and macrophages i n f e c t e d w i t h Le ishman ia may 
poss ib l y be c y t o t o x i c to the macrophages and p a r a s i t i c i d a l t o 
the l i b e r a t e d p a r a s i t e s (B ryceson e t al. , 1970a ) . The 
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lymphocytes being the active, and the macrophages being the 
relatively passive, partner in the interaction. Specificity 
inheres in the long lived, thymus dependent sensitized 
lymphocytes recognizing and interacting with its homologous 
antigens. 
Cell-mediated immunity develops slowly with the clonal 
replication of such specifically sensitized lymphocytes 
(Garnham and Humphrey, 1969). Lymphoblast transformation was 
more intense in the presence of homologous leishmanial 
antigen than in the presence of antigens from heterologous 
species. Kutish and Janovy (1981) showed that the infective 
stage of L. donovani suppresses macrophage function beyond 
the time at which initial lysosomal fusion with the 
parasitophorous vacoule occurs. Light and electron microscopy 
revealed that in the presence of lymphokines, macrophages are 
activated and intracellular Leishmanias develop specific, 
subcellular lesions in the kinetoplast mitochondria (Chang 
and Chiao, 1981a). 
Leishmaniasis, with the extensive changes it imposes on 
the lymphoid macrophage system, may non specifically affect 
the immune response to a host to other organisms or antigens. 
Human Polymorphonuclear cells (PMN) can ingest and kill L. 
donovani by the H2O2 - peroxidase halide system and may be 
capable of providing host defense against the invading 
promastigotes (Pearson and Steigbigel, 1981). The promas-
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t i g o t e s were found t o be suscept ib le t o k i l l i n g , in-vitro by 
HgOg and other in te rmed ia tes (Ha idar is and Bonventre, 1982). 
1.10. Experimental Leishmania I n f e c t i o n i n Animal Model 
A cons iderable amount of i n fo rmat ion has been gained 
f rom exper imenta l s t u d i e s of immune responses i n an imal 
models in the pas t few y e a r s . The c h o i c e o f l a b o r a t o r y 
animals models f o r human le ishmanias is has genera l l y been 
mice and hamsters. Monkeys are the recent a d d i t i o n to t h i s 
menagerie (Wo l f , 1976) . I t i s e v i d e n t t h a t r e s u l t s f r om 
animal e x p e r i m e n t a t i o n do not n e c e s s a r i l y p r o v i d e d i r e c t 
i n s i g h t i n t o s p e c i f i c human s i t u a t i o n as t h e p r e c i s e 
r e l a t i o n s h i p between i n f e c t i o n of labora to ry animals and the 
c o r r e s p o n d i n g human d i s e a s e s i s a l w a y s d i f f i c u l t t o 
e s t a b l i s h . Laboratory experiments usua l l y bypass the na tu ra l 
route of i n f e c t i o n and a given animal model w i t h respect t o 
i n o c u l a t i o n o f a p a r t i c u l a r p a r a s i t e , i n d i f f e r e n t ways 
according to va r i ous f a c t o r s such as age, dose and s i t e of 
i n o c u l a t i o n , g e n e t i c b a c k g r o u n d e t c . I n v i e w o f t h e s e 
shortcomings, however, i t i s a lso ev ident t h a t i n the absence 
of more appropr ia te means, animal exper imenta t ion remains the 
only r a t i ona l approach t o p rec ise ly understand the complex 
immunological r eac t i ons t h a t may be e l i c i t e d by the host as a 
r e s u l t of le ishman ia l i n f e c t i o n . The usefu lness of any animal 
model of human l e i s h m a n i a s i s i s c l e a r l y d e t e r m i n e d by t h e 
degree of s i m i l a r i t y of such models t o the human d isease, 
p a r t i c u l a r l y i t s immune responses and immunoprophylaxis. 
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I n f e c t i o n w i t h L. donovani in mice do not mimic the 
f a t a l v i s c e r a l i z i n g diseases caused by the p a r a s i t e in man. 
However, the broad spectrum of responses to t h i s i n f e c t i o n in 
mice provide an approp r ia te system f o r ana lyz ing the innate 
and acquired res is tance t o non l e t h a l systemic i n f e c t i o n s 
(B l ackwe l l , 1982). 
Since l a s t few years hamsters have been proved to be a 
b e t t e r animal model f o r L. donovani (Stauber, 1963). Stauber 
(1963) reported 50 f o l d increase in paras i te numbers i n f i r s t 
week w i t h an enormous p a r a s i t e load i n l i v e r and s p l e e n 
leading to death, f o l l o w i n g an i n t r a ca rd i a l i n o c u l a t i o n of 
a m a s t i g o t e s i n h a m s t e r s . However , p r o t e c t i o n a g a i n s t 
r e i n f e c t i o n i s s a i d t o be p r e s e n t a f t e r c u r e (Heyneman, 
1971). These models t hus p r o v i d e a p p r o p r i a t e sys tems f o r 
ana lyz ing p r o t e c t i v e c a p a c i t i e s of an t i gen ic p repa ra t i ons . 
They have s p e c i a l l y helped us t o def ine the basic p r o p e r t i e s 
requ i red f o r a vaccine aga ins t les ihman ias is , as a lso f o r the 
in vivo and in vitro t e s t s of b i o l o g i c a l f u n c t i o n needed t o 
i d e n t i f y , de f ine and assay such candidate vacc ines. 
1.11 Immunity i n V i sce ra l Leishmaniasis 
I n t e r e s t i n the immunology of le ishmanias is has been 
s p o r a d i c , s i n c e l e i s h m a n i a s i s c o u l d have i m p o r t a n t 
a p p l i c a t i o n s f o r t he o t h e r i n t r a c e l l u l a r i n f e c t i o n s as 
w e l l . I n a d d i t i o n a number of c o n s i d e r a t i o n s s u p p o r t t h e 
d e s i r a b i l i t y and f e a s i b i l i t y o f a v a c c i n e f o r d i s e a s e 
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control. These include the limited ability to control 
transmission with insecticides or by destroying animal 
reservoirs in many areas as well as through the use of 
chemoprophylactic drugs. The experimental leishmaniasis model 
in rodents has provided interesting insights into the disease 
and can potentially be exploited in developing novel 
immunological approaches to disease control in humans. 
When a leishmania infected sandfly attempts to take a 
blood meal from its mammalian host, promastigotes are 
inoculated. Although leishmania exists only transiently in 
the promastigote stage, the initial interaction of 
promastigotes with the mammalian host defense mechanism is 
critical to the development of infection. Based on in vitro 
studies with human serum and polymorphonuclear leukocytes, 
it appears that promastigotes must escape potentially lethal 
humoral and cellular host defense mechanisms in order to 
gain entrance into macrophages. But once the leishmanias 
transform into amastigotes within macrophages, the resolution 
of infection depends predominantly on cell-mediated immune 
mechanism (Mauel & Behin, 1974; Rezai et al. , 1978). Inspite 
of the above studies, a role of humoral immunity against 
leishmanial infection cannot be ruled out, usually humoral 
responses accompany cellular response in leishmaniasis as 
observed in laboratory animals. 
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1.11.1 Ce l l -med ia ted Immunity 
The p r o t e c t i v e immune response t o l e i s h m a n i a s i s i s 
p r i m a r i l y c e l l mediated. Several animal models and i n - v i t r o 
systems have been used t o i n v e s t i g a t e t he r o l e o f c e l l 
m e d i a t e d i m m u n i t y i n h o s t d e f e n s e a g a i n s t l e i s h m a n i a 
( Z u c k e r m a n , 1975 ; Graham and Humphrey , 1969 ; Tu rk and 
Bryceson, 1971) . Lymphokine c o n t a i n i n g s u p e r n a t a n t s can 
i n d u c e 1 e i s h m a n i a s t i c and 1 e i s h m a n i c i d a l a c t i v i t y i n 
amast igote i n f e c t e d mice p e r i t o n e a l macrophages (Behin & 
Louis 1984). Reed e t a l . , (1984) showed' t h a t mice i n f e c t e d 
w i t h L. donovan i and t r e a t e d w i t h l y m p h o k i n e r i c h 
supernatants (encapsulated in l iposome) have s i g n i f i c a n t l y 
fewer l i v e r pa ras i t es than the c o n t r o l group, demonstrat ing 
an in vivo a c t i v i t y of l ymphok ines a g a i n s t an i n f e c t i o u s 
organism. 
So lub ly (1972) suggested t h a t i n f ec ted macrophages i n a 
human l e s i o n may be ta rge ts f o r s e n s i t i z e d lymphocytes or f o r 
t h e i r s e c r e t e d lymphokines. The c rude l ymphok ines wh i ch 
pr ime t h e human monocyte d e r i v e d macrophages t o g e n e r a t e 
H2O2, e x e r t i n g a m ic rob i c ida l a c t i v i t y against i n t r a c e l l u l a r 
L. donovani were found t o be r i c h i n i n t e r f e r o n ( I F N ) 
gammas. I t was s u g g e s t e d t h a t IFN gamma i s t h e key 
macrophage a c t i v a t i n g m o l e c u l e s p r e s e n t w i t h i n human 
lymphokines. I t can enhance both the oxygen dependent and 
independent an t i p ro tozoa l mechanisms of human mononuclear 
phagocytes (Murray et al., 1983). In the ac t i ve stages o f 
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leishmaniasis cell mediated immunity was found absent or not 
prominent. But after drug induced healing, generally a 
vigorous delayed response appears and the individual becomes 
solidly immune (Manson Bahr, 1961; Rezai et al. , 1978). 
Allison et al., (1973) suggested that if infection 
macrophages should be inhibited in-vivo by the presence of 
sensitized lymphocyte secreting a migration inhibition 
factor, this would tend to confine the area of infection. 
Impairment of cell mediated immunity in kala-azar appears to 
be of generalized lesion (Haider et a7., 1983). Some other 
workers have also shown that immuno supression in visceral 
leishmaniasis is both specific and non specific (Carvalho et 
al., 1981; Ho et al., 1983). 
The available in vitro data indicate that the 
intracellular fate of amastigote depends upon the capacity of 
T-cells to activate macrophages (Zuckerman, 1975, Pompeu et 
a/., 1992, Lytton et al., 1993). Restoration of specific T-
cell responsiveness aided by antileishmanial drug therapy 
results in the reduction of antigenic load through parasite 
destruction along with decrease in the circulating antibody 
levels, particularly that of Immunoglobulin G class (Haider 
et al., 1983). Immunosuppresion of host guinea pigs by the 
administration of antilymphocyte screen (Bryceson and Turk, 
1971) or cyclophosphamide, by whole body irradiation (Lemma & 
Yau, 1973), or by the induction of tolerance (Bryceson et 
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al. , 1972) exacerbated infection and at the same time reduced 
cell mediated reactions, without necessarily affecting 
antibody synthesis. Since plasma cells continued to abound. 
The role in protection of each of the individual reactions 
that are the hallmarks of eel 1-medi ated immunity is still 
conjectural (Blewett et al., 1971; Allison et al., 1973). 
The fact that ce11-mediated immunity is somehow 
involved in protection is strongly suggested by the failure 
of protection, when cell-mediated immunity is suppressed. 
However, even though cell-mediated immunity may contribute to 
resistance, the degree of resistance is not always 
commensurate with the extent of delayed hypersensitivity 
(Dumonde, 1973; Targett, 1973). The immunosuppressed guinea 
pig with L. enriettii is considered analogous to the human 
being with diffuse cutaneous leishmaniasis (Bryceson, 1973). 
Whereas immunosuppression of cell-mediated immunity in 
guinea pig clearly damaged the protective mechanism against 
L. enriettii similar experiments in mice with human 
leishmaniasis were equivocal. The lesions of L. tropica major 
were exacerbated in thymus-deprived CBA mice (Preston et al. , 
1972) and in other mouse lines (Targett, 1973), but neonatal 
thymectomy did not modify the susceptibility of Balb/c mice 
to L. donovani (Schmunis & Herman, 1971). 
It was also found that affected human and rodent horts 
commonly show abnormalities of T - cell function which may 
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be related to change in macrophage physiology due to 
intracellular parasitism. Macrophages infected with L. 
donovani product increased amounts of arachidonic acid 
metabolites with the potential for influencing cellular 
immune functions and the inflammatory response to infection 
(Reiner and Malemud, 1985). It was further suggested that the 
protection by specific cell-mediated immunity against L. 
donovani infection is not quite absolute. Such protection is 
probably dependent on other host related factors leading to 
the destruction of parasite and recovery of patient (Haider 
et al., 1983). 
1.11.2 Humoral Immunity 
In the course of human visceral leishmaniasis the 
immunoglobulin titre rises very sharply, chiefly in the IgG 
and IgM compartments (Turk & Bryceson 1971, Manson - Bahr 
1971, Bray 1972). Gamma globulin may reach 50gm/ litre and 
may comprise 50% of the total serum proteins (Stauber 1970). 
Most of this product is not specific antibody, and is not 
protective (Clinton et al., 1969; Neal et al., 1969), but is 
attributed to the continuing synthetic activity of a greatly 
hypertrophied and damaged lymphoid macrophage system. The 
product may only be the antibody produced in response to 
damaged host cells (WHO/LEISH/6a7.7). This mass of globulin 
in the plasma can be coagulated, flocculated, or pre-
cipitated by a variety of reagents, and its presence is the 
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basis of formol gel and the antimony tests. These tests are 
simple to perform in the field (Cahill 1970, Chowdhury et 
al. , 1993). Depsite the non specific nature of the globulin, 
these tests are diagnostic of active kala-azar, and a plea 
has recently been accepted to retain them for field use. 
The view that antibody produced in human leishmaniasis 
is non protective is a widely accepted concept (Neal et al., 
1969; Stauber, 1970). However, many have noted the frequent 
presence of plasma 'cell', in leishmanial lesions denoting 
the probable local' production of antibody at the focus of 
infection (Stauber 1970). Furthermore, in lymphatic tissue of 
guinea pigs with L. enriettii infection both germinal centers 
(asociated with humoral immunity) and procortial regions 
hypertrophied (Bryceson and Turk, 1971). 
Similar hypertrophy of germinal centers occurs in mice 
with L. tropica infection and is accompanied by a marked 
rise in circulating antibody titer. Thus humoral responses 
accompany cellular responses in leishmaniasis in laboratory 
hosts. (Preston et al., 1972). It is suggestive that antibody 
is somehow associated with the healing process. This view is 
supported by the fact that cyclophosphamide, which damages 
the host's ability to produce antibody, interfered with 
healing when administered to mice with developed infections 
of L. tropica (Preston 1973). A factor in immune rabbit serum 
inhibiting the development of promastigotes in vitro was 
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ineffective in vivo (Rezai et a7., 1970). Antibody from 
guinea pigs immune to L. enriettii was also found cytotoxic 
to promastigotes in vitro. Mauel (1973) suggested that the 
same antibody may contribute to parasite destruction in vivo. 
The possibility thus still exists that some protection may be 
potentiated by antibody in leishmaniasis (Allison et al., 
1973). 
It was recently observed in hamsters with L. donovani that 
there exists a relationship between the increase in the 
number of antibody secreting cells per spleen and the 
increase in the number of parasites in this organ. These 
observations suggest that the hypergammaglobulinaemia 
present in infected hamsters may be the result of polyclonal 
activation of B-cells induced by components of this parasite 
(Campos-Neto and Bunn-Moreno, 1982). It was also suggested 
that hypergammaglobulinaemia may be the consequence of an 
imbalance of regulatory T-cells, possibly associated with 
direct stimulation of hamster B-cells by L. donovani 
components (Bunn- Moreno et. al.,1985). Hoover et al., (1985) 
showed that infection of individuals with L. donovani 
resulted in the production of a new quantitatively and 
qualitatively distinct immune mechanism directed against 
amastigote forms of the parasite. 
The immune mechanism was termed as antibody- directed 
and an alternate complement pathway - mediated cytotoxcity. 
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The res is tance of L. donovani t o screen complement f a c t o r s 
may be the pr imary reason f o r i t s a b i l i t y t o escape from the 
s i t e of i n o c u l a t i o n and cause d i sc r im ina ted d isease (Hoover 
e t al., 1984). Pearson and S t e i g b i g e l (1980) showed t h a t 
p romas t igo tes are k i l l e d by a c t i v a t i o n o f t h e c l a s s i c a l 
pathway. In con t ras t Chang (1981b) reported t h a t L. donovani 
promast igotes a c t i v a t e the a l t e r n a t e pathway. 
In vitro experiments showed t h a t amast igotes enter 
macrophages w i thou t being opsonized by a n t i b o d i e s . Wi th in the 
host macrophages amast igotes are protected f rom an t i bod ies as 
a lso from other c i r c u l a t i n g substances t h a t might be harmful 
t o the pa ras i te (Report of WHO expert committee, 1984). 
Na tu ra l IgM a n t i b o d i e s i n the se ra o f a r o d e n t and 
l agomorph h o s t s a g g l u t i n a t e and l y s e l e i s h m a n i a l 
p r o m a s t i g o t e s , but not amas t i go tes (Schmunis and Herman 
1970). In na ture , t h i s would tend to dest roy most of the 
p a r a s i t e s i n o c u l a t e d by s a n d f l y b i t e . Such e x t e n s i v e 
d e s t r u c t i o n has been o b s e r v e d w i t h h o u r s o f s y r i n g e 
i n o c u l a t i o n in hamsters rec iev ing L. tropica promast igotes 
(Zuckerman 1953). A n t i l e i s h m a n i a l a n t i b o d y f r e q u e n t l y 
p r o d u c e d i s o f t e n c r o s s r e a c t i v e w i t h t r y p a n o s o m a , 
p a r t i c u l a r l y w i th T. Cruzi, and i s non -p ro tec t i ve by passive 
t r a n s f e r (Neal et a l . , 1969; Stauber 1970; Heyneman 1971). 
I n n e o p l a s i a , an t i body may p o s s i b l y mask a n t i g e n i c 
determinants , thus b lock ing the induc t ion of a c e l l - m e d i a t e d 
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response and leading to enhancement of i n f e c t i o n ( C l i n t o n e t 
a l . , 1969; T u r k and B r y c e s o n 1 9 7 1 ) . A f t e r c u r e , t h e 
product ion of an t i l e i shman ia l ant ibody i s i n t e r p r e t e d as a 
s igna l of the con t inu ing presence of pa ras i t es or p a r a s i t i c 
amast igo tes i n the h o s t . S ince a n t i b o d y t i t r e s are no t 
a l t oge the r n i l on cure ; e r a d i c a t i o n of le ishman ia l disease 
from a given region by chemotherapy or o ther means can be 
monitored ( B i t t e n c o u r t e t a l . , 1968; Ambroise 1970). When 
ant ibody t i t e r s remain e levated despi te apparent c l i n i c a l 
recovery, con t i nu ing occu l t i n f e c t i o n ra the r than rad i ca l 
cure i s suspected (Walton 1970). 
1.12 Pathology o f V i sce ra l Lesihmaniasis 
K a l a - a z a r i s d e f i n e d as r e t i c u l o e n d o t h e l i a l o s i s 
r e s u l t i n g from the invas ion of the r e t i c u l o e n d o t h e l i a l system 
by L. donovani. F o l l o w i n g i n o c u l a t i o n by t h e s a n d f l y 
promast igotes enter r e t i c u l o e n d o t h e l i a l c e l l s and m u l t i p l y . 
At the s i t e of i n o c u l a t i o n a granuloma develops, c o n s i s t i n g 
o f h i s t i o c y t e s f i l l e d w i t h a m a s t i g o t e s and s u r r o u n d e d 
i n i t i a l l y by e p i t h e l i o i d c e l l s and l a t e r by g i a n t c e l l s as 
w e l l . Paras i tes spread t o loca l lymphnodes and homatogenously 
enter macrophages and then t o the l i v e r , spleen and bone 
marrow. They s t i m u l a t e a g ranu lomatous c e l l u l a r immune 
response t h a t r e s u l t s in s u b c l i n i c a l disease and spontaneous 
r e s o l u t i o n or when they m u l t i p l y f u r t h e r t h e y cause t h e 
c l i n i c a l synd rom o f k a l a - a z a r ( R e p o r t o f WHO E x p o r t 
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Committee, 1990). Once in the host tissue, the parasite is 
taken up by phagocytic cells and disseminates throughout the 
reticuloendothelial systems. It then resides and multiplies 
in macrophages as an obligate intracellular amastigote. Over 
a period of weeks to months, the host develops progressive 
hepatomagaly, splenomegaly and cachexia, and often dies from 
bacterial superinfection. 
Massive splenomegaly is common (1000 to 3000 g) and 
hypersplenism is believed to be a major cause of anaemia, 
neutropenia and the thrombocytopenia of kala-azar. Spleen is 
the most affected organ. It is grossly enlarged and the 
capsule is frequently thickened due to perisplenitis. It is 
soft and friable and cuts easily without resistance due to 
absence of fibrosis. The cut section is real or chocolate in 
colour due to the dilated and engorged vascular spaces. The 
trabeculae are thin and atrophic. Microscopically, the 
reticular cells are thin and increased in numbers and are 
loaded with LD bodies (Aikat et al. , 1979; Chulay et al. , 
1985). 
The pathological changes which occur in the liver in 
kala-azar are that the kupffer cells are affected and become 
enlarged and parasitized. The reticulo endothelial tissue 
invades the lobules and separates the hepatic parenchymal 
cells. In the central zone, the capillaries are dilated and 
the parenchymal cells are compressed and may be atrophied. 
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There i s u s u a l l y some f a t t y change i n the parenchymal c e l l s . 
At a l a t e r stage the r e t i c u l o - e n d o t h e l i a l t i s sue i s p a r t l y 
rep laced by f i b r o u s t i s s u e , p r o d u c i n g l o b u l a r c i r r h o s i s 
(Napier, 1951). These i n fec ted kup f f e r c e l l s have deformed 
mitochondr ia d i s rup ted endoplasmic re t i cu l um and l o c a l i z e d 
rupture of c e l l membrane. The hepatocytes i n the v i c i n i t y of 
damaged kup f f e r c e l l s a lso show degenerat ive changes w i t h i n 
e l e c t r o n dense m i t o c h o n d r i a . The c u t s u r f a c e may show a 
nutmeg appearance (Pampiglione e t a l . 1974). 
U s u a l l y , two t y p e s o f l e s i o n s a re o b s e r v e d 
m i c r o s c o p i c a l l y i n the l i v e r : a g ranu loma tous r e a c t i o n 
cons is t i ng o f h i s tocy tes and lymphogranulocyt ic c e l l s w i t h 
some e o s i n o p h i l s . The other type o f l es ion shows extens ive 
areas of haemorragic necros is , represent ing disappearance of 
hepa tocy tes , e r y t h r o c y t i c c o n g e s t i o n , e x t r a v a s a t i o n and 
r e t i c u l a r c o l l a p s e (Pampiglione e t a l . , 1974). 
The bone marrow i s heav i l y i n f i l t r a t e d w i t h p a r a s i t i z e d 
macrophages w h i c h may c r o w d o u t h a e m o p o i e t i c t i s s u e s . 
P e r i p h e r a l l ymph nodes and l y m p h o i d t i s s u e s o f t h e 
n a s o p h a r y n x and i n t e s t i n e a r e h y p e r t r o p h i c due t o 
i n f i l t r a t i o n w i t h the p a r a s i t i s e d c e l l s , though t h i s i s not 
f r e q u e n t l y seen i n I n d i a n cases ( R e p o r t o f WHO E x p e r t 
Committee, 1990), 
Anaemia occurs as a r e s u l t of i n f i l t r a t i o n of the bone-
marrow as w e l l as by t h e i n c r e a s e d d e s t r u c t i o n o f 
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erythrocytes due to hypersplenism. Auto antibodies to the red 
cells may contribute to haemolysis. Leucopenia with marked 
cells may contribute to haemolysis, leucopenia with marked 
neutropenia, and thrombcytopenia are frequently seen. 
Polyclonal hypergamma globuinaemia is a common finding (Aksoy 
et al., 1970; Bray and Wilson, 1972). Other changes include 
mucosal haemorrages due to thrombocytopenia and prothrombin 
depletion, intestinal ulceration, myocardial damage, 
amylodosis and cloudy swelling of the liver (Pampiglione et 
al., 1974). 
Experimental leishmaniasis in golden hamsters results 
in splenomegaly and hepatomegaly. Anaemia and leukopenia with 
marginal lymphocytosis, and having no increase in monocytes, 
are also some of the other features (Jalees et al. , 1981). 
Hamsters inoculated intraperitoneally with L. donovani show 
progressive testicular atrophy. Spermatogenic cells of the 
seminiferous tubules show vacuolar degeneration with a 
decrease in the number of sperm cells leading to a total 
azoospermia. Lymphoplasmacytic infiltrates with macrophages 
containing leishmania parasites in the inter lubular spaces 
were observed. Testicular amyloidosis is thought to be a 
pathogenic mechanism related to a dysfunction of the plasma 
cells. The stimulation of the RES is attributed to the 
antigenic character of parasites (Gonzalez et al., 1983). 
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1.13 Immunological Adjuvant 
Adjuvants are defined as substances that are 
incorporated into or infected simultaneous!/ or concomitantly 
with an antigen. These substances could stimulate cell 
mediated (delayed -type hypersensitivity) or.allergic 
responses and auto immune reactions against homologous or 
heterologous tissue antigens (WHO Tech. Rep. Series 595, 
1976; Elderman 1980). 
A good immunomodulating adjuvant must conform to the 
following attributes. 
1. It should not induce hypersensitivity reactions to 
the host's own tissues or to itself. 
2. It must not contain cross-reactive antigens with human 
tissues. 
3. It should not be carcinogenic, teratogenic or 
abortogenic. 
4. It should not be contaminated with substances that 
might stimulate other immunological events not involved 
in the specific response. 
5. It must be biodegradable in human body. 
6. It must never produce harmful nodules or abscesses if 
administered intramuscularly (im) or subcutaneously. 
7. It should not be unstable in the manufactured vaccine 
for at least a period of two years. 
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So far various adjuvants have been used in combination 
with leishmania antigen for immunization purposes. Adjuvants 
which were found in useful immunotherapy, or which have been 
major subjects of experimental investigations have been 
elucidated and discussed here. 
1.13.1 Freund's Adjuvant 
Freund's et al . , (1948) was the f i r s t to demonstrate 
the importance of using Freund's complete adjuvant (FCA) in 
combination with paras i t ic antigen material fo r achieving 
p ro tec t i ve immunity. Subsequent v a c c i n a t i o n i n a v i a n , 
roden t and s im ian m a l a r i a f u r t h e r con f i rmed the above 
f ind ings (Cohen et a l . , 1985, Maheswari et a l . , 1989). 
Freunds complete a d j u v a n t c o n s i s t s o f dead 
mycobacter iurn suspended i n m ine ra l o i l w i t h an added 
emuls i f ie r . I t induces a powerful cell-mediated response, 
humoral immunity, breaks tolerance and potent iates tumor 
r e j e c t i o n . Freunds incomplete ad juvant ( i e o i l emulsion 
adjuvant) i s used in veter inary vaccines but because of i t s 
tendency to cause s t e r i l e abscesses at the s i t e of i n jec t ion 
i t has been abandoned fo r human use. In m a l a r i a , many 
invest igators used FIA in t h e i r vaccination studies (Freunds 
et a l . , 1948, Target t and F u l t o n , 1965, S i d d i q u i 1977; 
Per r in et al . , 1984; S i d d i q u i , 1987 and Ho lder , 1988). 
Although the FCA is a very e f fec t i ve adjuvant but because of 
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i t s t o x i c s ide e f f e c t s i t i s t o t a l l y unacceptable f o r human 
use. 
1.13.2 Aluminium Sa l t s 
Recent ly , alum hydrox ide, the on ly adjuvant approved 
f o r human use, i s employed p a r t i c u l a r l y t o r a i s e t h e 
immunogenecity of toxo ids in the development of a n t i b i o t i c 
a n t i s e r a . The f i r s t a p p l i c a t i o n of alum as an adjuvant was 
repor ted by Gleny e t a l . , (1926), who used d i p h t h e r i a toxo ids 
p r e c i p i t a t e d w i t h potassium alum KAI (50^)2 . 12H2O) f i l t e r e d 
and emu l s i f i ed w i th water i n exper imental vacc ina t i on of 
guinea p i gs . 
J a r e c k i - Black i n 1988 demons t ra ted t h a t immuno-
p r o p h y l a x i s i s f e a s i b l e u s i n g a c o m b i n a t i o n o f k i l l e d 
p romas t igo tes and aluminium h y d r o x i d e i n a subcu taneous 
immunizat ion. I t can success fu l l y induce res is tance aga ins t 
L. donovani i n f e c t i o n . The mechanism r e s p o n s i b l e f o r t h e 
success of aluminium hydroxide as an adjuvant s t i l l remains 
to be i d e n t i f i e d . I t i s known t h a t c e l l u l a r responses t o the 
i n f e c t i o n o f a n t i g e n a l u m i n i u m g e l i n c l u d e g r a n u l o m a 
f o r m a t i o n and t h e i n f l u x o f e f f e c t o r c e l l s such as 
macrophages and plasma c e l l s . 
1.13.3 B a c i l l u s Calmette Guerin (BCG) 
BCG as a potent immunostimulant i s p resen t l y the most 
commonly used non s p e c i f i c s t i m u l a t i n g substance i n human 
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t h e r a p y . I t enhances t h e p r o d u c t i o n o f a n t i b o d i e s and 
increases the number of the spleen ant ibody producing c e l l s . 
I t a l s o i n c r e a s e s d e l a y e d t y p e h y p e r s e n s i t i v i t y f o r 
p a r t i c u l a t e and so lub le ant igen (Pinhata e t a l . , 1993). I t 
acce lera tes the r e j e c t i o n of sk in a l l o g r a f t and t ransp lan ted 
tumors i n mice and i n h i b i t s carc inogenes is . I t a lso tends to 
m o d i f y t h e a c t i o n o f c h e m o t h e r a p e u t i c , such as 
cyclophosphamide (Mackaness, 1970). In respect t o t o x i c i t y , 
the BCG may ac t s y n e r g i s t i c a l 1 y o r a n t a g o n e s t i c a l 1 y w i t h 
c e r t a i n chemotherapeutic drugs ( M i l s t e i n and Gibson, 1990). 
1.13.4 Muramyl Di Peptide (MDP) 
Another ad juvan t , muramyl d i pept ide has been known 
f o r more than a decade to be a minimal s t r u c t u r e capable of 
rep lac ing mycobacter ia i n Freund's complete adjuvant (E l l ouz 
e t a l . , 1974). The compound has been shown t o enhance 
an t ibody response t o a v a r i e t y o f n a t u r a l o r s y n t h e t i c 
an t i gens even when a d m i n i s t e r e d o n l y i n s a l i n e (Ched id e t 
a l . , 1 9 7 6 ) . When i n c o r p o r a t e d i n t o l i p o s o m e s MDP i s 
e f f e c t i v e i n i n c r e a s i n g c e l l u l a r immun i ty (Masek e t a l . , 
1978). Severa l i n v e s t i g a t o r s examined t h e r e l a t i o n s h i p 
between chemical s t r u c t u r e and a d j u v a n t i c i t y (Chedid e t a l . , 
1976; Azuma e t a l . , 1976). 
1.13.5 Trehalose Di Mycolate (TDM) 
The f i r s t w e l l de f i n ed immunoact ive m y c o b a c t e r i a l 
g l y c o l i p i d was i d e n t i f i e d as a cord f a c t o r - a mix ture of 6-
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6-di es ters of -D t reha lose w i th na tu ra l mycol ic ac ids , 
which i s p u r i f i e d from mycobacteria and o the r microorganisms 
i s known t o have adjuvant a c t i v i t y . I t has a n t i i n f e c t i o u s , 
a n t i p a r a s i t i c and a n t i tumor ( L e d e r e r 1982) a c t i v i t y . 
I n t r a - p e r i t o n e a l i n j e c t i o n of TDM in o i l emulsion was able to 
p ro tec t aga ins t an i n t r a p e r i t o n e a l cha l lenge by Salmonella 
typhi and Salmonella typhimurium. (Yarkoni & Back ierkunst , 
1976). O i l emulsion of TDM is also ac t i ve aga ins t tumors (Old 
et a l . , 1980, Sakuvai e t a l . , 1989). 
TDM emulsion in the presence of o i l i s t o x i c , s ince the 
t o x i c i t y l a r g e l y depends on t he p e r c e n t a g e o f o i l used 
Aqueous emulsions are very s t a b l e , they are a c t i v e in mice 
aga ins t Klebsiella pneumoniae and Listeria monocytogenes 
(Parant e t a l . , 1977) and can p r o t e c t mice aga ins t Babesia 
microti ( C l a r k , 1979) , Schistosoma mansoni (O lds e t a l . , 
1980), Taxoplasma gondii (Masihi e t a l . , 1979) and Trypansoma 
cruzi (Leon e t . a l . , 1983). P ro tec t i on s tud ies w i t h TDM were 
also c a r r i e d out by Kumar and Ahmad (1984) and Lederer (1986, 
1988) i n t he mouse model i n f e c t e d w i t h P. bergei. They 
observed good p r o t e c t i o n in mice. 
In vitro experiments w i th mouse macrophages pre t r e a t e d 
w i t h an aqueous s u s p e n s i o n o f TDM showed enhanced 
phagocytosis of l i v e r g lu tara ldehyde - k i l l e d Trypanosoma 
cruzi and l a t e x p a r t i c u l a t e s i n d i c a t i n g t h a t TDM molecules 
m o d u l a t e macrophage f u n c t i o n s by a u g m e n t i n g b o t h 
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i n t e r n a l i z a t i o n and i n t r a c e l l u l a r d e s t r u c t i o n (Kierszenbaun 
e t a l . , 1984). 
1.14 Biochemical changes 
1.14.1 In L i ve r 
Ever s ince the d iscovery of L. donovani i n the v iscera 
of humans by Leishman & Donovan in 1903, ex tens i ve research 
on v a r i o u s aspec ts o f the p a r a s i t e i n c l u d i n g m e t a b o l i c 
p r o c e s s e s , membrane s t r u c t u r e and f u n c t i o n , e n z y m a t i c 
machinery and t h e i r chemotherapy and immune system of host 
have been c a r r i e d o u t . But even t i l l d a t e c o m p a r a t i v e l y 
l i t t l e i s known about the sequent ia l changes t h a t occur in 
the var ious biochemical markers such as macromolecules and 
enzymes o f t h e h o s t d u r i n g t h e c o u r s e o f L. donovani 
i n f e c t i o n . I n o t h e r p r o t o z o a l i n f e c t i o n s such as 
t rypansomiasis and ma la r i a , however, ex tens i ve researches 
have been made on metabo l ic processes and enzymatic machinery 
of the host . 
I n k a l a - a z a r the l i v e r i s e n l a r g e d and c o n s i d e r a b l e 
biochemical and p a t h o l o g i c a l changes in the organ take place 
(Napier 1951). Paras i tes mostly der ive t h e i r n u t r i t i o n from 
the host mate r ia l and l i b e r a t e metabol ic end products in the 
host system. Upto a c e r t a i n l i m i t no d e l e t e r i o u s e f f e c t s 
man i fes t i n the h o s t , though host- immune sys tem does get 
s t i m u l a t e d , when the balance breaks down. I l l e f f e c t s of 
pa ras i t i sm are observed i n the form of p a t h o l o g i c a l les ions 
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and nutritional deficiencies. Significant changes in 
biochemical parameters occur comprising of different enzymes 
and chemical constituents of liver. 
Common histological feature of the liver tissue in 
leishmaniasis is that of the so called "fatty degeneration" 
in addition to centrilobular necrosis. Mercado and Von Brand 
(1958), who biochemically examined this aspect and observed a 
total increase in the hepatic lipid in animals infected 
with malaria. A similiar observation was made by Riley and 
Maegraith (1962), who biochemically examined this aspect and 
found a total increase in the liver fats from 10-25% over 
control value. The finding by gas chromatography of the fatty 
acid contents of these lipids supported the above 
observation, besides showing a significant increase in 
unsaturated fatty acids, such as oleic acid and linoleic 
acids along with corresponding dicrease in the saturated 
palmitic and steric acids. 
In electron microscopy, simple lipid deposition in the 
form of droplets in close proximity to the damaged 
mitochondria was a common finding in liver from infected 
animals (Fletcher, 1964). 
Gutierrez et al. , (1976) have demonstrated increase in 
lipid contents of liver in Actus monkeys infected with P. 
falciparum Maegraith (1966) has also observed significant 
increase in lipid contents of liver of rhesus monkeys 
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infected with T. knowlesi. Mercado and Von Brand (1958) and 
Angus (1971) on histochemical examination reported the 
presence of lipid in the liver of mice and monkeys infected 
with P. knowlesi and P. berghei respectively. Further, 
Fletcher (1987), Rajvir et al. (1981) Saxena et al. , (1981) 
and Gupta (1988) have also found raised levels of total lipid 
contents. 
A close co-relationship between the cellular injury, 
peroxidation of membrane lipids and oxidative damage to 
cells have been reported by Sharma & Krishnamurty (1976). In 
consonance with observations on animals under the effect of 
toxic chemicals or pathological conditions, liver homogenates 
of golden hamsters infected with L. donovani produce higher 
amount of lipid peroxides and this increase is directly 
proportional to the number of amastigotes in the liver of 
golden hamsters. 
Saxena et al., (1981) have shown that liver and spleen 
produce higher amounts of lipid peroxidation due to an 
increased susceptibility of these tissues to oxidative 
damage under the stress of the infection. In Vivo experiments 
have shown that L. donovani cells are killed by oxidative 
radicals. One mechanism of survival of the parasite in the 
host phagocytic cells may be the alternation in production 
of the toxic metabolites by leishmanial phosphatase activity. 
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Hypoglycaemia in malaria infections has also been 
described (Maegraith 1948). Srivastava et al . , (1984) have 
reported that during acute P. knowlesi infection in rhesus 
monkeys, glycogen was depleted for a considerable extent. 
This depletion was mainly due to excessive breakdown of 
glycogen by phosphorylase. 
In the ecology of hypoglycaemia, the possibility of 
monokines acting as a significant mediators cannot, however, 
be ruled out (Clark et al. , 1981). Clark and his co-workers 
have produced experimental evidence which according to them 
indicates a central role for these monokines with regards to 
protein metabolism. Significant decrease was reported in the 
protein contents which mainly causes hypoproteinamiea. 
Von Brand (1973) has noted decreased protein synthesis during 
malaria. In our studies, we have also found a decrease in 
liver protein. This might be due to decrease in synthesis of 
nucleic acids. 
1.14.2 Serum Analysis 
It is well documented that leishmania infection impairs 
liver function. The liver damage caused by invading parasites 
during leishmaniasis can be detected by means of several 
immunological and serological tests. Sadun et al.,(1965, 
1966) have observed a significant increase in transaminase 
(viz. SGPT, & SGOT) levels in serum, which is indicative of 
abnormal liver function. Lai & Hussain (1978) have reported 
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a s i g n i f i c a n t decrease i n the GPT and and GOT a c t i v i t y i n 
the l i v e r of mice i n f e c t e d w i th P. berghei. 
1.15 Current Treatment o f Leishmaniasis (An t i le ishman ia l drugs) 
Response t o t rea tment va r ies cons iderab ly f rom one form 
of the d isease t o ano the r and among d i f f e r e n t geog raph i c 
areas when the same d isease i s i n v o l v e d . For examp le , i n 
I n d i a , China and B r a z i l , ka la-azar responds r e l a t i v e l y wel l 
t o one course o f ant imony t r e a t m e n t w h i l e i n Sudan i t i s 
no to r i ous l y r e s i s t a n t . East A f r i can and Medi terranean ka la -
azar may r e q u i r e t h r e e courses of t h e u s u a l d rugs or 
r e t r e a t m e n t w i t h s e c o n d a r y a g e n t s . T h r e e c o u r s e s o f 
ant imonia ls are o f t e n necessary in South American muscosal 
l e i s h m a n i a s i s . The i n i t i a l cu re r a t e i s a b o u t SOX. The 
d e c i s i o n r e g a r d i n g t r e a t m e n t o f cu taneous l e i s h m a n i a s i s 
depends upon the area of the world and the l o c a t i o n of the 
l e s i o n . 
In the Eastern Hemisphere, Mexico and po r t i ons of 
Centra l America, where spontaneous r e s o l u t i o n i s the r u l e and 
t h e u l c e r i s n o t i n s i g h t t h a t w o u l d p r o d u c e a 
d i s f i g u r i n g l e s i o n when heal ing occurs, t rea tment may not be 
necessary. In o the r areas, such as most o f South America, 
where t h e r e i s a h i g h i n c i d e n c e o f mucous membrane 
involvement, t rea tment w i t h ant imonia ls i s recommended by 
many au thors ' ( O l l i a r o and Bryceson, 1993). 
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In the New World, the identification of the parasite 
is important in determining the need for treatment, 
1.15.1 The Antimonials 
[A] Tartar Emetic (Antimony Potassium Tartrate) 
This was the first effective antileishmanial drug to be 
given clinical trial, when Caspar Viannia successfully used 
it against mucocutaneous leishmaniasis in Brazil in 1912. 
Inspite of the toxicity of this chemical, it must have been 
heralded as a "miracle drug" by the inhabitants of India, 
where its subsequent use against kala-azar reduced the 
mortality rate by about 95^. Tartar emetic has also been 
extensively used against Mediterranean Kala-azar (L. 
infantum) and oriental sore (L. tropica). 
[B] Stibophen (Sodium Antimony III) Bis Catechol-3,5-
disulfonate) 
The considerable side effects, of tartar emetic soon 
prompted the investigation of a variety of other antimonials, 
but all other trivalent agents proved to be only slightly 
less toxic. Stibophen (Fouadin,, Reprodral) is perhaps the 
best known of these and was widely used until the advent of 
the pentavalent drugs. It appears to be much more effective 
against cutaneous leishmaniasis than against kala azar. 
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[C] Pentostam,Bayer 561, So lus t ibosan (Sodium antimony (V) 
Guconate) 
The only an t i l e i shman ia l chemotherapeutic agent w i t h a 
c l e a r l y favourab le the rapeu t i c index is pentava lent antimony 
(Sb) comp lexed t o c a r b o h y d r a t e i n t h e f o r m o f sod ium 
s t i b o g l u c o n a t e ( P e n t o s t a m ) o r meg lumine a n t i m o n a t e 
( G l u c a n t i m e ) . Pentastam i s manu fac tu red by t h e Wellcome 
F o u n d a t i o n i n t h e U n i t e d Kingdom and G l u c a n t i m e i s 
manufac tured by Rhone-poulence i n France and i s used i n 
French and Spanish-speaking c o u n t r i e s . 
Pen tava len t a n t i m o n i a l s can be t o l e r a t e d a t much 
h igher dose l eve l s than the t r i v a l e n t onces, and they are 
excre ted more s l ow ly . The d iscovery was a major step forward 
i n the chemotherapy of l e i shman ias i s , and the pentava lent 
an t imon ia l s remain the drugs of choice f o r many i n present 
day t r e a t m e n t o f b o t h c u t a n e o u s and v i s c e r a l d i s e a s e 
(Johnson, 1990). 
The s t r u c t u r e s of the c l i n i c a l a n t i l e i s h m a n i a l agents 
are shown i n ( F i g u r e 1 ) . A commonly drawn s t r u c t u r e of 
Pentostam shows two molecules of gluconate complexed v i a 
oxygens t o two molecu les o f Sb, w i t h t h r e e sod ium atoms 
b a l a n c i n g the t h r e e n e g a t i v e charges on t h e r e s t o f t he 
m o l e c u l e ( R o l l o , 1 9 6 5 ) . The m o l e c u l a r w e i g h t f o r t h i s 
s t r u c t u r e i s 746, and the osmo la r i t y of a s o l u t i o n of 100 mg 
o f Sb/ml would be 1,644 mol . 
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Pentavalent antimonials such as urea stibamine 
stibosan and neostibosan became available in the 1920 (Shortt 
1945). Pentostam was first manufactured and used between 
1935 and 1945, (Kerk R. & Sti N.H.). There has been no 
valid comparison of efficacy between the preparation of 
(Pentostam and glucantime) and both are given by slow 
intravenous infusion or by intramuscular injection during a 
ten day course, Pentostam is given in a daily dose of 6 ml 
(0.6 gm of antimony). Glucantime is supplied as a 3035. 
solution and given as 10 or 20 ml per day to a total dose of 
200-250 ml. Indian visceral leishmaniasis usually responds 
to one course of therapy whereas the disease seen in Africa 
often requires three courses (one month). 
Antimonials have toxic effects although less toxic than 
the trivalent compound. Vomiting may follow an intravenous 
infusion. Chulay et al., (1985) described in detail the 
cardiotoxicity in Kenyan kala-azar treated with pentostam. 
There may be abdominal pain and hypotension, as well as 
hepatic dysfunction. Renal insuffiency is not uncommon. 
[D] Glucantime 
A n o t h e r w e l l t o l e r a t e d p e n t a v a l e n t a n t i m o n i a l , 
Glucantime has been found to be e f f e c t i v e aga ins t most forms 
of l e i s h m a n i a s i s . I t can be g i v e n i n t r a v e n o u s l y b u t t he 
i n t r a m u s c u l a r r o u t e i s recommended. Compounded w i t h 
Pentostam, i t has the disadvantage of r e q u i r i n g much l a r g e r 
49 
amounts of inoculation. It is produced in ampules of 5 ml 
aqueous solution, each containing 1.5 gm of meglucantime 
antimonials. Half the initial dose is given as a sensitivity 
test followed by a big dosage from 5 to 10 ml for 10-20 days. 
Glucantime has been successfully used against canine kala-
azar in France and Brazilian (Barrios et al., 1986). 
[E] Neostibosan (Ethyl Stibamine) 
The stibanitic and derivative is comparitively non 
toxic and is useful in the treatment of kala-azar. Its 
drawback is that, it is not very stable in solution and 
should be freshly prepared for each adrai ni stration. It 
contains upto A2% antimony and can be given in 25^ solution 
intravenously, usually on alternate days. F-or the adults, the 
initial dose is 0.1 gm, followed by 0.2 gm and 0.3 gm. A 
total of 2.7 gm is recommended in ten injections. 
The drug has been extensively used in treating 
infantile kala-azar. In children under 1 year the total dose 
is 0.1 to 0.15 gm in a course of sixteen intravenous 
injections. 0.2 - 0.25 gm for children under two years, and 
0.3 gm in older children. 
[F] Urea Stibamine (Carbostibamine, Carbantine, Stiburea) 
Early trials with this pentavalent antimonials gave 
exceptionally good results against Indian kala-azar. 
Unfortunately, batches seen to vary considerably in the mode 
of preparations, antimony content, toxicity and efficacy, as 
50 
an antileishmanial agent. This drug is often used in 
combination with Neostibosan. The drug is administered 
intravenously an aqeous solution. The total amount 
recommended is 3 grains given in doses of 100 to 200 mg on 
alternate days over a period of 4 weeks. 
1.15.2 The Aromatic Diamindenes 
If the treatment with antimony is unsuccessful the 
aromatic diamines may be used (Rees et al . , 1985, Sand et 
al . , 1985). They are very effective for the treatment of 
kala-azar but because of their many and frequent side 
effects they are considered drugs of second choice. 
[A] Stibamidiene Isothionate 
This compound was found to be one of the most efficient 
agents known against kala-azar, even against those obstinate 
cases of the Sudanese disease that resisted antimonial 
treatment. However, this drug has a very serious side effect. 
It was found that in Medeterranean region, the kala-azar 
cases treated with this drug developed a serious trigeminal 
neuropathy and these neuropathological signs have been noted 
for as long as twenty years after the treatment. 
Now a days stibamidine is used mostly as a last resort 
in antimony resistant visceral leishmaniasis. It is given 
daily by the slow intravenous injections of a 10% aqeous 
solution. The initial dose for an adult is 0.025 gm and the 
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dose is increased very slowly to reach a total of 2.0 gram 
per kilogram body weight over a period of ten days. 
[B] Pentamidine Isothionate 
Among the aromatic diami dine pentomidine isothionate 
has been extensively used against Sudanese kala-azar. It is 
given intramuscularly at a dose of 4 mg/kg diluted in water 
on successive or alternate days. Side effects include 
hypotension, nausea and vomiting. It is nevertheless linked 
with possible subsequent polyneuritis and the development of 
diabetes. Hypoglycaemia has been reported and may be severe 
as to cause death. Reversible renal insufficient occurs as 
well (Bryceson et al., 1985). 
1.15.3 Other Antileishmanial Drugs 
[A] Berberine Chloride 
This is a derivative of the plant alkaloid berberine 
and has had some success when used to infiltrate lesion due 
to L. tropica (oriental sore). It is very effective against 
post kala-azar dermal leishmaniasis. 
[B] Cycloguanil Pamoate (Cycloguanil Embonate) 
Camolar is a "Single shot" intramuscularly administered 
drug with a repository action. Its efficacy against 
leishmaniasis was observer by chance in initial trials on 
malaria prophylaxis in the Americans. Interestingly although, 
good results have been obtained against American cutaneous 
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leishmaniasis. The drug seems uneffective against oriental 
sore due to L. aethiopica in Ethiopia. 
1.15.4 Antibiotics 
1) Amphotericin B (Fungizone) 
This antibiotic is derived from the soil fungus 
Streptomyces nodosus, first discovered in Venezuela and it 
is a potent antileishmanial agent (Sampaio et al.,(1970). 
However, its use is largely restricted to the treatment of 
advanced cases of mucocutaneous leishmaniasis that have not 
responded to the more conventional drugs, since it is highly 
toxic and very expensive (Thakur et al., 1993). 
A test dose (1 mg) of the drug should be used to 
determine patient response to this polyene. If there is no 
reaction then the drug may be started at 0.1 mg/kg of the 
body weight per day and enclosed by 0.1 mg/kg per day to a 
daily doe of 0.3 - 0 .7 mg/kg dose of 1-1.5 gm. The immediate 
side effects are nausea, vomiting, chills, and fever 
associated with infusion of the drug. Later anemia may occur 
along with progressive renal insufficiency. The renal 
insufficiency usually disappears upon discontinuation of the 
drug but can be a serious problem during treatment. 
[B] Monomycin 
Russian workers (Arustcumyan 19 67; Akovyan and 
Mukhamedov, 1968) have reported on the efficacy of this 
antibiotic after insection into skin lesions due to L. major. 
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but there seems to have been no work on this substance for 
other forms of leishmaniasis. 
[C] Rifampicin 
This antibiotic has recently been used to treat 
cutaneous leishmaniasis due to L. tropica in Kuwait. Results 
have not been clear cut and the drug is at present very 
expensive. 
1.15.5 Other Potential Agents for Visceral Leishmaniasis 
There are several approaches which are still in the 
pre- clinical evaluation. It may be quite appropriate because 
only these modalities are reasonably likely to supplant Sb as 
primary ttierapy for kala-azar. WR 6026 is the primaquine 
analogue with high activity against visceral disease in some 
animal models. WR 6026 would be the first effective orally 
administrable agent for kala-azar. 
Liposomes are artificial lipid particles that are 
predominantly phagocytized by macrophages of the visceral 
reticuloendothelial system. The administration of drug 
containing liposomes delivers large quantities of drug to the 
macrophage in which amastigotes reside. Infact, a disease du 
to an obligate intra macrophage microorgranism such as 
leishmaniasis would seem to be ideally suited for liposomial 
theraphy. At least several formulations of liposomes contain 
antimony (Berman, 1985) and one containing amphotericin B 
(Berman et al., 1986) is being considered for human trials. 
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The e x c i t i n g p o t e n t i a l of the l iposomal approach has to 
be tempered by t h e r e a l i t y o f d e v e l o p i n g an agent t h a t 
r e q u i r e s new t e c h n o l o g y t h a t meets US Food & Drug 
A d m i n i s t r a t i o n r e q u i r e m e n t s and t h a t w i l l be m a r k e t e d 
p r i m a r i l y i n the developing wor ld . 
1.15.6 New Ora l Agents 
There are pub l ished repor ts on the use of a l l o p u r i n o l 
i n v i s c e r a l d i s e a s e and o f k e t o c o n n a z o l e i n c u t a n e o u s 
disease. In I nd i an ka la-azar a l l o p u r i n o l t rea tment f o r 14-31 
days (11-36 mg/kg per day) produced cures i n e i g h t out of 
s i x t e e n p a t i e n t s on t h e b a s i s o f n e g a t i v e bone marrow 
cu l tu res a f t e r t he rapy , but only th ree (19%) of the s ix teen 
cases cou ld be shown not t o r e l a p s e ( J h a , 1 9 8 3 ) . I n a 
d i f f e r e n t s tudy , f i v e pa t i en t s in whom Sb therapy had f a i l e d 
were cured w i t h a l l o p u r i n o l plus the same d a i l y dose of 
Pentostam t h a t had f a i l e d . 
One adverse reac t i on t o a l l o p u r i n o l i n these s tud ies 
has been rash . A major t h e o r e t i c a l concern about high dose 
a l l o p u r i n o l therapy i s metabolism of the drug v i a xanthine 
ox idase t o o x y p u r i n o l and g e n e r a t i o n o f o x y p u r i n o l r e n a l 
s t o n e s . The r i b o n u c l e o s i d e o f a l l o p u r i n o l has been 
administered a t a dosage of 1,5000 mg (25 mg/kg) w i thou t 
apparent t o x i c i t y (Research T r iang le Park, 1984).The upper 
l i m i t on dose may be based on cleavage of the r ibonuc leos ide 
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to allopurinol by gastrointestinal bacteria and on the 
toxicity of allopurinol and secondarily generated oxypurinol. 
The first reported clinical use of ketoconazole was 
Nicaraguan cutaneous leishmaniasis, and several studies have 
investigated this oral agent for American cutaneous disease. 
Treatment with 200 mg twice a day for 3 months resulted in 
cure of all of six Nicaraguan patients (Urcuyo, 1982). The 
data on the efficacy of ketocornazole for cutaneous 
leishmaniasis are encouraging in part. In the ongoing 
Panamanian study, this oral agent is as active as the 
positive control drug (Pentostam) and patients are being 
randomized between the two groups. 
Ketoconnazole does not seem to be very active against 
L. braziliansis disease in other regions of the New World. 
As in the case of allopurinal ribonucleoside, biochemical 
considerations suggest that keto conzale is likely to be 
active and the drug should be tested in randomized trials 
with positive and negative control on regions endemic for 
cutaneous leishmaniasis. 
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AIMS AND OBJECTIVES 
Leishmaniasis, the disease caused by the i n f e c t i o n of a 
i n t r a c e l l u l a r f l a g e l l a t e p ro tzoan , Leishmam'a donovani, i s 
a s s o c i a t e d w i t h a number o f s t r u c t u r a l , f u n c t i o n a l and 
pa tho log i ca l a l t e r a t i o n s in d i f f e r e n t organs of hos t , namely 
l i v e r , spleen and k idney. The phagocyt ic c e l l s of the l i v e r 
( k u p f f e r c e l l s ) a lso p lay an i m p o r t a n t r o l e i n t he h o s t 
defence, as wel l as in inf lammatory processes and immune 
mechanisms. 
In v i s c e r a l le ishman ias is the re i s a ser ious problem 
s ince bone marrow sp leen or l i v e r b i o p s i e s a re g e n e r a l l y 
requ i red t o conf i rm the i n f e c t i o n . Sero log ica l t e s t s g ive 
on ly a presumptive i n d i c a t i o n of the disease and are found 
p o s i t i v e on ly in an advanced s tage. The only drug a v a i l a b l e 
to t r e a t le ishmanias is are pentava lent antimony compounds 
which are t o x i c and need t o be repeatedly i n j e c t e d under 
c l o s e s u p e r v i s i o n f o r t h r e e weeks or more. Common s i d e 
e f f e c t s o f the drug i n c l u d e v o m i t i n g , nausea, m a l a i s e , 
h e a d a c h e , l e t h a r g y and e l e c t r o c a r d i o g r a p h i c c h a n g e s . 
C u r r e n t l y , the schedules f o r t h e t r e a t m e n t a re n o t a lways 
success fu l . 
P r e s e n t s t u d y was t h e r e f o r e d e s i g n e d t o f u r t h e r 
i n v e s t i g a t e , develop and t o p o s s i b l y sugges t some more 
e f f e c t i v e methods f o r the t rea tment of l e i shman ias i s . The 
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study made use of male golden hamsters as the animal model. 
These investigations were further aimed to study the 
combined effect of an immunomodulator with smaller doses of 
drug for the treatment of Leishmaniasis. To accomplish this 
haematological, biochemical and immunological studies were 
carried out in the normal, infected and treated animals. The 
animals were treated with drugs alone and in combination with 
TDM. 
The details of the proposed study plan as they were 
carried out are as follows 
1. Promastigote stage of L. donovani (NICD-CII strain) was 
cultured on BHMARB medium for antigen isolation 
purpose. 
2. BHMARB medium was used only for in vitro maintenance 
of parasite. 
3. Golden hamsters were used for in vivo maintenance of 
parasites. 
4. The whole antigen was prepared by ultra sonication of 
promastigote grown on BHMARB medium. 
5. The whole antigen was fractionated by using high speed 
contrifugation (105,000 x g for one hour) to separate 
the soluble antigen fraction. 
6. The whole antigen and other antigen fractions were 
characterized by estimating the protein, carbohydrate 
and DNA contents. 
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7. The antigenicity of whole antigen and its various 
fractions was tested and checked by means of IHA and 
agar diffusion techniques against Kala-azar patient 
sera. 
8. Golden hamsters were infected with /.. donovani and the 
patenting assessment of infection was checked through 
parasite count by Stauber's method. 
9. The haematological studies were carried out in the 
normal and infected hamsters. 
10. Biochemical analyses of various constituents in the 
liver included estimations for total lipid, total 
cholesterol, phospholipid, total DNA and total RNA 
contents. 
11. Serum enzyme estimations were done as follows 
1) Serum Glutamic Pyruvic Transaminase (SGPT) 
2) Serum Glutamic Oxalo Acetic Transaminase (SGOT) 
3) Acid Phosphatase and Alkaline Phosphatase 
12. The cell mediated immunity was demonstrated by the 
appearance of Delayed-Type Skin Hypersensitivity (DTH) 
reaction; Macrophages Migration Inhibition Test (MMIT) 
was also used for the determination of CMI. 
13. Following the infection, a study to establish a drug 
dose pattern was carried out through routine checks of 
parasite load in the liver and spleen. 
14. The infected animals were treated with drugs alone and 
in combination with TDM using smaller amounts of drug. 
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15. The intensity and the extent of tissue damage by 
Leishmania parasites was determined by establishing the 
number of parasites in the liver and spleen. Histoche-
mical and histopathological changes in the tissues were 
studied in the normal, infected and treated animals. 
16. After the treatment, the haematological, biochemical 
and humoral and cellular immune responses were assayed 
by employing several in vitro and in vivo test 
procedures. 
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2. MATERIALS 
2.1 Laboratory Culture 
Leishmania donovani pa ras i t es (NICD-CII s t r a i n ) were 
c u l t u r e d on b r a i n hear t i n f u s i o n agar w i t h i n a c t i v a t e d 
r a b b i t b l o o d (BHMARB). The above s t r a i n was i n i t i a l l y 
o b t a i n e d f rom the B iochemis t ry D i v i s i o n o f t he N a t i o n a l 
I n s t i t u t e of Communicable Disease (NICD), D e l h i , I n d i a . 
2.2 Media and Buf fe r 
Dehydrated Brain heart i n f u s i o n powder and Bacto-Agar 
from D i f co Labora to r ies ; D e t r o i t , Mich igan, USA were used f o r 
c u l t u r i n g t he p a r a s i t e s . The N u t r i e n t B r o t h , Sabou raud ' s 
Dextrose Agar and cooked meat medium were prepared according 
t o the manufac tu re rs i n s t r u c t i o n s and s t e r i l i z e d i n t h e 
l a b o r a t o r y . Hanks balanced s a l t s o l u t i o n (HBSS) and 0.1M 
phosphate b u f f e r sa l i ne (PBS) pH 7.2 were prepared i n the 
l abo ra to ry according to the p resc r ibed procedure. 
2.3 Animals 
H e a l t h y male g o l d e n h a m s t e r s ( C D R I - s t r a i n ) each 
we igh ing around 60-100 gms were purchased f rom t h e An imal 
House f a c i l i t y of the Central Drug Research I n s t i t u t e (CDRI), 
Lucknow, I n d i a . Hamsters were r o u t i n e l y used f o r in vivo 
maintenance of Leishmania p a r a s i t e s and f o r e x p e r i m e n t a l 
purposes. 
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2.4 Anticoagulants 
Sodium citrate and ethylene di amine tetra acetic acid 
(EDTA) were purchased from B.D.H. England. 
2.5 Preservatives and Antibiotics 
Sodium azide was obtained from Riedel, Germany, 
Penicillin, Streptomycin and Gentamycin were locally 
purchased. 
2.6 Immune adjuvant 
An aqueous suspension of tre-halose-dimycolate (TDM), 1 
mg/ml prepared from the myco-bacterium bovis strain AN5 was 
supplied by the kind courtesy of Late Prof. Edgar Lederer, 
Laboratories de Biochemie, Central National de la Racherche 
Scientifique, 9119 Gif-Sur-Yvette France. 
2.7 Conjugate and Substrate 
Anti hamster IgG, alkaline phosphatase and para -
nitrophenyl phosphate were purchased from Sigma, U.S.A. 
2.8 Drug 
Sodium stibogluconate (Pentostam) equilvalent to 0.3 
mg/ Sb mg~^ was obtained from the Welcome Foundation, U.K. 
2.9 Chemicals 
A n a l y t i c a l grade potass ium phospha te (monobas ic ) 
p o t a s s i u m c h l o r i d e ( d i b a s i c ) sod ium c h l o r i d e , c o p p e r 
s u l p h a t e , sodium potass ium t a r t a r a t e sod ium h y d r o x i d e , 
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sodium hydrogen phosphate , d i s o d i u m hydrogen phospha te , 
phosphoric ac id l i t h i u m su lphate , sodium t u n g s t a t e , sodium 
molybdate, ga lac tose , magnesium c h l o r i d e , sodium barb i tone , 
sod ium c i t r a t e , sod ium c a r b o n a t e , sod ium b i c a r b o n a t e , 
s o r b i t o l , f e r r i c c h l o r i d e , and magnesium c h l o r i d e were 
purchased from Sarabhai M chemical Company, I n d i a . Standard 
glycogen, DNA, RNA, bovine serum albumin were obtained from 
Sigma Chemical Company, U.S.A. Sudan b lack,methy l green 1 , 
py ron in , glucose oxide and peroxidase were purchased from 
Sigma Chemical Company, U.S.A. 
The r e a g e n t s p u r c h a s e d f r o m S. Merk ( I n d i a ) were 
methano l , e t h a n o l , g l y c e r o l d i s o d i u m - h y d r o g e n phosphate 
potassium dihydrogen phosphate. 
Hydroch lo r ic a c i d , su lphur i c a c i d , ch lo ro fo rm, a c e t i c 
a c i d ( g l a c i a l ) i s o p r o p a n o l , ammonium per s u l p h a t e , per 
c h l o r i c ac id acetaldehyde and formaldehyde were purchased 
through loca l s u p p l i e r s . 
A l l g lassware was s t e r i l i z e d b e f o r e use and doub le 
g lass d i s t i l l e d water (DDW) was r o u t i n e l y used f o r making the 
s o l u t i o n s . 
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3. METHODS 
3.1 In v i t r o C u l t i v a t i o n of Paras i te^ 
The p r o m a s t i g o t e s o f L. donovani ( N I C D : C I I s t r a i n ) 
were m a i n t a i n e d on b r a i n h e a r t i n f u s i o n a g a r w i t h r a b b i t 
b lood (BHMARB) medium a c c o r d i n g t o t h e method o f Ja lees et 
al. ( 1 9 8 2 ) . 
3 . 1 . 1 . P r e p a r a t i o n of BHMARB Medium 
[A] C o l l e c t i o n o f Rabbi t Blood 
Two ml o f 3.8% sodium c i t r a t e s o l u t i o n was taken i n 
each c leaned v i a l . The capped v i a l s were a u t o c l a v e d a t 121°C 
f o r 15 m i n u t e s . By u s i n g a s e p t i c t e c h n i q u e s , a b o u t 8 ml 
r a b b i t b lood drawn by d i r e c t c a r d i a c p u n c t u r e was d e l i v e r e d 
i n t o t he v i a l c o n t a i n i n g a n t i c o a g u l a n t and g e n t l y mixed t o 
p r e v e n t c l o t t i n g . For i n a c t i v a t i o n t h e v i a l s w e r e k e p t a t 
56°C i n a w a t e r b a t h f o r 30 m i n u t e s . 
[B] Prepara t ion o f S o l i d Phase 
C o m p o s i t i o n : 
B r a i n H e a r t i n f u s i o n powder 3 .7 gm 
(DIFCO) 
Bacto Agar ( D i f c o ) 2 gm 
Double distilled water 100 ml 
Citrated Rabbit Blood 15 ml 
All the above ingredients, except the citrated rabbit blood 
were dissolved in 250 ml flask in a water bath and sterilized 
at 121°C for 15 minutes. The medium was allowed to cool to 
37°C. 
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Thereafter citrated rabbit blood was added aseptically 
to the above flask. For the preparation and maintenance of 
medium slants, 3 ml samples of prepared medium were 
transferred to each sterilized tube. This was left for 
solidification in a slanting position for 30 minutes. Each 
tube was then corked. To check the sterility of the above 
medium, tubes were kept in the incubator at 37°C for 48 hrs. 
3.1.2 Preparation of Hank's Balanced Salt Solution (HBSS) 
Stock - A 
Composition 
(1) Sodium chloride 16 gm 
Potassium chloride 8 gm 
Magnesium sulphate 0.2 gm 
Double distilled water (DDW) 80 ml 
(2) Calciun^  chloride 0.28 gm 
D.D.W. 10 ml 
Solution 1 & 2 were mixed slowly by constant shaking and the 
volume made to 100 ml by adding double distilled water 
Stock - B 
Di-sodium hydrogen phosphate 0.75 gm 
Potassium di hydrogen phosphate 0.12 gm 
Double distilled water 80 ml 
The final volume was made upto 100 ml by adding DDV/ 
Sodium bicarbonate (1.4%) 
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Sodium carbonate 
DDW 
Glucose solution 
Dextrose 
DDW 
0.14 gm 
10 ml 
(5%) 
0.5 gm 
10 ml 
3.1.3 Final Solution 
Aliquots of 5 ml solution from Stock A and Stock B were 
dispensed in sterile flask and mixed thoroughly in 5 ml. 5% 
dextrose and 2.5 ml of 1.45S sodium bicarbonate were added and 
the final volume made to 100 ml. 
3.1.4 Final Preparation of Medium 
For in vitro maintenance of parasites, 3 ml of HBSS was 
aseptically added to each tube containing 3 ml of basic 
medium (BHMARB). The tubes were stored for their subsequent 
use. 
The slides were examined under an oil immersion objective 
lens for detecting any contaminants like beicteria and fungus 
etc. 
3.1.5 Preparation of Leishman Stain 
Leishman stain was prepared by mixing 150 mg of 
Leishman stain powder with 100 ml of acetone free methyl 
alcohol (98%). The above solution was kept in a clean dry 
container. 
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3.1 .6 Rate of Mu l t ip l i ca t ion and Parasite Counts 
The r a t e of p a r a s i t i c m u l t i p l i c a t i o n was c a l c u l a t e d 
a c c o r d i n g t o J a l e e s e t al., ( 1 9 8 2 ) . The r a t e o f 
m u l t i p l i c a t i o n was c a l c u l a t e d by d i v i d i n g the promast igote 
count per ml w i t h the i n i t i a l count, or w i t h the previous 
day 's count. The fo rmula used f o r t h i s was as f o l l o w s : 
Counts per ml 0 day = 
Time of M u l t i p l i c a t i o n = 
No. o f promast igote inocu la ted 
V o l . of ove r l ay / media + 
Vol of inoculum 
count a f t e r 6 days 
count on 0 day 
A ten f o l d d i l u t i o n of the c u l t u r e over lay or the in fec ted 
homogenate was made i n normal s a l i n e , w h i l e t h e m o t i l e 
n u c l e a t e d p r o m a s t i g o t e s were c o u n t e d i n a Neubauer 
Haemocytometer count ing chamber. 
3.1 .7 In Vi t ro Maintenance of Parasite 
Each tube con ta i n i ng basic medium (BHMARB) and HBSS (3 
ml each) rece i ved an 0.1 ml o v e r l a y c o n t a i n i n g 1.2 x 10 
promast igotes / m l . The inocu la ted tubes were incubated a t 
25°C ± 2°C i n a BOD incubator f o r 6 days. The pa ras i t es were 
r o u t i n e l y checked by t a k i n g a small sample from the c u l t u r e 
tube and examing the smears a f t e r s t a i n i n g them w i t h Leishman 
s t a i n . 
67 
3.1.8 Sterility Test 
To check the sterility of the medium a smear from the 
culture overlay was made by using a grease free slide. The 
smear was air-dried and fixed in methanol for 5 minutes 
before being stained. The staining solution was prepared by 
mixing equal volumes of Leishman stain and phosphate buffer 
saline (0.01 M, pH 7.2). Slides smears were stained by 
pouring the dye over the slides which were left for 30 
minutes and later washed with water. The stained smears were 
then airdried and examined under an oil immersion objective 
for detecting any contaminents like bacteria and fungus etc. 
3.2 In-vivo maintenance of parasites 
Five hamsters were inoculated intraperitoneally with 
about 1 X 10 promastigotes of NICD - CII strain of L. 
donovani grown in BHMARB medium. After seven weeks, one 
hamster was killed by ether. The spleen was excised in 
sterile conditions and homogenized in 10 ml Tris (0.2 M) 
sucrose (0.25 M) buffer, pH 7.8, using a Ten Broeck glass 
homogenizer. The homogenate was centrifuged at 150 x g for 10 
minutes and the pellet was discarded. The supernatant was 
centrifuged at 1000 x g for 20 minutes and the resultant 
supernatant (first wash) discarded. The pellet was 
resuspended in 10 ml Tris - sucrose buffer. The above 
procedure was repeated twice (Brun et al., 1976). 
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Af te r resuspending the washed amastigotes i n a small 
amount o f T r i s - s u c r o s e b u f f e r , one m i l i l i t e r o f t h i s 
homogenate was i n o c u l a t e d i n t o BHMARB med ium. S e v e r a l 
impress ion smears were a i r d r i e d , f i x e d w i t h methano l and 
s ta ined w i th Leishman s t a i n . 
3.3 Antigen Isolation 
The overlay of 6th day old culture was taken and 
centrifuged at 2000 rpm for 15 minutes. The supernatant was 
discarded and the pellet was washed three times with sterile 
normal saline. After washing, the precipitate was suspended 
in normal saline and kept overnight at 0°C. After that it was 
sonicated for 25 minutes. This was taken as a whole antigen. 
After centrifugation at 3000 rpm for 20 minutes, soluble and 
particulate antigen fractions were obtained. 
3.4 Fractionation of Antigen 
Fractionation of whole antigen samples was carried out 
according to the method described by Ghatak et a/., (1982) 
with slight modification. A portion of whole antigen was 
centrifuged at 105,000 x g (Sorvall ultra centrifuge, OTD 
50B) for one hour at 4°C. The deposit obtained after 
centrifugation was employed as particulate antigen fraction 
while the supernatant was used as soluble antigen fraction. 
3.5 Biochemical Characterization of Antigen 
3.5.1 Protein Estimation 
Protein was estimated by Lowry's method (Lowry et al., 
1951) using bovine serum albumin as the standard. 
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[A] Preparation of Folin Phenol Reagent 
Folin phenol reagent was prepared according to the 
method of Folin and Ciocalteu (1927). The reagents contained 
100 gm of sodium tungstate 
25 gm of sodium molybdate 
50 ml of phosphorus acid (85515) 
100 ml of concentrated hydrochloric acid 
A 1.5 litre capacity round bottom flask was used to 
dissolve the above constituents in 700 ml of distilled 
water. The contents of the flask were refluxed for 10 hours 
continuously by using a reflux condenser. Subsequently, 150 
gm of lithium sulphate, 50 ml of water and a few drops of 
liquid bromine were added to the flask. The whole mixture was 
boiled for 15 minutes to remove excess bromine. The mixture 
was allowed to cool. Finally the total volume was brought to 
one liter by the addition of distilled water. The above 
solution was filtered and stored until used in a dark brown 
bottle kept in a dark cupboard. 
[B] Preparation of Copper Reagent 
Copper reagent was prepared by, mixing the following 
reagents: 4% w/v sodium carbonate in double distilled water, 
4% w/v potassium sodium carbonate and 2% w/v copper sulphate 
in the ratio of 100:1:1 (v/v/v). 
About 0.1 ml of antigen or bovine serum albumin was 
brought to 1 ml by the addition of distilled water. A 5 ml 
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sample of freshly prepared copper reagent was added to it and 
incubated for 10 minute at room temperature. After incubation 
one ml of diluted folin phenol reagent was added to each 
tube. The tubes were shaken vigorously and left undisturbed 
for 30 minutes. The colour intensity of the reaction was read 
at a wave length of 700 nm by using a Bausch and Lomb 
spectronic-21 spectrophotometer. 
3.5.2 Carbohydrate Estimation 
Carbohydrates were estimated by using the method of 
Dubois et al (1956). Glucose solution was used as the 
standard. 
[A] Preparation of Standard Solution 
10 mg of glucose was dissolved in 100 ml of double 
disti1 led water. 
[B] Preparation of Phenol Reagent 
Phenol reagent was prepared by dissolving 8 gm of 
phenol in 100 ml of double distilled water. 
An 0.1 ml of antigen or glucose solution was brought 
upto 2 ml volume by the addition of double distilled water. 
Then one ml of freshly prepared phenol reagent was added. 
Later, 5 ml of concentrated sulphuric acid (95.55K) was added 
to the above mixture. The tube was shaken vigorously and 
cooled at room temperature. The colour intensity was read at 
a wave length of 490 nm. 
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3.5 .3 DNA Est imat ion 
E s t i m a t i o n of DNA was c a r r i e d ou t a c c o r d i n g t o t h e 
Bur ton ' s method (Bur ton , 1956). 
a) Diphenyl amine Reagent 
This was prepared by the addition of 750 mg of 
diphenylamine to 50 ml of glacial acetic acid containing 0.75 
ml concentrated H2S04^ . 
After mixing 1 ml of antigen to 1 ml IN perchloric 
acid, the mixture was kept at 70°C in a water bath for 15 
minutes. Then 0.1 ml of 5.43 mM acetaldehyde was added after 
the addition of 2 ml of diphenylamine reagent. The tubes were 
left at room temperature for 16 hours. The colour intensity 
was recorded at 600 nm. 
3.5.4 Measurement of pH 
A pH-meter (Elico L^  -120) was used for all pH 
measurements. Sodium tetra borate (0.1 M, pH 9.18) and 
potassium hydrogen phosphate (0.005 M, pH 4.0) were used as 
standard buffer solutions to calibrate the pH meter. 
3.5.5 Spectrophotometric Measurements 
Spectrophotometr ic measurements in the u l t r a v i o l e t and 
v i s i b l e range were c a r r i e d o u t i n a Bausch and Lomb 
Spect ron ic-21 Spectrophotometer. A l l these measurements were 
c a r r i e d out at room temperature. 
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3.6 Checking the Antigenicity of Parasite Antigens 
The antigenicity of whole antigen was further checked 
against clinically positive human serum samples obtained 
from kala-azar patients by employing indirect haemaglu-
tination (IHA) tests. The antigenicity of soluble and 
particulate antigen fractions was checked by agar diffusion 
technique against the above serum samples. All the sera 
samples were first checked for the presence of specific 
antibodies against a reference, standard antigen sample by 
Indirect Flourescent Antibody (IFA) tests. 
3.6.1 Indirect Flourescent Antibody (IFA) test 
(A) Preparation of Antigen 
Indirect fluorescent antibody test was carried out 
according to the method of Abdalla (1977). The Promastigotes 
used for IFA test were harvested by centrifugation of overlay 
taken from 6 day old cultures at 750x g for 10 minutes. The 
supernatant was discarded and the deposited pellet washed 
with PBS, pH 7.0 - 7.2, five to six times till the 
supernatant became clear. The pellet was resuspended with PBS 
then a drop (3 - 5 ml) was spotted on a clean slide. The 
slides were air dried, fixed in acetone for 15 minutes and 
again air dried. The acetone fixed slide were wrapped in 
tissue papers and packed in air tight containers in small 
batches and stored at 4°C. 
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[B] Staining Procedure 
Fluorescein iso thiocyanate conjugated with anti-human 
IgG ( -chain specific) was used in the test. The test sera 
were inactivated at 56°C for 30 minutes. Two fold serial 
dilutions were prepared with PBS. Antigen coated slides were 
removed from freezer and air dried. The antigen spots were 
covered with drops of successive serum dilution and incubated 
in a humid chamber at 37°C for 30 minutes. After incubation, 
slides were rinsed off with PBS in two or three changes of 
PBS for 10 minutes each. The smears were blotted dry and 
optimum dilution of conjugate was applied to the antigen 
spots. The slides were then mounted with cover slips using 
buffered glycerol (90%). The edges of coverslips were sealed 
with finger nail polish. Two control slides were prepared by 
placing a drop of PBS buffer on one slide and the positive 
Kala-azar antiserum on the other. The slide were stained as 
above. The stained slides were then examined immediately 
using a fluorescent microscope equipped with appropriate 
filters (Olympus, Japan). 
3.6.2 Indirect Haemagglutination Test (IHA) 
Indirect haemagglutination test was done according to 
the method of Mathews et. al . , (1975) for checking the 
antigenicity of Leishmania whole antigen, 'U' bottomed micro 
litre plates were used. Sheep red blood cells (SRBC) were 
washed four times in isotonic phosphate buffer saline (PBS), 
pH 7.2, by centrifugation for 10 minutes at 1500 rpm. A 3% 
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suspension of SRBC was prepared in isotonic PBS. The diluted 
SRBC suspension was mixed with an equal volume of 1/20,000 
tannic acid and incubated at 4°C for 30 minutes with 
intermittent shaking after incubation. The suspension was 
centrifuged at 1200 rpm for 10 minutes and tanned SRBCs were 
washed twice with PBS containing 0.5% bovine serum albumin 
(BSA). The above was resuspended in PBS containing BSA to 
obtain a final concentration of 3% (v/v). The tanned SRBCs 
were sensitized with an equal volume of diluted antigen and 
incubated at 37°C for 30 minutes with intermittent shaking 
so that the RBCS were uniformly coated with antigen. After 
incubation, they were centrifuged to remove the uncoated 
antigen supernatant. The pellet was washed three to four 
times with PBS containing BSA. A 1.5% (v/v) antigen coated 
RBC suspension was finally made for use in the tests. The 
antisera samples were serially double diluted from 1:2 to 
1:32768. Each well in the plate received 25 ul of Kala-azar 
serum along with an equal volume (25 ul ) of tanned and 
antigen sensitized RBCs. The plates were rotated gently for 
five minutes, covered and sealed in a humid chamber and 
incubated at room temperature for 2 hours. The plates were 
kept overnight at 4°C. The formation of mat-like carpet 
line patterns indicated a positive reaction. The highest 
dilution of the serum giving a positive reaction was 
recorded. 
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3.6.3 Agar Diffusion Technique 
Agar diffusion technique was used for testing the 
antigenicity of whole antigen along with soluble and 
particulate fractions. The test was performed according to 
the method described by Ouchterlony (1949). Clear slides were 
first coated with 0.2% agar and after drying them at room 
temperature 1% w/v agarose (Sigma) in PBS containing 0.2% 
sodium azide was then poured on the slides. The slides were 
allowed to solidify and wells of 2mm diameter at a distance 
of 5mm apart were later cut in agar. The central well was 
filled with reacting antisera, while the peripheral wells 
were filled with antigen samples. The glass slides were kept 
overnight in a moist chamber at room temperature and 
subsequently stored at 4° for 72 hours. The slides were then 
stained with 0.1% Comassic brilliant blue after drying. 
3.7 Animal and Infection 
3.7.1 Animal 
Male golden hamsters {Meso criticus auretus) were 
purchased f rom, Cen t ra l Drug Research I n s t i t u t e (CDRI) 
Lucknow. 
3.7.2 Parasite 
Leishmania donovani strain (NICD-CII strain) 
3.7.3 Infection with Promastigotes 
The axenic culture of L, donovani was maintained on 
BHMARB medium containing HBSS as an overlay. The primary 
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inoculum was subcultured after 5 days. Promastigotes were 
harvested at 4°C after six successive washing in sterile 
normal saline containing gentamycin following centrifugation 
at 3000 rpm for 15 minutes. The supernatant was decanted and 
promastigote pellets were in small amounts of sterile normal 
saline. Promastigotes were sampled and counted in a 
haemocytometer. Thirty hamsters were infected intra-
peritonially using an inoculum of about 1x10 promastigotes/ 
0.1 ml per hamster (Stauber's method, 1958). 
Two weeks after the inoculation the hamsters were split 
into six groups containing five animals each. These groups 
were as follows 
1) Normal (non infected non treated) 
2) Normal, treated with TDM alone 
3) Infected control 
4) Infected and treated with TDM alone 
5) Infected and treated with drug 
6) Infected and treated with drug and TDM 
3.7.4 TDM Treatment 
An aqueous suspension of TDM (1 mg/ml) prepared from 
the Mycobacterium bovis strain AN5 was supplied by kind 
courtesy of Late Prof. E. Lederer, of Laboratories de 
Biochemie, Central National de la Racherche Scientifique, 
91190 Gif-Sur-Yvette France. 
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3.7.5 Drug Treatment 
Sodium stibogluconate (Pentostam) equivalent to 0.3 
mg/sb mg~ was obtained from the Welcome foundation, U.K. On 
post inoculation day No.30, the animals were given pentostam 
at a dose of 10 mg and 20 mg/kg of body weight for 5 days. 
3.18 HAEMATOLOGICAL STUDIES 
Total leukocyte counts (TLC) and differential leukocyte 
counts were made from normal, infected and treated animals. 
The above blood samples were collected in vials 
containing EDTA as anticoagulant 
3.8.1 Total Leukocyte Count (TLC) 
This test was carried out according to the method 
described by Dacie and Lewis (1970) for the detection of 
circulating peripheral leukocytes. The blood samples from the 
normal, infected and treated animals were collected before 
infection, following infection and after the treatment. The 
blood samples were collected in white blood cell counting 
pipettes up to 0.5 marks and diluted, with Turk's fluid (3% 
glacial acetic acid in distilled water) to which some 
methylene blue was also added. The leukocytes were counted in 
a leukocytometer. 
3.8.2 Differential Leukocyte Count (DLC) 
The DLC were made according to_^e^j3|^^d described by 
Dacie and Lewis (1970). 
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3.8.3 Estimation of Haemoglobin 
The haemoglobin was estimated according to the Sahle's 
method. The graduated tubes of the haemometer were filled 
with N/10 solution of hydrochloric acid to the mark 10, with 
the help of lancet. The pipettes were filled with blood up to 
mark 20. Immediately the blood was placed in the graduated 
tube containing the hydrochloric acid solution. Then it was 
allowed to stand for 10 minutes, the mixture in the graduated 
tube was diluted with distilled water until! it had the same 
intensity of colour as the standard tube. When both tubes 
were of the same colour, the percentage figure on the tube at 
the level of the bottom of the miniscus was noted. 
The gram haemoglobin per 100 ml of blood was converted 
according to the following formula 
gm % haemoglobin in blood 
Haemoglobin factor = 
average scale of reading 
3.9 BIOCHEMICAL STUDIES 
Body weight: Body weight of the normal infected and treated 
animals were recorded 
i. Tissue Collection 
Infected and treated animals were sacrified under light 
ether anaesthesia and the liver tissues were excised and 
processed according to the experimental design. 
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i i. Wet and Dry weight of Liver 
(a) Wet weight 
The whole liver was taken out from the normal and 
infected animals at high parasitemia, blotted dry on filter 
paper and weighed quickly. 
(b) Dry weight 
The liver tissues from the above animals were dried at 
50°C for 24 hours. They were weighed, dried and, washed till 
a constant weight was obtained. 
3.9.1 EXTRACTION OF LIPIDS 
Liver (50-200 mg) was homogenized in a glass 
homogenizer to a final volume of 6 ml chloroform in methanol 
(2:1, v/v) according to the method of Folch et al (1951). 
Homogenate was shaken periodically for an hour and filtered 
through sintered glass funnel (G-4) under vacum. The residue 
of each test tube was again homogenized with 2 ml chloroform 
- methanol and then filtered. The test tubes were rinsed with 
fresh chloroform - methanol and again filtered. The final 
volume of each extract was made upto 10ml with fresh 
chloroform - methanol mixture. Thereafter ,2.5 ml of normal 
saline solution was added to the extracts in each testtube 
(4:1 v/v). This was shaken vigorously on cyclomixer for 
complete mixing and placed at - 20° in a deep freeze 
overnight for complete separation of the two layers. The 
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j u n c t i o n of the two layers t o in each t e s t tube was marked. 
The lower layer was c o l l e c t e d in stoppered tubes w i t h the 
help of a syr inge and s to red a t - 20°C u n t i l l used. The t e s t 
tubes in which the two laye rs were allowed t o separate were 
d r i e d and the volume of lower layer in each t e s t tube was 
measured. This e x t r a c t was used f o r the e s t i m a t i o n of t o t a l 
l i p i d s , phosphol ip id and cholesterol. 
3.9 .2 ESTIMATION OF TOTAL LIPIDS 
Total l i p i d s were est imated according t o the method of 
Woodman and Pr ice (1972) descr ibed as fo l l ows 
i ) Standard Solution 
A s t a n d a r d s o l u t i o n o f 0.5mg l i v e r l i p i d / m l o f 
ch lo ro fo rm (2:1) was prepared by d i l u t i n g 1.0 ml r e f r i g e r a t e d 
stock s o l u t i o n (50 mg l i v e r / 10 ml ch loroform - methanol) i n 
a 10 ml standard f l a s k and made upto a volume of 10.0 ml w i t h 
ch lo ro fo rm methanol (2:1 v / v ) . 
i i ) Colouring Reagent 
Six gram potassium dihydrogen orthophosphide and 0.3 gm 
v a n i l i n e were d isso lved by heat ing in a 100 ml vo lumet r i c 
f l a s k and the volume was made up t o 100 ml w i t h doub le 
d i s t i l l e d water. 
i i i ) Sulphuric Acid (concentrated) A.R. Grade 
i v ) Liver Lipids 
L i p i d s were i s o l a t e d f rom the hamster l i v e r by t h e 
t echn ique desc r ibed e a r l i e r ( F o l c h et al., 1 9 5 1 ) . The 
81 
extract was dried by vacuum rotatory evaporator at 40°C. The 
dried lipid preparations were stored at 4°C. 
v) Procedure 
An 0.1 ml of duplicate liver extract and a duplicate 
set of standard with 50 to 500 mg of liver lipids were taken 
in 18 X 150 mm corning test tubes. Each tube after receiving 
2.5 ml concentrated sulphuric acid was heated in a boiling 
water bath for 20 min. After cooling, 5.0 ml colouring 
reagent was added and absorption was read at 530 nm after 10 
min. against a reagent blank by Beckman DU-6 spectro-
photometer. Calculations were made as under. 
c X V 
Total lipids (mg/g fresh weight) = 
vt X wt 
where C = Concentration of lipids in ug/0.1 ml liver extract 
V = Total volume of lower layer 
vt = Volume taken for estimation 
wt = Fresh weight of tissue in mg 
The above formula was also used for calculating the 
concentration of phospholipid and cholesterol. 
3.9.3 ESTIMATION OF PHOSPHOLIPIDS 
Phospholipid was estimated by the method of Fiske and 
Subbarow and as described by Martinetti (1962). 
i) A standard solution of 0.01 mg inorganic phosphate/ml 
was prepared by diluting 5.0 ml refrigerated stock 
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s o l u t i o n (0 .438 gm KH2PO4/ 500 ml DDW) i n a 100 ml 
standard f l a s k w i t h DDW. 
i i ) Perch lo r i c ac id 70% A.R. 
i i i ) Ammonium molybdate s o l u t i o n 2.5% 
i v ) Reducing Reagent: 
Reducing reagent was prepared by d i s s o l v i n g 3.0 gm 
sod ium b i s u l p h i t e , 0 .6 gm sod ium s u l p h i t e and 0 .05 gm 
r e c r y s t a l 1 i z e d , 1 -amino-2-naptho l -4 -su lphur ic ac id (ANSA) in 
2.5 ml DDW. A s l i g h t ye l low s o l u t i o n thus obta ined was s tored 
i n a dark coloured b o t t l e . The co lour was found s tab le f o r 
about a week a t room temperature. 
v) Recrys ta l ! i za t i on of ANSA 
F i f t e e n gm sod ium m e t a b i s u 1 p h a t e , 1.0 gm sod ium 
sulphate (anhydrous) and 1.5 gm crude ANSA were d isso lved in 
100 ml DDW by heat ing on a b o i l i n g water ba th . Hot s o l u t i o n 
was f i l t e r e d through a f i l t e r paper and 1.0 ml concentrated 
h y d r o c h l o r i c a c i d was added t o the f i l t r a t e and s t i r r e d . 
Subsequent ly t he p r e c i p i t a t e was f i l t e r e d w i t h a s u c t i o n 
pump, washed i n about 30 ml doub le d i s t i l l e d wate r and 
f i n a l l y w i t h a l c o h o l t i l l washing was c o l o u r l e s s . T h i s 
p u r i f i e d ANSA was d r i ed in an oven a t 100°C f o r one hour 
w i t h leas t poss ib le exposure t o l i g h t and was t r a n s f e r r e d to 
an amber coloured b o t t l e . 
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vi) Procedure 
An 0.2 ml of duplicate liver lipid extract (lower 
layer) was placed in 18 x 150 mm corning test tubes and all 
the solvent was dried up by heating in a boiling water bath. 
1.0 ml AR grade 70% perchloric acid was added to the sampler 
after which they were heated on a digester for 30 minutes, or 
until the sample became clear. After complete digestion, 
samples were cooled at room temperature. There after, 1.5 ml 
ammonium molybdate, 0.2 ml reducing reagent and 70 ml DDW 
were added with vigorous shaking after each addition. The 
test tube were heated agains in a boiling water bath for 7 
minutes After 30 min, the colour intensity was read at 700 
nm. A calibration curve was plotted using 1 mg to 8 mg of 
phosphorous and 1.0 ml perchloric acid A blank was prepared 
with 1 ml perchloric acid alone. 
vii) Calculation 
The absorption of light being a linear function of the 
phosphorous content in a solution, its concentration in an 
unknown sample can be calculated as directly proportional to 
the absorbance obtained from the standard solution. The 
amount of phospholipid was calculated by multiplying with a 
factor of 25. 
3.9.4 ESTIMATION OF CHOLESTEROL 
Cholesterol was calculated by Lieberman-Butchard 
reaction as described by Bloor et. al. (1922). 
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Reagents 
i) Standard 
Cholesterol standard at a concentration of 1.0 mg/ ml 
in chloroform was prepared by diluting 10 ml refrigerated 
stock solution of recrystal1ized cholesterol (100 mg/10 ml 
chloroform) in a 10 ml standard flask and the volume made 
upto 10 ml by the addition of AR grade chloroform. 
ii) Colouring Reagent 
Fifty ml of AR grade acetic anhydride was first placed 
in a deep freeze for one hour, and then 5.0 ml concentrated 
sulphuric acid (AR) was added to it drop-wise with constant 
stirring. It was then allowed to stand for an additional 10 
minutes before using. This reagent was prepared fresh for 
each use. 
iii) Procedure 
An 0.5 ml o f l i v e r e x t r a c t was taken i n 15 x 125 mm 
screw capped c u l t u r e tubes. To t h i s , 4.5 ml ch lo ro fo rm (AR) 
and 1.0 ml co l ou r i ng reagent were added and mixed w e l l . The 
t u b e s were k e p t i n d a r k a t 25°C f o r 30 m i n u t e s . The 
absorbance was read a t 660 nm a g a i n s t a r e a g e n t b l a n k . A 
c a l i b r a t i o n c u r v e w i t h d i f f e r e n t c o n c e n t r a t i o n s o f 
cho les te ro l (100 - 800 ug) was drawn according t o the same 
procedure as descr ibed above 
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3.9.5 ESTIMATION OF LIPID PEROXIDATION 
The amount o f m a l o n a l d i a l d e h y d e f o r m e d a f t e r 30 
minutes of l i p i d pe rox ida t i on was est imated accord ing to the 
procedure of U t ley e t al., (1967), as descr ibed below: 
Reagents 
i) 0.15 M Potassium Chloride 
2.2368 gm KCl dissolved in 200 ml DDW 
ii) 10% (W/V) Trichloroacetic Acid 
10 gm TCA dissolved in 100 ml DDW 
iii) 0.67% 2 - Thiobarbituric Acid (TBA) 
This was prepared by dissolving 0.67 gm TBA in 25-30 ml 
DDW by adding two pellets of NaOH. The pH of the solution was 
adjusted to 9.2 with the help of 1N HCl. The final volume was 
made upto 100 ml with DDW. 
iv) Procedure 
The liver was homogenized (10% w/v) in chilled 0.15 M 
KCl. One ml of each homogenate was taken in a 25 ml conical 
flask and incubated at 37 ± 1°C in a metabolic shaker (120 
strokes / min amplitude 1 cm) for 2 hours. After incubation, 
1.0 ml of 10% TCA was added to each sample, both the 
incubated as well as non-incubated samples were centrifuged 
at 3000 rpm for 10 minutes One ml of the clear supernatant 
was mixed with 1.0 ml of 0.67% TBA and 1 ml DDW and the tubes 
were placed in a boiling water bath for 10 minutes cooled and 
the absorbance of the colour was measured at 535 nm. 
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vi) Calculation 
Lipid peroxidation was calculated using the following 
formula 
OD X 30 X 1000 X 1000 x 1000 x 3 x 2 
1.56 X 100,000 X 1000 x 180 
X = 
O.D X 10 
or = X = 
1 .56 
where x = nanomoles of malonaldehyde formed/ 30 min 
OD = change of optical density at zero hour 
and 2 hours incubation of the same sample 
3.9.6 ISOLATIOIN OF NUCLEIC ACIDS 
Nucleic acid were isolated following the method of 
Searchy and Maclnnis (1970). Weighed liver tissues were 
homogenized in 5 ml of 0.5 N perchloric acid. The homogenates 
were heated at 90°C in a boiling water bath for 10 minutes 
then cooled and centrifuged at 3000 rpm for 10 minutes. The 
supernatants were taken in the graduated test tubes and the 
volume was maintained upto 5 ml with 0.5 N perchloric acid. 
This extract was used in the estimation of DNA and RNA. 
[A] ESTIMATION OF DEOXY RIBONUCLEIC ACID 
DNA was estimated following the method of Bruton 
(1956). 
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Reagents 
i) Diphenyl amine Reagents 
1.5 gram of diphenyl amine was dissolved in about 50-60 
ml of concentrated H2SO4 and the final volume was brought to 
100 ml. 
ii) Procedure 
2 ml supernatant of the nuclei acid extract was taken 
in a test tube. To this, 4.0 ml di phenyl amine reagent was 
added, and the tubes were heated on a boiling water bath for 
15 minutes. After cooling, the colour intensity was measured 
at 600 nm against a reagent blank. 
[B] ESTIMATION OF RIBONUCLEIC ACID 
RNA was estimated by the method of Dische (1955). 
i) Orcinol Reagent 
Thirty three mg ferric chloride was dissolved in about 
50 ml concentrated HCl and 3.5 ml of 6% orcinol (dissolved 
in absolute alcohol) was mixed in it, and the volume was made 
upto 100 ml with HCl. 
ii) Procedure 
Two ml supernatant samples of the above were taken in 
the tubes to which 4.0 ml of the orcinol reagent was added. 
Test tubes were heated on a boiling water bath for 15 minutes 
then cooled and the absorbance read at 660 nm against a 
reagent blank. 
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iii) Calculation 
Both DNA and RNA were calculated by the following 
formula 
DNA and RNA (mg/g fresh tissue wt) 
C X V 
Vt X Wt 
where C = concentration in mg in 2 ml extract 
Vt = Volume taken for the estimation 
V = Total volume of the extract (4 ml) 
Wt = Fresh weight of the tissue in mg 
3.9.7 ESTIMATION OF PROTEIN 
Protein was assayed following the well known metnod of 
Lowry et al (1951). 
Reagents 
i) A standard solution of 1.0 mg BSA/ml was prepared in 
PBS 
ii) Copper reagent 
Reagent A : A% Sodium carbonate in DDW 
Reagent B : 2% Copper sulphate in DDW 
Reagent C : 4x Sodium potassium carbonate in 
DDW 
Copper reagent was prepared by mixing reagent A, B and 0 in a 
ratio of 100:1:1 respectively at the time of use. 
iii) Folin - Ciocalteu Reagent 
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i v ) Procedure 
R e s i d u e l e f t i n t h e l a s t t u b e a f t e r t a k i n g t h e 
superna tan t f o r n u c l e i c ac id e s t i m a t i o n v;as d i s s o l v e d i n 5.0 
ml DDW. An 0.1 ml a l i q u o t was taken in the t e s t tubes f rom 
t h i s s o l u t i o n and the volume was brought upto 1.0 ml w i t h 
ODW. To t h i s , 5.0 ml of copper reagent was added and the 
tubes were shaken t h o r o u g h l y on a c y c l o - m i x e r . A f t e r 10 
m inu tes 1.0 ml F o l i n ' s r e a g e n t was a d d e d . The c o l o u r 
i n t e n s i t y was measured a t 700 nm a f t e r 30 minutes a g a i n s t a 
reagent b lank . 
3.9.8 ESTIMATION OF GLYCOGEN, CARBOHYDRATE AND GLUCOSE 
[A] Glycogen Estimation 
Glycogen was extracted according to the method of Le 
Boron (1955) and estimated colorimetrically as described by 
Montogomery (1957). 
Reagents 
(i) Standard solution 
Glycogen standard of 0.1 mg/ml in DDW was prepared by 
dissolving 5 mg glycogen in 50 ml of DDW 
(ii ) TCA (5%) 
5 gm TCA was dissolved in 100 m1 DDW. 
(iii) Phenol (805^ ) 
80 gm phenol was dissolved in 100 ml DDW 
iv) Ethanol (96%) 
v) Concentrated sulphuric acid 
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Procedure 
(a) Ex t rac t i on 
A known quan t i t y of t i s s u e was homogenized i n 5 ml of 
5% f r e s h l y prepared TCA and cen t r i f uged a t 3000 rpm f o r 10 
m i n u t e s . The s u p e r n a t a n t was t a k e n and made u p t o a 
c o n c e n t r a t i o n o f 70% w i t h 96% e thano l . I t was c e n t r i f u g e d 
aga in a t 3,000 rpm f o r 10 m i n u t e s , t h e s u p e r n a t a n t was 
removed and the res idue d i s s o l v e d i n DDW. I t was then 
t r a n s f e r r e d to a 5 ml vo lumet r i c f l a sk and f i n a l l y made upto 
5 ml w i t h DDW. 
(b) Est imat ion 
A 2 ml aliquot was taken in each test tube and then 0.2 
ml of 80% phenol and 5 ml of concentrated sulphuric acid was 
added. Tubes were shaken thoroughly and allowed to stand for 
30 minutes at room temperature. The colour intensity was 
added at 490 nm. A calibration curve with different 
concentrations of glycogen (10 - 60 gm) was drawn according 
to the same procedure as described above. The values were 
plotted by the least square method and expressed as mg/g of 
tissue. 
(B) Total Carbohydrate 
Acid hydrolysis of the liver homogenate was carried out 
for the estimation of carbohydrate and glucose. For the acid 
hydrolysis equal volume of 1.5 M HCl were used to hydrolyze 
equal aliquots of normal and infected liver homogenates. The 
hydrolysis reaction was performed at 110°C for 10-12 hrs in 
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closed containers. It was cooled, filtered and the filtrate 
was then neutralized with 0.1 N NaOH. 
The amount of total carbohydrate was estimated 
according to the method of Montogomery (1957). 
(C) Glucose Estimation 
Total glucose was estimated according to the method of 
Bergmeyer and Bernut (1963). 
Reagent 
i) Standard solution 
Glucose standard of 0.1 mg/ ml in DDW was prepared by 
dissolving 5 mg glucose in 50 ml of DDW 
ii) 0 - Tolidine {^%) 
This was prepared by dissolving 1 gm 0-Tolidine in 
absolute ethanol by using a magnetic stirrer. 
iii) Sodium Acetate Buffer (pH 5) 
This was prepared by mixing approximately 3 volume of 
0.15 M acetic acid to volume 0.15M Na acetate. The pH of 
this solution was adjusted to pH 5. 
iv) Peroxides 
This was prepared by dissolving 20 mg peroxidase in 100 
ml acetate buffer. 
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v) Glucose oxidase Reagent 
Glucose oxidase reagent was prepared by dissolving 200 
mg of glucose oxidase in 80 ml acetate buffer and 1 ml of 0-
tolidine solution. The solution was made upto 100 ml with 
buffer. 
vi) Procedure 
The final preparation of homogenate for glucose 
estimation was carried out similarly as for glycogen and 
carbohydrate. 
vi) Estimation of Glucose 
A 2 ml aliquot was taken in tubes then 3 ml of 
glucose oxidase reagent was added in each tube at 2 minutes 
interval. The solution was mixed gently and set aside for 
exactly 10 minutes. When blue coloured appeared in tubes, the 
optical density of the solution was measured at 480 nm. 
3.9.9 ENZYMATIC ASSAYS IN LIVER TISSUES 
Liver tissues of normal, infected and treated hamsters 
were excised and washed in cold KCl 150 mM and homogenized in 
the same medium to give a 10% (w/v) homogenate. 
Homogenization required 60-120s with a motor driven Teflon 
pestle. The suspension was centrifuged at 15,000 x g for 20 
minutes and the supernatant was transferred to a clean tube. 
Freezing and thawing of the supernatant was done a number of 
times to release acid and alkaline phosphatase before assays. 
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[A] Estimation of Liver Transaminases 
Aliquots from suitably diluted homogenates were taken 
separately for glutamic pyrurate transaminase (GPT) and 
glutamic oxaloacetic transaminase (GOT) determinations. It 
was calculated according to the method of Reitman and Frankel 
(1957) using sodium pyruvate as a standard. 
Preparation of Reagents 
i) Phosphate buffer (0.1M, pH 7.4) 
A 420 ml volume of 0.1M disodium phosphate was mixed 
with 80 ml of 0.1M potassium dihydrogen phosphate. 
ii) Pyruvate 2mM per liter (for standard curve) 
A 22.0 mg sample of sodium pyruvate was dissovled in 
100 ml of phosphate buffer. 
iii) K-ketoglutarate, 2mM per liter, d 1-alanine, 200 mM per 
liter (for GPT substrate) 
About 29.2 mg of cK-ketoglutaric acid was placed with 
1.78 gm dl-alanine in a small beaker. The pH was 
adjusted at 7.4 with sodium hydroxide and the solution 
transferred quantitatively with buffer solution to a 
100 ml volumetric flask, and then diluted with buffer 
solution. 
iv) fK(-ketoglutarate, 2mM per liter, diasparate 200 mM per 
liter (for GOT substrate and standard curve) 
A 29.2 mg sample of cK'-ketoglutamic acid was placed in 
2.66 gm. dl aspartic acid in a small beaker. The above 
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preparation was adjusted to a pH of 7.4 with sodium 
hydroxide and transferred quantitatively with buffer 
to a 100 ml volumetric flask, and then diluted to the 
mark with buffer solution. 
v) 2.4-dinitrophenyl hydrazine, 1mM/liter. 
About 19 .8 mg o f 2 , 4 d i n i t r o p h e n y l h y d r a z i n e was 
d isso lved in 100 ml of IN hyd roch lo r i c a c i d . 
v i ) Sodium Hydroxide, 0.4N 
v i i ) Procedure 
One ml of the desired substrate was pipetted into a 
test tube and placed in a water bath at constant temperature 
(940°C) for 10 minutes Following the addition of 0.2 ml of 
homogenate the contents were mixed and after an incubation 
period of exactly 30 minutes for GPT or 60 minutes for GOT, 
the tubes were later removed from the water bath. One ml of 
the 2,4-dinitrophenyl hydrazine reagent was added 
immediately, thereby stopping the reaction. After the tubes 
were allowed to stand at room temperature for a minimum of 20 
minutes, 10 ml of 0.4 N sodium hydroxide was added. A rubber 
stopper was inserted to each tube while the contents were 
mixed by inversion. At the end of exactly 30 minutes the 
optical density of the solution was measured at 505 nm, using 
water as the blank. While the samples were incubating, a 
control tube for each homogenate sample was prepared. One ml 
of the substrate, 0.2 ml of homogenate and 1 ml of 2,4-
dinitrophenyl hydrazine reagent were mixed in a test tube. 
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After 20 min. 10 ml of 0.4N sodium hydroxide was added and 
the optical density of the solution measured. 
The level of enzymatic activity was calculated in 
terms of micro mole of the keto acid formed per min, per gram 
tissue protein. 
[B] Estimation of Liver Phosphatases 
(a) Acid phosphatase 
Acid phosphatase activity was determined according to a 
slightly modified method of Nelson (1966). A typical reaction 
mixture in a final volume of 2.0 ml contained 0.5 ml 
homogenate, 6.0 moles of ethylene diamine tetra acetic acid 
(EDTA), 75 u moles of p-nitropheny1 phosphate (disodium 
salt) and 150 u moles of acetate buffer (pH 5.0). 
(b) Alkaline phosphatase 
The enzyme concentration of alkaline phosphatase in 
liver was measured according to the method of Morton (1954). 
For estimating the concentration of alkaline phosphatase, the 
reaction mixture in a total volume of 2.0 ml contained 75 
moles of p-nitro phenyl phosphate (disodium salt), 3 u moles 
of MgCl2, 150 moles of bicarbonate buffer (pH 9.5) and 0.5 ml 
of a suitably diluted enzyme. 
Procedure 
Test tubes containing the reaction mixtures were 
incubated for 30 minutes at 37°C with occasional shaking. 
The reaction was stopped by the addition of 2.0 ml NaOH 
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(0.1N). The enzyme in control tubes was supplemented after 
stopping the reaction. One unit of enzyme was taken as that 
amount which liberated 1N moles of p-nitrophenol/ minutes 
3.9.10 ENZYMATIC ASSAYS IN SERUM 
Preparation of Serum 
The blood from normal, infected and treated animals was 
collected in clean and dry tubes. It was kept at room 
temperature, for 30-60 minutes, then at 37°C for 30 minutes 
and finally, it was kept at 4°C overnight. Next day it was 
centrifuged at 4000 rpm for 20 minutes. The clean serum 
(supernatant) was transferred to small vials and stored at -
20°C. 
[A] Estimation of Serum Transaminases 
Serum g lu tamine p y r u v i c t r a n s a m i n e (SGPT) and serum 
g lu tam ic o x a l o a c e t i c t ransaminase (SGOT) i n normal and 
i n f e c t e d serum were est imated according to the procedure of 
R e i t m a n and F r a n k e l ( 1 9 5 7 ) u s i n g sod ium p y r u v a t e as a 
s t a n d a r d . The l e v e l o f enzyme a c t i v i t y was c a l c u l a t e d i n 
terms of micromoles of pyruvate formed per minute per ml of 
serum. 
[B] Es t imat ion o f Serum Phosphatases 
The a c t i v i t y of ac id and a l k a l i n e phosphatase was 
determined by a m o d i f i c a t i o n of the procedure descr ibed by 
Nelson (1966) and Morton (1954). Rest of the procedure was 
the same was used f o r l i v e r phosphatase es t ima t i ons . 
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S t a t i s t i c a l Ana lys is 
The data were analyzed us ing s t u d e n t ' s ' t ' t e s t . 
S i g n i f i c a n t d i f f e rences between means of exper imental and 
c o n t r o l groups were ca l cu la ted and ' p ' va lues less than 
0.01 were considered as s i g n i f i c a n t . 
3 . 9 . 1 1 HISTOCHEMICAL METHODS 
Sl i ces of l i v e r t i s sue (2-3 u t h i c k ) from normal, 
i n f e c t e d and t r e a t e d animals were c o l l e c t e d i n c h i l l e d 
normal s a l i n e . A f t e r a b r i e f wash i n s a l i n e , t h e t i s s u e 
p ieces were kept i n 5% p o l y v i n y l a l c o h o l s o l u t i o n f o r 15 
minutes and mounted on microtome chucks over a drop of water 
and "quenched" (Snapf rozen) i n l i q u i d n i t r o g e n a t about 
- 190°C. The t i s s u e were then t r a n s f e r r e d t o a micro tome 
chamber (S lee, England), maintained a t -25°C. About 7-8 urn 
t h i c k sec t ions were cut and mounted on c l e a r g lass s l i d e s . 
The s e c t i o n s were a i r d r i e d and used f o r d i f f e r e n t 
h is tochemica l reac t ions immediately. 
[A] Histochemical Staining of Glycogen 
Demonstration of the d i s t r i b u t i o n p a t t e r n of glycogen 
i n the normal as we l l as L. donovani i n f e c t e d and t rea ted 
hamsters l i v e r s e c t i o n s were c a r r i e d o u t a c c o r d i n g t o t h e 
procedure of Pearse (1968) by Per iod ic Acid - S c h i f f ' s (PAS) 
reac t i on f o r Glycogen (Carney's f i x a t i v e ) . 
Reagents 
So lu t i on A : Per iod ic ac id - 1 gram 
DDW - 100 ml 
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Solution B : Schiffs reagent 
Basic fuchsin - 1 gram 
DDW - 200 ml 
1 N HCl - 20 ml 
Sod. bi sulphite - 1 gram 
(anhydrous) 
Activated charcoal - 0.5 gram 
Solution C : Sod. meta bi sulphite - 6 ml 
(10% aq) 
1 N HCl - 5 ml 
DDW - 100 ml 
Solution D : Harris Haematoxyline 
Procedure 
The basic fuchs in was d i sso lved in measured amount of 
DDW and bo i l ed a t 50°C. F i l t e r and add IN HCl, the s o l u t i o n 
was cooled t o 25°C and bi s u l p h i t e was added. The f l a s k was 
kept i n dark f o r 24-48 hours, dur ing which t ime the s o l u t i o n 
become s t r a w c o l o u r e d . Shake up w i t h c h a r c o a l , f i l t e r 
immed ia te l y . Then t r a n s f e r t o a brown c o l o u r e d b o t t l e and 
s to re i n a r e f r i g e r a t o r . 
S ta i n i ng 
For staining, the section was dewaxed and hydrated. 
Then keep the slide in solution A for 5 minutes, rinse in 
DDW. Then place in Schiff's reagent for 5 minutes. After that 
the section was kept in solution C, for 2 minutes and rinsed 
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in DDW. The slide was stained with solution D for 30 seconds 
and washed in DDW. It was dehydrated, cleaned and mounted. 
[B] Histochemical Localization of Nucleic Acid 
Methyl green pyronin method (Kurnick 1950) was used for 
localization of DNA and RNA. 
Pyronin Y - 2. gms dissolved in 100 ml DDW. The extraction 
of pyronin was carried out by chloroform. 
Methyl green : 2 gm methyl green was dissolved in 100 ml DDW 
The extraction of methyl green was carried out in chloroform. 
The slides were stained in a solution for 6 minutes 
whereas DNA was stained black and the RNA bright Red. 
3.10 IMMUNOLOGICAL STUDIES 
3.10.1 Detection of Cell Mediated Immune Response (CMI) 
The delayed type skin hypersensitivity reaction (DTH) 
and macrophage migration inhibition tests (MMIT) were 
employed for the assessment of CMI response. 
[A] Skin test 
The t e s t was c a r r i e d ou t a c c o r d i n g t o t he method 
desc r i bed by Cook and Ho lbrook ( 1 9 8 3 ) . T h e de layed t y p e 
h y p e r s e n s i t i v i t y response (DTH) was moni tered by g i v i ng f o o t 
pad i n j e c t i o n s o f washed p r o m a s t i g o t e s suspended i n 0.5% 
pheno l - sa l i ne (0.25 ml , 2.0 x 10° m l ) . The th ickness cf the 
inocu la ted foo t -pad was measured by us ing d i a l c a l i p e r s (IME 
England) a t 24 hours f o l l o w i n g i n j c t i o n s . The r e s u l t s were 
expressed as percen t inc rease i n f o o t pad t h i c k n e s s when 
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compared with the uninjected foot pad the swelling obtained 
following injection of phenol suspension of promastigote as 
an index of cellular immune responsiveness. 
[B] Macrophage Migration Inhibition Test (MMIT) 
Capillary migration inhibition test was performed 
according to the published procedure of Bloom and Bennett 
(1971). Following infection, animals showing positive DTH 
reaction from each experimental group (with or without TDM) 
were injected intraperitoneal1y with 10 ml of sterile 
paraffin oi1 . 
After 48 hours the animals were sacrificed and their 
peritoneal cavities washed with heparinized Hanks balanced 
salt solution (5 u/ml). The peritoneal fluid was collected 
into a separating funnel and allowed to settle for one hour. 
The aqueous phase was then separated from oil phase by 
centrifugation at 1200 rpm for 10 minutes at 4°C using 
sterile disposable plastic centrifuge tubes. The supernatant 
was separated and the cells were pooled and washed twice by 
HBSS. After the last washing, the cells were suspended in 
RPMI 1640 (GIBCO) medium containing penicillin (100 units/ 
ml) and streptomycin (100 ug/ml) as antibiotics. The cells 
were counted in a haemocytometer. The viability of the cells 
was determined by 0.2% trypan blue dye exclusion test. The 
viability was not less than 95%. The peritoneal exudate 
cells were adjusted at a concentration of 3x10^ cells/ml. 
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These cells were filled in 75 ml capillary tubes (1.1 mm 
internal diameter). The capillary tubes were sealed with 
sterile plasticin at one end and centrifuged at 800 rpm for 
10 minutes. Then they were cut at cell-fluid interface and 
placed in Mackaness migration chambers containing RPMI medium 
with 15 ug/ml antigen protein. Fetal calf serum (10%) and 
antibiotics (Streptomycin and benzyl penicillin) were also 
added to the filled chambers. The control chambers were 
devoid of Leishmania antigen. The cells were allowed to 
migrate for 48 hours at 37°C in an atmosphere of 5% CO2 in a 
CO2 incubator (New Burnswick Scientific U.S. A Model CO-20). 
The area of migration in control and antigen chambers was 
recorded on a graph sheet with the help of camera Lucida. The 
percent migration inhibition was calculated as follows 
Percent Migration Inhibition 
Migration area with Antigen 
X 100 
Migration area without Ag 
3.10.2 Detection of Humoral Immune Response 
The sera samples obtained from different groups of 
infected and treated animals were tested for the presence of 
specific anti L. donovani antibodies by means of IHA and 
ELISA. 
[A] Indirect Haemagglutination Test 
This test was done according to the method of Mathews 
et. al. (1975). A 3% suspension of sheep RBC were tanned with 
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tannic acid (1: 20,000) for 30 minutes at 4°C. The tanned 
cells were added to two fold dilutions of the serum. The 
highest dilution of serum showing the reaction was recorded 
as the titration end point. 
[B] Enzyme Linked Immunosorbent Assay (ELIvSA) 
This test was performed according to the method of Lin 
et a7., (1981) with slight modification,. Anti hamster IgG 
used in this test was purchased from Sigma,, 
About 2 mg of anti-hamster IgG in 0.1 ml of PBS was 
added to 5 mg of alkaline phosphatase and mixed at room 
temperature. The mixture was dialysed extensively against PBS 
at 4°C. Later gl uteraldehyde was added to give a final 
concentration of 0.2^ of the above mixture and incubated for 
102 hours at room temperature. After incubation it was 
first dialyzed against PBS at 4°C and then against 0.05 M 
Tris (hydroxy methyl amino methane) buffer, pH 8.0 at 4°C. 
To remove the insoluble materials the solution was 
centrifuged at 5000 rpm for 10 minutes. The supernatant was 
diluted with Tris buffer containing 0.02X sodium azide and ^% 
fetal calf serum . The conjugate was stored in the dark at 
4°C until used. 
Preparation of Reagents 
i) Coating buffer 
A 0.05 M carbonate bicarbonate buffer containing 0.02% 
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sodium azide was prepared in distilled water and the pH 
adjusted to 9.6. 
ii) Phosphate buffer saline - Tween 20 
A solution containing 0.15 M PBS with 0.05% Tween 
20 (V/V) was prepared (pH 7.4). 
iii) Diethanol amine buffer 
A 10% diethanol amine containing 0.01% MgCl2.6H20 and 
0.02% sodium azide was prepared (pH 9.8). 
iv) Antihamster IgG (whole molecule) alkaline phsphatase 
conjugate was used in the study. 
v) Substrate 
One tablet of p-nitrophenyl phosphate was dissolved in 
5 ml of 10% diethanol amine buffer and warmed at room 
temperature. 
vi) Procedure 
The ELISA test was performed in flat microtitre plates 
which were coated with 20 ug antigen protein in carbonate 
buffer. The plates were incubated at 37°C in a water bath 
for 6 hours at 4°C and kept overnight. The plates were then 
washed thrice with phosphate buffered saline containing Tween 
20 and BSA solution (100 ug/100 ml) for one hour and kept at 
37°C. The plates were again washed and allowed to react with 
0.2 ml of serially diluted test serum which was added to 
each well and incubated for 2 hours at 37°C. After 
incubation, the plates were again washed three times. An 0.2 
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ml of ant ihamster IgG a l k a l i n e phosphatase conjugate (1:400 
d i l u t i o n w i th PBS/T) was incubated f o r 2 hours a t 37°C. The 
p la tes were again washed three t imes w i t h PBS/T. An 0.2 ml 
s u b s t r a t e was added t o each w e l l . A f t e r 30 m i n u t e s 
i ncuba t i on , the reac t i on was stopped by adding 0.05 ml of 3N 
NaOH. The colour i n t e n s i t y was measured a f t e r 15-20 minutes 
a t a wave l e n g t h o f 400 nm u s i n g a Bausch and Lomb 
Spectronic-21 spectrophotometer. 
3.11. HISTOPATHOLOGICAL STUDIES 
On S a c r i f y i c i n g the animals, l i v e r and spleen t i ssues 
were excised f o r s e c t i o n i n g . The organs were f i x e d in 10% 
f o r m a l i n e s a l i n e . The s l i d e s were s t a i n e d w i t h i r o n 
h e m a t o x y l i n and e o s i n (H and E) and l a t e r examined 
m ic roscop i ca l l y . 
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4. RESULTS 
4.1 In Vitro Culture of Leishmam'a donovani 
The cell line (NICD: C-II strain) was cultured in Brain 
Heart Infusion Agar Medium with rabbit blood (BHMARB). Hank's 
balance salt solution was used as an overlay. No antibiotics 
were added to the medium. The cultures were generally seeded 
with 1.7x10^ parasites (0.1 ml) per 3 ml of overlay. 
Parasite counts were carried out at 24, 48, 72, 96, 120, 144, 
168, 192, and 216 hours. The rate of multiplication was found 
to be satisfactory in the above medium (Figure 2,3). The 
promastigote count in BHMARB was found to increase from 8.12 
X 10^/ml to 12.35 x 10^ / ml in 24 hours. The maximum 
parasite growth was obtained at 144 hours, the culture showed 
no further increase in the promastigote count even after 
longer hours of incubation. The decrease in parasitic count 
was seen after 168 hours of incubation. The maximum 
multiplication was 9.84 after 96 hours of incubation. The 
multiplication rate of promastigotes in BHMARB medium was 
about 77.83 times after 6 days of incubation (Table I). 
4.2 Antigen Preparation 
L. donovani promastigotes were obtained from 6 days old 
they were free from contaminants and, as such, containments 
were pooled and subjected to six successive washings in 
normal saline to which gentamycin was added. The washed 
promastigotes were then osmolysed in double distilled 
106 
0) 
r— 
E 
D 
T ' 
•a 
(1) 
z: 
03 
a: 
< 
z X C 
CQ 0 
•r" 
c+f 
•r- C3 
0 
. 4 -j o 
.. ® 
0 (0 
, cr 
+5 1 
C 0) 1 
2-c 1 
0 4 J 1 
u 1 T5 1 
© C ( 
•P (0 1 
0 1 
D) 1 
•r- 1 
•P 1 
(0 1 
cd 1 
E 1 
0 1 
L . 1 
Q. 1 
1 C 1 
1 0 1 
1 *f~ 1 
1 +J 1 
1 U3 1 
1 0 1 
1 *r" 1 
1 »~~ 1 
1 a 1 
1 T" i 
1 -p 1 
I •""" 1 
1 13 1 
1 2: 1 
1 It- 1 
1 0 1 
1 0) 1 
1 - p 1 
1 «J ( 
1 Q : 1 
r— 1 
1 E 1 
\ 1 
P 1 
C 1 
3 1 
0 1 
0 1 
0 1 
•^~ 1 
P 1 
- I - 1 
CO 1 
aa 1 
u 1 
Bj 1 
Q. 1 
CO 1 
L. 1 
3 1 
0 1 
X 1 
• • 1 
(D 1 
E 1 
•r- 1 
t - 1 
0 
10 
0 
X 
cvj 
T — 
CO 
(/D 
L. 
X 
0 
CM 
IT) 
t — 
to 
0 
X 
in 
C\l 
CVJ 
T — 
CO 
i-
s: 
• t 
CJ 
00 
1 ^ 
-^ 
<o 
0 
X 
• < * 
00 
ID 
CO 
L. 
^ 
CO 
Tl-
C\J 
'^ 
CO 
r~ 0 
X 
CM 
Oi 
^ 
to 
L. 
sz 
CM 
1 ^ 
rf-
CO 
on 
00 
0 
X 
• * 
00 
• * 
(0 
s^  
x: 
<o 
CD 
0 
00 
0 
CO 
0 
X 
CO 
CO 
CO 
CO 
i-
£ 
0 
CM 
f — 
cr> 
0 
T — 
CO 
0 
X 
•^  
CM 
• ^ 
(0 
l-
X 
Tl-
• * 
T " 
CO 
0 
0 
r~ 
0 
X 
<D 
CO 
CO 
CO 
S^  
X 
CO 
<D 
T— 
0 
<D 
0 
X 
CO 
CO 
f— 
CO 
L. 
x: 
CM 
•J) 
• r -
0 
m 
0 
X 
CM 
ID 
•r— 
CO 1 
i - 1 
SZ 1 
<o 1 
.r- 1 
CM 1 
CO 
0) 
3 
r— 
td 
> 
CD 
H-
0 
c CO 
0) 
E 
0 
-r-
P 
£ 
^ P 
- I -
i -
80 
0 
C SZ 
0 P 
1 -
P 
CO 
0 
-T— 
r— 
(D 
i-
«J 
C 
Q 2 
0 
•P ±. 
1 — 
3 
Z 
H -
CO 
(0 
p 
fl3 
0 -D 
CD 
E 
T -
(D 
r 
H H 
» 
Figure 2 : Photomicrograph showing Leishman s ta ined L. 
donovani p r o m a s t i g o t e s f r o m a 6 day o l d 
c u l t u r e in BHMARB (X200) 
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Figure 3 : Photomicrograph showing Leishman stained L. 
donovani promastigotes from a 6 day old 
culture in BHMARB medium (X1000). 
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water. The osmolysad suspensions represented the whole 
antigen from L. donovani promastigotes. The above preparation 
was checked under the microscope for complete cell lysis. The 
osmolysis generally resulted in 100% cell lysis. 
4.3 Fractionation of Whole Antigen 
The osmolysed suspension of L. donovani promastigotes 
in double distilled water representing whole antigen was 
subjected to centrifugation at 105,000 x g for one hour. The 
supernatant thus obtained represented the particulate 
antigen fraction. The smears made from each fraction after 
ultra sonication showed that they were completely 
homogenized. 
4.4 Biochemical Characterization of Antigen 
4.4.1. Protein Concentration 
Protein concentrations in whole, soluble and 
particulate antigen fractions were estimated according to 
the method of Lowry et al. (1951) as 4.66 mg/ml, 1.70 mg/ml 
and 2.93 mg/ml respectively. These results are shown in Table 
II. 
4.4.2 Carbohydrate Concentration 
Carbohydrate concentration in the whole, soluble and 
particulate antigen fractions, as estimated according to the 
method of Dubois et al (1956) were 1.28 mg/ml, 0.45 mg/ml and 
0.64 mg/ml respectively. The results are shown in Table II. 
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4.3 DNA Concentration 
The DNA concentration per ml of whole soluble and 
particulate antigen fractions, estimated according to the 
method of Burton (1956) were 110 ug/ml, 0.45 ug/ml, 0.90 
ug/ml respectively. The results are shown in Table II. 
4.5 Antigenicity Testing 
4.5.1 Indirect Fluorescent Antibody (IFA) Test 
Indirect fluorescent antibody test was carried out 
according to the method of Abdalla (1977) for checking the 
antigenicity of the isolated antigen fractions. Positive 
human sera samples were used against the above antigen 
preparations. The sera employed for this purpose were first 
subjected to antibody assays by IFA test. 
4.5.2 Indirect Haemagglutination (IHA) Test 
Indirect haemagglutination test was done according to 
the method of Mathews et al . (1975) for checking the 
antigenicity of the whole antigen fraction. An antigen 
dilution of 1:16 was found to be the optimum working 
dilution for use in IHA tests. All antigen titrations were 
carried out against a known positive human serum sample. The 
highest antibody titre value was 1:2048 as obtained from 
the positive human sera sample. The results are shown in 
Table III. 
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Figure 5 : A precipitin reaction profile of various 
antigen fractions versus human antisera. 
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4.5.3 Agar Diffusion Techniaue 
Agar gel d i f f u s i o n technique was used f o r t e s t i n g the 
a n t i g e n i c i t y of the whole, s o l u b l e and p a r t i c u l a t e ant igen 
f r a c t i o n s against Kala-azar p o s i t i v e human sera samples. A l l 
t h e above a n t i g e n p r e p a r a t i o n s showed a w e l l d e f i n e d 
p r e c i p i t a t i o n l i n e between t h e a n t i g e n and t h e a n t i s e r a 
(F igure 5 ) . 
4.6 Gross changes in L. donovani Infected Liver of Hamsters 
I n V i s c e r a l l e i s h m a n i a s i s t h e l i v e r was u s u a l l y 
enlarged and considerable pa tho log i ca l changes in the organ 
were c l e a r l y v i s i b l e . The s u r f a c e o f t h e l i v e r became 
granu la ted and the colour of the l i v e r changed t o dark brown 
or even black in chronic d isease. 
4.6.1 Dry Weight of Liver 
The change in dry weight of liver observed in infected 
animal was insignificant. 
4.6.2. Wet Weight of Liver 
Wet weights of liver samples from infected hamsters 
were found to have increased, significantly. The 'P' value 
was less than 0.001 (P <.001) (Figure 6). 
4.6.3 Drug Dose Pattern in L. donovani Infected Hamsters 
Consequent to the administration of drugs in the manner 
described below, the response in the infected hamsters was 
varied depending on the dosages. 
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1 ) Normal infected 
2) Infected and treated with 5 mg drug 
3) Infected and treated with 10 mg drug 
4) Infected and treated with 15 mg drug 
5) Infected and treated with 20 mg drug 
The mean liver parasitic count + S.D. on 15 days 
treatment was found to be 47.0 ± 2.82, 42.4 ± 3.05, 30.6 ± 
2.3, 28.8 ± 4.43 and 13 ± 2.12 respectively. Similarly, the 
mean splenic parasitic load ± SD was found to be 96.8 ± 
1.64, 93.6 ± 2.51, 81.2 ± 2.17, 21.8 ± 1.92 and 15.8 ± 3.11 
respectively (Table IV). 
After 30th day of drug treatment the mean liver 
parasitic count was found to be 23.2 + 2.38, 22.0 ± 1.87, 
19.6 ± 4.82, 16.0 ± 3.08 and 8.4 ± 0.55. Similarly the mean 
splenic parasitic count after 30th day of drug treatment was 
242.4 ± 7.67, 241.0 + 1.87, 182.8 ± 8.50, 141.0 ± 10.84, 49.0 
+ 1.58 respectively (Table V). 
It is quite apparent from these values that on a dosage 
of 10 mg the parasitic count shows a significant fall. In 
case of splenic parasite count there is a remarkable drop on 
20 mg dosage. 
4.7 HAEMATOLOGICAL STUDIES 
4.7.1 Total Leukocyte Count 
Total leukocyte count in normal animals were found to 
be 4797.6. This count was increased in infected animals 
120 
0) 
r — 
1-
E 
•r-
C 
< 
•a 
•p 
03 
o 
L. 
T3 
C 
(d 
+J 
O 
c 
(d 
E 
O 
c 
0 
o 
<\) 
> 
o 
o 
0) 
CD 
+J 
0 
I -
c ^ 
o c 
r - 0 - ~ -
Ol- i - I— 
O -P E 
£ CO 
0) Su. O 
(0 -P O 
X C T-
0) 
u \ 
C E 
O CJl 
c 
to 
Q 
CO 
+1 
E 
E 
\ . 
O 
_J 
I -
c 
(0 
0) 
2 
CO 
Q 
O 
i_ 
Ol 
03 
(0 
E 
C 
< 
<D 
CO 
in 
CM 
CD 
o 
o 
1X5 
o 
+1 
en 
00 
T-
+ 1 
CD 
O 
+1 
i n 
o 
+1 
CM 
O 
CO 
+ 1 
CM 
O 
o 
1^ 
• ^ 
o 
+1 
CJl 
Oi i n in 
CD 
CD 
• 
.,— 
CM 
CD 
+ 1 
CD 
r-
<T) 
r-
•<t 
,— (0 
E 
l_ 
0 
z 
CM 
1 — 
CM 
i n 
r-
T — 
+ 1 
CM 
• 
• * 
i n 
o 
i n 
2 : 
a 
H 
+ 
1 — 
(0 
E 
L 
O 
2 
CJ 
r— 
CD 
o 
o CM 
+1 
00 
. 
CO 
o 
-* 
1 ^ 
n 
Q) 
•P 
o 
Q) 
<+-
c 
l-H 
CM 
i n 
00 
CD 
CO 
• ^ 
+1 
00 
• CO 
T — 
i n 
<o 
1 -
+ 
•D 
0) 
P 
O 
<D 
<t-
C 
M 
CD 
CO 
CD 
00 
r-
• ^ 
+1 
r~ 
i n 
CO 
CD 
E 
O 
T — 
-^^  
Dl 
3 
t . 
Q 
+ 
1—1 
cn 
Tt 
i n 
o CD 
• ^ 
+1 
CD 
• CD 
r--
O 
in 
Q 
1 -
+ 
Dl 
E 
O 
1 — 
^^ 
cn 
3 
i . 
Q 
+ 
M 
o 
CM 
O 
i n 
^ 
+1 
o 
o 00 
i n 
Dl 1 
E 1 
O 1 
CM 1 
^-^ 1 
Dl 1 
3 1 
L. 1 
Q 1 
+ 1 
t—I 1 
CO 
i_ 
0) 
•P 
CO 
E CO 
sz 
o 
-p 
TO 
Q) 
C 
CO 
P 
c 
0 
o 
Q 
Z5 
0 
i_ 
CJl 
x: 
o (0 
LU 
>t 
Q 
• CO 
+1 
CO 
CD 
4J 
CO 
E 
CO 
^ 
i n 
o 
CO 
c 
to 
0) 
E 
o 
-p 
G 
E 
-p 
*r— 
L. 
< 
¥: 
¥: 
• CO 
+1 
CO 
(1) 
CO 
E CO 
i : 
i n 
O 
CO 
c 
to 
0) 
E 
o 
+J 
tl) 
E 
x: +J 
•r-
l_ 
< 
* )^  
ii 
•p 
c 
3 
O 
o 
tU 
+-> 
> , 
o 
o 
15 
0) 
to 
p> 
o 
o 
121 
(7408.8) and as well as in animals treated with lesser drug 
doses. The overall change in the TLC counts was not very 
significant. When the animals were treated with a 
combination of lower drug doses and TDM the count 
was 5076.6 (Table VI). 
4.7.2 Mean Haemoglobin Concentration 
Mean haemoglobin concentration was decreased from 17.89 
gm/100 ml to 9.45 gm/10 ml in infected animals. When only 
lower drug doses were used the concentration was 10.02 gm/100 
ml. In the animal group in which a combination of lower drug 
doses and TDM was used, the values were comparable to the 
values obtained by using higher drug doses (Table VI). 
4.7.3. Differential Leukocyte Count 
In our study, the change in differential leukocyte 
count was not very significant. The mean polymorph count 
decreased from 32.4 to 17.2, while in the infected and the 
treated animals (lower drug) the count was 20.8. The count 
was increased in the animal group treated with the 
combination of lower drug and TDM. The lymphocyte, monocyte 
and esonophil counts were 75.6, 3.6 and 2 respectively in 
infected animals. The animal group which was treated with 
lower drug doses the counts of polymorph, lymphocyte, 
monocyte and esonophil were 20.8, 72.4, 3.0 and 1.8 
respectively. The counts obtained by using a combination of 
lower drug doses and TDM were comparable to those obtained 
by using higher drugs (Table VII). 
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4.8 BIOCHEMICAL STUDIES 
A l t e r a t i o n s i n chemical c o n s t i t u e n t s o f L. donovani 
i n fec ted l i v e r were analysed. A p a r a l l e l ana lys i s of normal 
and t r e a t e d a n i m a l s was a l s o c a r r i e d o u t i n a l l t h e 
es t imat ions i n l i v e r homogenates. 
4.8 .1 Total L ipid 
The r e s u l t s f rom our s t u d i e s showed a s i g n i f i c a n t 
inc rease i n t o t a l l i p i d con ten t s i n i n f e c t e d a n i m a l s . The 
lower drug doses alone were not very e f f e c t i v e as such. The 
combined use o f drugs in lower amounts and the TDM e f fec ted 
s i g n i f i c a n t changes in the values which were comparable t o 
the a d m i n i s t r a t i o n o f only high drug doses (Table V I I I ) . 
4 .8 .2 Phospholipid 
A fall in the phospholipid content was observed in the 
infected animals. When a combined therapy of 10 mg drug and 
TDM was given the value obtained was close to the normal 
value (P < 0.001) while on administration of 10 mg drug 
alone, it was not significant (p < 0.05) (Table VIII). 
4.8.3 Total Cholesterol 
The result from our studies showed a significant 
increase in total lipid in the infected animals. The drug 
treatment alone was not very effective (p < 0.05), while the 
combined therapy of drug and TDM was vary effective; the 
values obtained were comparable to those obtained with high 
drug doses alone (p < 0.001) (Table IX). 
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4.8.4. Lipid Peroxidation 
A significant increase in the lipid peroxidation was 
obtained in infected animals due to the oxidative damage of 
host of liver. The drug treatment (10 mg) did not cause 
significant change while the drug and TDM combination was 
very effective and the value obtained by this was comparable 
to those obtained by giving higher amounts of drug alone. 
These values were quite close to the normal value (p < .001, 
Table IX). 
4.8.5 Total Carbohydrate 
The total carbohydrate content in the infected liver 
was found to be greatly decreased in the infected animals 
(p < 0.001). The drug treatment (10 mg) alone was not 
significant (P < 0.001) as the combined use of 10 mg drug and 
TDM (P < .001) (Table X). 
4.8.6 Total Glycogen and Glucose Content 
Depletion of total carbohydrate contents of liver 
during Leishmaniasis infection was closely associated with 
glycogen and glucose contents of liver. The decrease in 
glycogen and glucosoe contents was of a lesser degree in the 
lower drug doses (p < 0.05 and p < 0.01, respectively), 
while the values obtained in combined therapy of drug and TDM 
appeared to be more effective (Table X). 
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4.8.7 Total DNA 
Total DNA content was found to be decreased in the 
infected animals (p < .001). The depletion was less with 
lower amounts of administered drug. But a similar amount of 
drug with TDM was found more effective and the values 
obtained were comparable with the values obtained in animals 
treated with high drug doses along (p < 0.001) Table XI). 
4.8.8 Total RNA 
Total RNA was also found decreased in infected animals 
(p < .001). Treatment with lower drug doses in combination 
with TDM appeared to normalize these value. While in the 
animal groups treated with lower amounts of drug alone, the 
depletion in the RNA content was more than apparent (Table 
XI). 
8.9 Total Protein 
In our study, the decrease in the total protein 
contents compared to the normal values was not very much (p 
< 0.01). The treatment of animals with lower drug doses 
alone (p<0.05) and with TDM combination (p < 0.001) showed 
normal values (Table XI). 
4.8.10 Liver Transaminase 
A s i g n i f i c a n t and rap id decrease in the l i v e r g lutamic 
p y r u v a t e t r a n s a m i n a s e (GPT) and g l u t a m i c o x a l o a c e t i c 
transaminase (GOT) was observed in the i n f ec ted animals. The 
d r u g t h e r a p y (10 mg) a l o n e was n o t v e r y s i g n i f i c a n t l y 
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Figure 7 : Figure showing ac id phosphatase and a l k a l i n e 
phosphatase con ten t s p r o f i l e f r o m n o r m a l , 
i n f ec ted and t r e a t e d an imals . 
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effective in altering the enzyme values alone (p < 0.05), 
while the combined therapy of drug and TDM very effectively 
normzalized the level of enzymes (p < 0.001) Table XII. 
4.8.11 Liver Phosphatase 
Liver phosphatase increased significantly during 
Leishmania infection. The level of this enzyme was also found 
to be increased in animals treated with lower drug doses (p < 
0.05) but quite normal values were obtained in the animal 
group which was treated with a combination of lower amounts 
of drug and TDM (Figure 7). 
4.9 SERUM ANALYSIS 
4.9.1 Serum Transaminase 
Serum acid and alkaline phosphatase levels in L. 
donovani infected liver of hamsters were increased 
significantly (p < 0.001, p < 0.001, respectively) (Table 
XIII) 
Serum glutamic oxaloacetic transaminase (SGOT) level 
was also increased very rapidly and significantly (p < 0.001) 
in infected animals. The drug treatment (Tower doses) alone 
was not as much effective as the combined therapy of drug and 
TDM (p < 0.001) (Table XIII) in bringing these values to 
normal. 
4.9.2 Serum Phosphatase 
Serum acid and alkaline phosphatase levels in L. 
donovani infected liver of hamsters were increased 
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significantly (p < .001, Table XII). The increase in acid and 
alkaline phosphatase in the drug treated animals were (p < 
0.01 and p < 0.001) respectively. A more noteworthy effect 
was observed p < 0.001) in the animal groups which were 
treated with a combination of drug and TDM and as well as 
with higher amounts of drugs only (Figure 8). 
4.10. HISTOCHEMICAL STUDIES 
4.10.1 Total Glycogen 
It was observed that in normal liver sections, the 
distribution of glycogen was indistinct in the entire lobules 
(Figure 5). However, the liver sections from an infected 
animal showed degenerative changes in the hepatocytes. The 
animals which were treated with drug only showed decreased 
amounts of glycogen in the liver sections. While the liver 
sections from the animals treated with a combination of drug 
and TDM showed glycogen contents increased with an indistinct 
distribution in the hepatocytes (Figure 9-16). 
4.10.2 Nucleic Acid 
We have a l so c a r r i e d out h i s t o c h e m i ca l s t a i n i n g f o r 
i d e n t i f i c a t i o n of DNA and RNA c o n t e n t s o f i n f e c t e d and 
t r e a t e d hamsters. I t was observed t h a t there was a marked 
d e p l e t i o n i n t h e n u c l e i c a c i d c o n t e n t s i n i n f e c t e d 
i n d i v i d u a l s . Sma l l d r o p l e t - l i k e s t r i c t i o n s ( p e r h a p s 
represen t ing DNA and RNA) were found w i th g rea te r i n t e n s i t y 
i n l i v e r sec t ions from con t ro l animals than those seen i n 
Figure 9 : Liver section from a normal animal showing 
distribution of glycogen droplets in the 
lobules (X200). 

Figure 10: Liver section showing depletion in the 
glycogen droplets in the lobules. 
Hepatocytes showing degenerative changes 
(X200). 

Figure 11 : Photomicrograph f rom an i n f e c t e d an ima l 
t rea ted w i th lesser drug only showing less 
pigmentat ion of glycogen d rop le ts (X200). 
^ ' " i ' ^ 
t^^ ,. f^* i^-'^H^i 
6r^  H ^m-. ' r . 
% 
%il - *Xi* 
*^W i?« / . 
Figure 12 : Photomicrograph f rom an i n f e c t e d a n i m a l , 
t r ea ted w i t h a combined therapy of drug and 
TDM. Showing normal d i s t r i b u t i o n of glycogen 
d rop le ts (X200). 

Figure 13: Spleen section from a normal animal showing 
distribution of glycogen (X200). 

Figure 14: S p l e e n s e c t i o n f r o m an i n f e c t e d a n i m a l 
showing d e p l e t i o n in t h e g l y c o g e n c o n t e n t 
(X200). 

Figure 15: Spleen s e c t i o n f rom an i n f e c t e d an ima l 
t r ea ted w i th lesser drug only showing less 
p igmentat ion of glycogen (X200). 

Figure 16: S p l e e n s e c t i o n f r o m an i n f e c t e d a n i m a l 
t r e a t e d w i t h combined t h e r a p y o f d rug and 
TDM showing normal d i s t r i b u t i o n of glycogen 
(X200). 
:;^ -s&i.y 
Figure 17: Normal liver section showing distribution of 
nucleic acid throughout the lobules (X100). 
* r f . 
* ?• 
6 Wit-
Figure 18: L. donovani in fected l i ve r section showing 
loss of nucleic acid (x400). 

Figure 19: L i v e r s e c t i o n f r o m an i n f e c t e d a n i m a l 
t r e a t e d w i t h 10 mg d r u g show ing l e s s 
pigmentat ion of n u c l e i c ac id (X200). 

Figure 20: L i v e r S e c t i o n f r o m an i n f e c t e d a n i m a l 
t r e a t e d w i t h combined t h e r a p y o f d rug and 
TDM showing normal d i s t r i b u t i o n of n u c l e i c 
ac id (X200). 
J 
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infected ones (Figure 17). The combined therapy of drug and 
TDM was found to be more effective than drug treatment alone 
(Figure 16-20). The depletion of nucleic acid was found to 
be more in the drug only treated groups. 
4.11. IMMUNOLOGICAL STUDIES 
4.11.1 Detection of Cell Mediated Immune Response 
Foot pad swelling, a measure of delayed type 
hypersensitivity response (DTH), following administration of 
phenol suspended promastigotes was negative in normal animals 
and the animals treated with TDM . The DTH response was 
maximum in infected groups, lesser than in the drug treated 
(10 mg) animals (Figure 21). The DTH reaction appeared 
negative in the animals given a combined therapy of drug and 
TDM (Table XIV). 
4.11.2 Macrophage Migration Inhibition 
The results of macrophage migration inhibition are 
shown in Table (XV). Infected animal groups showed maximum 
migration inhibition (Table XV). The lower drug doses did not 
appear to affect this situation very significantly, while the 
use of combined therapy (drug and TDM) significantly, 
affected the macrophage migration inhibition values. Table 
(XV). 
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Figure 21 : Graph Showing The Humoral and Cellular Immune 
Responses in Infected and treated Animals. 
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4.12 . Detect ion o f Humoral Immune Response 
4.12.1 I n d i r e c t Haemaglut inat ion Test (IHA] 
Serum samples f rom the an ima ls o f d i f f e r e n t groups 
showed v a r i a t i o n i n t he an t i body t i t r e s ( T a b l e X V I ) . No 
ant ibod ies were detec ted in con t ro l animals which received 
s a l i n e and TDM o n l y . Serum samples f r o m t h e i n f e c t e d 
animals and those t r e a t e d w i th lower amounts of drug showed 
t h e h i g h e s t r e c i p r o c a l t i t r e v a l u e s o f 2 2 3 1 , and 1920 
r e s p e c t i v e l y . Fo l low ing a combined therapy o f drug and TDM, 
the t i t r e va lue was 7 0 . 4 . Resu l t s o f s p e c i f i c a n t i b o d y 
de tec t ion in IHA t e s t s are shown in Table XVI . 
4 . 1 2 . 2 . Enzyme-l inked Immuno-sorbent Assay 
Serum samples ob ta ined f rom a n i m a l s o f d i f f e r e n t 
groups showied v a r i a t i o n in the ant ibody t i t r e (Table X V I I ) . 
an t ibod ies were detec ted in the con t ro l animal which rec ived 
sa l i ne and TDM o n l y . Serum samples from i n f e c t e d and lower 
drug dosage t r e a t e d animal groups showed the r i s e in the 
ant ibody t i t r e (Table X V I I ) . The rec ip roca l t i t r e values are 
1024 and 256 r e s p e c t i v e l y . In the combined therapy of drug 
and TDM, the t i t r e was 32. R e s u l t on s p e c i f i c a n t i b o d y 
de tec t ion by ELISA t e s t are shown in Table ( X V I I ) . 
4 .13 . HISTOPATHOLOGICAL STUDIES 
Four weeks a f t e r the i n o c u l a t i o n o f p a r a s i t e s , t h e 
animals f rom the i n f e c t e d groups were s a c r i f i c e d and an 
assessment of t he e x t e n t of i n f e c t i o n was carried out by 
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Figure 23: L i v e r s e c t i o n f r o m an i n f e c t e d c o n t r o l 
animal showing granulamatous les ions (H&E x 
200) . 

Figure 24: L i v e r s e c t i o n f r o m an i n f e c t e d a n i m a l 
showing Kupf fer c e l l s (H&E x 400). 
fA"^  
Figure 25: L i v e r s e c t i o n f rom an i n f e c t e d an ima l as 
seen i n h igher magn i f i ca t i on showing L.D. 
bodies i n s i d e Kupffer c e l l s (H&E x 1000). 

Figure 26: Photomicrograph of l i v e r f r om an i n f e c t e d 
animal t r e a t e d w i t h l e s s e r dosage o f d rug 
on ly showing c l u s t e r s of macrophages (H&E x 
200). 

Figure 27: Photomicrograph of l i v e r f r om an i n f e c t e d 
animal t r e a t e d w i t h a combined t h e r a p y o f 
d r u g and TDM s h o w i n g l e s s i n f l a m m a t i o n 
around the po r t a l ve in but the c e l l s do not 
con ta in L.D. body. 
* ' ^ , 1 
Figure 28: Photomicrograph of liver from an infected 
animal treated with high dosage of drug only 
showing less inflammation. (H & E x 200). 
^ 
Figure 29: Spleen section from a normal animal (H&E x 
100). 
mmm. 
Figure 30: S p l e e n s e c t i o n f r o m an i n f e c t e d a n i m a l 
showing wh i te pulp invades w i t h macrophage 
(H&E X 100). 

Figure 3 1 : S p l e e n s e c t i o n f r o m an i n f e c t e d a n i m a l 
showing p a r a s i t i z e d macrophages invading the 
whi te pulp (H&E x 400) . 

F i g u r e 32 : Sp leen s e c t i o n f r o m an i n f e c t e d a n i m a l as 
s e e n i n h i g h e r m a g n i f i c a t i o n s h o w i n g 
numerous L.D. b o d i e s i n s i d e t h e macrophages 
(H&E X 1000) . 

Figure 33: Spleen section from an infected animal 
treated with lesser drug dosage only. 
Showing inflammation. Some macrophages 
containing L.D.are also seen (H&E x 200). 
4m 
!*%•. *ilm^^ -tt 
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Figure 34: S p l e e n s e c t i o n f r o m an i n f e c t e d a n i m a l 
t r ea ted w i t h a combined therapy of drug and 
TDM showing normal d i s t r i b u t i o n o f c e l l s 
(H&E X 200). 
fr^;}*.-<::'•' \ 
V ^ ; 
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making parasite counts in the organ impression smears 
according to Stauber's method (1958). Animals treated with 
lower doses of drug and with combined therapy of drug and TDM 
and with higher doses of drug were sacrified on post drug 
treatment day 7 by cervical dislocation. The spleen and liver 
tissues were excised and weighed for histopathological 
studies. 
Twentyeight days following inoculation, each animal 
showed about 15-30 amastigotes / 100 spleen cell nuclei. 
Hyperplasia in Kupffer cells with the accumulation of normal 
macrophages were regularly observed. These results were found 
to be in agreement with those of Melency, 1925 (Figure 24). 
The results obtained by using lower amounts of drug 
alone are shown in figure 26. There was a marked 
proliferation of kupffer cells and alteration in the 
parasitic burden in the hepatic, large lobules of reticulo-
endothelial cells (Figure 26). The combination of TDM and 10 
mg drug caused significant reduction in the parasitic 
burden. There was very little inflammation of the 
macrophages but the cells did not contain LD bodies 
(Figure 27). With 20 mg drug the liver appeared to be more or 
less normal (Figure 28); only very small areas of 
inflammation were seen. The cut sections of spleen from the 
infected animals showed accumulation of macrophages the red 
pulp. Additionally, there was as a diffuse hypertrophy of the 
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w h i t e p u l p . I t was e x t e n s i v e l y i n v a d e d by p a r a s i t i z e d 
macrophages. With lesser dosage o f drug t rea tment the p i c t u r e 
was somewhat s i m i l a r . The combined therapy o f drug and TDM 
s i g n i f i c a n t l y r e d u c e s t h e i n f l a m m a t i o n and t h e s p l e e n 
appeared t o be more or less normal (F igure 29-34) . 
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5. DISCUSSION 
V i s c e r a l Le ishman ias is or K a l a - a z a r i s a d i s o r d e r 
produced by a f l a g e l l a t e d protozoan, Leishmania donovani. The 
d isease i s o f major h e a l t h impor tance l e a d i n g t o sev/re 
m o r b i d i t y and m o r t a l i t y . The m o r b i d i t y r a t e i s r e p o r t e d 
around 85* w i t h o u t t r e a t m e n t i n t r o p i c a l and s u b t r o p i c a l 
c o u n t r i e s ( A i k a t et al. , 1 9 7 9 ) . The i m p o r t a n c e o f 
Leishmanial i n f e c t i o n has been f u l l y r e a l i s e d only in recent 
years . In accordance w i t h the goals of the W.H.O.'s Trop ica l 
Disease Research Programme, V iscera l l e i shman ias is has been 
given a high p r i o r i t y , being next t o ma la r i a . Although there 
i s no q u a n t i t a t i v e e v a l u a t i o n a t t h e moment, bu t rough 
es t ima tes based on e x t r a p o l a t i o n s o f t h e r e s e a r c h d a t a 
a v a i l a b l e i n d i c a t e t h a t some 350 m i l l i o n people in the wor ld 
are a t r i s k of i n f e c t i o n (WHO Tech Rep. S e r . , 1990 ) . But 
on ly a few exper imental at tempts have been made t o analyse 
the b iochemica l , immunological and the d i agnos t i c aspects o f 
the disease. T i l l date no e f f e c t i v e non - tox i c therapy f o r L. 
donovani i n f e c t i o n i s a v a i l a b l e . Chemotherapeutic agents 
p resen t l y in use inc lude several Amphoter ic in B, pentavalent 
a n t i m o n i a l s ( P e n t o s t a m ) and G l u c a n t i m e , a d i a m i d i n e 
(Pentamid ine) and a broad spec t rum o f a n t i b i o t i c s . A l l o f 
these drugs when used as r e q u i r e d may e x e r t seve re t o x i c 
reac t ions in t r e a t e d i n d i v i d u a l s . Common s ide e f f e c t s dur ing 
t reatment are vomi t i ng and g idd iness , j aund i ce , hematur ia, 
pneumonia, ECG abno rma l i t i es and anaphy lac t ic shock which may 
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further complicate the treatment. Furthermore, the above 
drugs often do not effect complete cure. 
For drug treatment to be successful, the cooperation 
of the immune mechanism of the host is often required. In 
the case of Disseminated Leishmaniasis, the T cell-mediated 
arm of the immune-response is of paramount importance in 
containing and eventually eliminating the parasites from 
infected macrophages (Garnham & Hamphery, 1969). 
Thus, one of the strategies which might be exploited in 
the treatment of Leishmaniasis is specific or non-specific 
immunostimulation with microbial products or synthetic 
polymers. Several recent studies have documented the 
effectiveness of immunostimulation in reducing the parasite 
burden in L. donovani infected mice. 
The work done in this thesis is an extension of our 
previous observations on vaccination studies against L. 
donovani infection. This work further provides the first 
evidence that a combined treatment with lower concentrations 
of drug dose and adjuvant tre-halose - di mycolate (TDM) is 
equally or more effective than the currently employed 
standard procedure. 
Tre-halose dimycolate (6-6'-diester's of trehalose), 
synthesized by Mycobacteria, Corynaebacteria and Nacardiae 
as a part of their cell wall has been shown to possess 
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several immunopotent iat ing p r o p e r t i e s (Lederer, 1979). The 
s i z e o f the e s t e r i f y i n g f a t t y a c i d s ranges f rom C28 i n 
corynebacteria ( c o r n y e m y c o - c o l i c a c i d s ) t o C80 i n 
Mycobacteria ( m y c o l i c a c i d s ) m y c o b a c t e r i a t r e - h a l o s e 
d imycolate p u r i f i e d by c e n t r i f u g a l chemotherapy, has been 
named "P3" by Rib i et al., (1976) . Rapp e t a l . , (1978) have 
i n t r o d u c e d t h e t e r m TDM ( t r e - h a l o s e d i m y c o l a t e ) f o r 
mycobacter ia l cord f a c t o r p repara t ions to d i s t i n g u i s h them 
from s y n t h e t i c t reha lose d i e s t e r s . 
Aqueous suspensions of TDM were f i r s t p r e p a r e d by 
Masahiko Kato of Osaka (1967) . Such emulsions are s tab le and 
less t o x i c , they are a c t i v e aga ins t Klebsiella pneumoniae and 
Listeria monocytogens (Parant et al. , 1977). Kumar et al. , 
(1984), repor ted the absolute p r o t e c t i o n of mice f o l l o w i n g 
t h e i r immunization w i th P. berghei ant igen - TDM (aqueous 
suspension) combination and Kierszenbaum et a l , (1984) have 
r e p o r t e d t h a t aqueous TDM s u s p e n s i o n m o d u l a t e s mouse 
macrophage f u n c t i o n , in vitro, by a u g m e n t i n g b o t h 
i n t e r n a l i z a t i o n and i n t r a c e l l u l a r d e s t r u c t i o n of Trypanosoma 
cruzi. 
The importance of macrophages i s we l l documented f o r 
h o s t p r o t e c t i o n a g a i n s t i n t r a c e l l u l a r p a r a s i t e s . A 
p a r a l l e l i s m e x i s t s between the c y t o t o x i c a c t i v i t y of t r e -
ha lose d i e s t e r mediated macrophages and t h e i r a b i l i t y t o 
re lease H2O2 upon pharmacological t r i g g e r i n g . This suggests 
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that H2O2 plays a role in the antitumor activity of these 
macrophages (Lepovire et al., 1982). A direct interaction of 
TDM with cell-surfaces is also indicated by experiments that 
'an expansion' of selected population (macrophages) triggered 
by TDM, is involved in the manifestation of adjuvant 
activity and possibly other immunological properties of 
'cord factor' (Kierszenbaum et al.,. 1984). 
The biochemical studies and the immune enhancement/ 
stimulation of the host was studied using a combined therapy 
of lower concentrations of drug and TDM. The drug treatment 
alone has also been assayed and characterized in detail. For 
these investigations L. donovani whole antigen was prepared 
from the promastigotes grown in BHMARB medium. The whole 
antigen preparation was further fractionated into soluble and 
particulate fractions. All such preparations were partially 
characterized prior to their use in immunological studies. 
Sufficient evidence is available to indicate that 
infection of laboratory animals and humans with L. donovani, 
or related species, results in the accumulation of parasites 
in the liver, spleen, peritonial exudate cells, lymph nodes 
and bone-marrow, producing pathological changes. Initially 
the number of amastigotes of L. donovani increases in the 
liver followed by a decrease during the later stages of 
infection. Whereas, in the spleen the amastigote appeared on 
day 14 post infection (PI) and their number increased till 
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the animal died. The results suggest that liver is the 
first sight of infection of L. donovani in Visceral 
Leishmaniasis. 
It is sufficiently clear from the results of drug dose 
pattern experiments that 10 mg drug dose decreases the 
parasite load. But a remarkable decline in parasite burden 
was achieved when the drug was combined with TDM. Total 
leukocyte count was increased in the infected animal group 
and in the drug (lower concentration) treated animal groups. 
TLC was around 6357 when drug and TDM were combined at a 
parasite count of 5076. The haemoglobin concentration was 
also found increased in the infected animal groups. The 
combined use of drug and TDM more effectively reduces the 
anaemic condition than the lower drug alone. Haemoglobin was 
found increased from 9.45 to 15.14 with a higher therapy of 
15.9 gm/100 ml concentration. 
The differential leukocyte count was shown in Table 
VII. In the infected animal group, the polymorph was reduced 
from 32.4 ± 2.07 to 17.2 ± 1.40, lymphocyte increased from 63 
± 2.12 to 75.6 + 2.19 monocyte increased from 2.4 + 0.55 to 
3.6 ±0.89 and eosonophil from 1.4 ± 0.55 to 2 +1.73. The 
lower concentrations of drug were not found as effective as 
in combined therapy using drug and TDM. In Kala-azar there 
is a marked reduction in the number of all forms of 
granulocytes leading to leucopenia, with relative 
lymphocytosis (Aikat et aJ., 1979, Srivastava et al., 1984). 
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Inspite of the enormous amount of literature available 
on leishmaniasis, very limited information exists on the 
physiological changes produced in the host by L. donovani. 
This deficiency can be described primarily due to the fact 
that biochemical studies on liver and serum of human subjects 
naturally infected with leishmaniasis are often complicated 
by the presence of concurrent infections and nutritional 
deficiencies (Desowitz, 1987). 
In view of the above considerations, studies were set 
up to determine some of the detectable biochemical changes 
occurring in infected and treated hamsters. Liver has been 
shown to be involved both directly and indirectly in L. 
donovani infection. Phenomenon of fatty acid degeneration in 
addition to centrilobular necrosis was mainly observed in 
liver during leishmanial infection, this was later confirmed 
by some biochemical studies. In our finding total liver fats 
were found to have increased in the infected animal. The 
lower drug treatment did not significantly reduce the 
increased level of total lipid, while the same amount of drug 
when combined with TDM caused significant drop in the 
increased level of total lipid and the level was more or less 
equal to the normal. 
A similar pattern of increase in hepatic lipid content 
was also observed in rats, monkeys, and humans infected with 
P. berghei, P. knowlesi and P. falciparun, respectively (Rao 
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et al., 1969; Angus et al., 1971; Fletcher et a1., 1987 and 
Bajpai and Dutta, 1990). Accumulation of lipid in liver of 
animal was also detected by electron microscopy (Fletcher et 
al. , 1987) and by histochemistry (Angus et al., 1971 and 
Mercado and Von Brand; 1958). So the increase in the level 
of total lipids in the tissue mainly causes hyperlipidaemia 
in heavy infections. There are several reasons for 
accumulation of fat in liver which causes fatty liver in 
animals and humans during leishmanial infection. Liver plays 
a decisive role in metabolism and transport of lipids, as 
well as in the maintenance of lipid levels in the liver and 
in blood circulation. 
Similarly, fall in phospholipid levels in the liver has 
been observed during the course of leishmanial infection in 
hamsters. Sharma et al . (1979) also reported decrease in 
phospholipid contents in the infected rat, but the decrease 
was insignificant. The combined treatment of drug and TDM 
more effectively normalized the level as compared to the 
lower drug treatment alone. 
More significantly our results indicate a remarkable 
alterations in the rate of lipid peroxidation during 
leishmaniasis. These results get further support from the 
observations given by previous workers on other protozoal 
diseases (Saxena et al. , 1981, Chauhan, et al. , 1981) who 
have also shown an increased level of lipid peroxidation in 
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the liver of mice during malarial infection. Enhancement in 
the rate of lipid peroxidation following malarial infection 
is similar to the observations of Bajpai and Dutta (1987). 
Recently, a significant increase in the rate of lipid 
peroxidation in cerebellum and brain system of mice following 
P. berghei infection was shown by Mahdi et„ al., (1989). Such 
raised levels of lipid peroxidation are perhaps available due 
to an increased susceptibility of liver to an oxidative 
damage under the stress of leishmanial infection (Sharma et 
al., 1979). The drug treatment repaired this oxidative damage 
by reducing the parasite load in the liver. Combined therapy 
of drug and TDM more effectively controlled leishmanial 
infection and more or less normalized the level. 
A close corelation exists between the cellular injury, 
peroxidation of membrane lipids and oxidative damage to 
cells. In consonance with the observations on the effect of 
toxic chemicals or in pathological conditions, the liver 
homogenates of golden hamsters infected with L. donovani are 
shown to produce higher amounts of 1ipidperoxides. Such an 
increase is directly proportional to the number of 
amastigotes in the liver of golden hamsters. This increase in 
lipid peroxides may be due to increased susceptibility of 
hepatic tissues to oxidative damage under the stress of L. 
donovani infection. 
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The decrease in the level of cholesterol in the 
infected animals might be due to an increased uptake by the 
infecting parasites. In biochemical studies, fatty, acid 
infiltration in the liver was not observed, though a state of 
hypoglycaemia was seen. Decrease in hepatic glycogen is 
rather a common feature during protozoan or heliminthic 
infections. A simliar decline in the polysaccharide reserves 
has also been observed by many workers (White et al.. 1983). 
Homewood and Neama (1980) and Saxena et al. , (1981) have 
observed depletion in total carbohydrate contents of liver in 
mice and monkeys infected with P. berghei and P. knowlesi 
respectively. Recently, Phillips et al. , (1989) and Kawo et 
al., (1990) have also reported a state of hypoglycaemia in 
humans during P. falciparum infection and in golden hamsters 
infected with Ancylostoma ceylam'cum (Von brand, 1973). 
In case of L. donovani infection the decline in 
glycogen may be due to the fact that amastigotes residing in 
macrophages drain glycogen from the hepatic cells for 
deriving energy. Disturbance in other aspects of host liver 
metabolism during L. donovani infection may also contribute 
to this decline. Similar findings were found in other 
protozoan diseases such as trypanosomiasis and malaria. 
Earlier, Sadun et al., (1965) and Srivastava et al., (1984) 
have reported depletion of glycogen contents in liver during 
malarial infection. Devakul and Maegraith (1958) have 
observed considerable decrease of liver glycogen in Macaca 
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mulatta i n f e c t e d w i t h P. knowlesi. C h a t t e r j i and Gupta (1957) 
have repor ted s i m i l a r f i nd i n gs in female r a t s in fec ted w i t h 
P. berghei. 
Glucose contents were a lso es t imated in the i n f ec ted 
and t r e a t e d expe r imen ta l a n i m a l s . I n our s t u d i e s , we have 
found the d e p l e t i o n i n g lucose c o n t e n t , i n t he l i v e r o f 
i n f e c t e d h a m s t e r s . The d e p l e t i o n o f g l u c o s e was more 
e f f e c t i v e l y c o n t r o l l e d by the combined therapy compared to 
the animals t r e a t e d w i t h lower concen t ra t ions of drug a lone. 
Fa l l i n glucose content of l i v e r was a lso observed by Saxena 
et al. , (1981) i n Mastomys natalensis d u r i n g P. berghei 
i n f e c t i o n . R e c e n t l y , Paul et al. , (1991) a l s o r e p o r t e d 
hypoglycaemia i n a l b i n o mice i n f e c t e d w i t h P. berghei 
i n f e c t i o n . P o s s i b l e mechanism f o r hypog l ycaem ia d u r i n g 
l e i s h m a n i a s i s i n f e c t i o n i n c l u d e s a c c e l e r a t e d t i s s u e 
metabol ism and inc reased m e t a b o l i c r e q u i r e m e n t s of t h e 
p a r a s i t e . I m p a i r e d h e p a t i c g l u c o n e o g e n e s i s w i t h f a t t y 
i n f i l t r a t i o n causes hypoglycaemia ( F i l k i n s and C o r n e l l , 
1974). Increase i n the concent ra t ion of l a c t i c ac id in the 
blood of host causes t o x i c i t y leading t o t i s s u e damage due to 
the u t i l i z a t i o n o f glucose through g l y c o l y t i c pathway by the 
pa ras i t es . 
Present f i n d i n g s a l so r e v e a l e d dec reased amount o f 
t o t a l r i b o n o n u c l e i c (RNA) and d e o x y r i b o n u c l e i c (DNA) 
contents . In o the r protozoal d iseases, such as ma lar ia , the 
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reduction in nucleic acid values as observed in the 
present studies has not been shown by Rao et al. , (1969). 
Kreier (1980) and Weber (1988) have suggest-ed that nucleic 
acids are made up of purine and pyrimidine nucleotides. In 
mammals, purines are both synthesized denovo and obtained 
through salvage pathways. While leishmania parasites are 
incapable of synthesizing purine de novo and as such are 
totally dependent on salvage pathways. Absorption of 
nucleotides by the parasites from host under such conditions 
might be one reason for reduction of nucleic acid contents in 
liver during leishmaniasis. 
Nucleic acid contents in infected liver were further 
assayed by histochemical techniques in present thesis. The 
depletion was overcome after treatment with the drug. When 
the drug (10 mg) was combined with TDM, the depletion was 
controlled more effectively. The values such obtained were 
comparable only with higher drug concentration. 
There is a significant fall in the rate of synthesis 
of liver proteins in the infected, experimental hamsters. 
This would suggest an appreciable alteration in the protein 
status of the organ of the host. An extensive proteolysis 
makes readily available a pool of free amino acids which are 
needed for rapid proliferation of parasites (Saxena et al., 
1981, Fern et al. , 1985). The decrease in tne protein level 
is another reason for the depletion of RNA and DNA contents 
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within the liver of the infected animals. Infact, poor 
availability of nucleic acid could be responsible for lower 
levels of protein (Chander and Kapoor, 1990). 
It is obvious that the interaction of L. donovani and 
the host gives rise to certain somatic alterations, which may 
ultimately be reflected in biochemical changes in the body 
fluids. Therefore, correlation of clinical observations with 
multiple quantitative determination of serum components may 
contribute to the diagnosis and progress of this infection 
and may even permit an early assessment of the effect of 
various chemotherapeutic agents (Sadun, 1966). The liver 
damage caused by the parasites during leishmaniasis can be 
more conveniently demonstrated by means of several routine 
functional tests. The enzymes generally used as indicators of 
liver dysfunction are glutamic oxaloacetic transaminase 
(GOT), glutamic pyruvic tranaminase (GPT) acid phosphatase 
and alkaline phosphatase. 
It has been observed that liver GPT and GOT were 
decreased significantly. The results are in agreement with 
the earlier observations made by Lai and Hussain (1978) in 
other protozoal diseases. They have also observed decreased 
levels of GPT and GOT activity in the liver of P. berghei 
infection indicating a dysfunction of liver during infection. 
We have also observed marked alterations in the SGPT and 
SGOT levels in the serum of infected hamster. SGPT and SGOT 
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levels are increased during leishmaniasis. Similar findings 
were also reported by Sadun et al. , (1965), Lai and Hussain 
(1978) and Khanna et al. , (1986) in malarial infections. 
During leishmanial infections, an increase in the number of 
macrophages, lymphocytes and kupffer cells were also observed 
in the liver. It was confirmed by estimating the acid and 
alkaline phospahtase levels in the liver tissues. Biochemical 
estimations have shown a significant elevation of alkaline 
phosphatase activity. The increased levels of acid 
phosphatase activity in the liver was observed in our 
studies and was found increased significantly. Saxena et 
al. , (1985) also reported simliar findings in various animal 
models including mice, rats, and Mastomys natalenesis. During 
F. berghei infection Banyal et al., (1980) also reported acid 
and alkaline phosphatase activity in monkeys infected with 
P. knowlesi. They noted altered levels of these enzymes due 
to the membrane disruption of the cytoplasmic organelles 
which ultimately leads to liver damage. When the infected 
animals were treated with drug the elevated levels of enzymes 
were more effectively controlled with the combined therapy of 
drug and TDM. These results are comparable to the higher 
drug treatment alone. It has been found that the combined 
therapy repaired the oxidative damage effectively and 
normalized the level of enzymes. 
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In our study, we found that in experimentally induced 
leishmaniasis,there is a significant reduction of parasites 
in the liver and spleen by using the combined therapy of TDM 
and sodium stibogluconate as compared to the infected 
controls. The effect of TDM was dependent upon the amount of 
TDM given to each mouse. One of the advantages of TDM is 
certainly the long duration of its action. The immuno-
stimulation by TDM is supposed to increase gradually over 
the weeks. Mice were better protected against Babesia microti 
seven weeks after an intravenous infection of 200 TDM in 
aqueous suspension than after three or five weeks (Clark, 
1979). These workers have also reported that mice which were 
inoculated with 10 ug or 50 ug TDM intravenously were not 
protected, Olds et al. , (1980) also showed that number of 
Shistosomulae recovered from mice treated with 200 ug TDM was 
reduced, but an intravenous dose of the 100 ug per mouse 
was not protective. TDM in a 1% equalane in water emulsion 
was also found to protect mice against Toxplasma gondii four 
weeks after intra peritonial infection (Masini et al., 1986). 
Lederer (1986) also obtained protection in mice following 
administration of TDM against P. berghei. Toxoplasma and 
Mesocestoides corti. They showed infection rate ranging 
from 40 to 100 per cent and the reduction in the infected 
rate from 30 to 100 percent. Recently, very good protection 
was observed in mice against P. berghei infection (Lederer, 
1988). TDM has been shown to enhance non specific immunity 
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aga ins t va r ious i n f e c t i o n s . I t can a lso induce loca l immunity 
aga ins t an a i r bo rne , t ube rcu los i s i n f e c t i o n . Pimm et al. , 
(1979) a lso demonstrated tha t i n t r a p e r i t o n e a l i nocu la t i on of 
TDM causes suppress ion of an a s c i t i c r a t t umor . S i m i l a r 
ant i tumor a c t i v i t y of TDM in mice has a lso been reported by 
Sakurai et al., (1988). Yarkoni et al., (1977) showed t h a t 
a f t e r i n t r a - p e r i t o n e a l a d m i n i s t r a t i o n o f TDM i n t o m i c e , 
phagocytosis of L. monocystogenes by p e r i t o n e a l macrophages 
increased. On the basis of these f a c t s , Ya rkon i ' s et al. , 
(1977) concluded t ha t TDM a c t i v a t e s macrophages. S i m i l a r l y , 
Kierszenbaun (1984) observed macrophages a few days a f t e r 
i n t r a p e r i t o n e a l a d m i n i s t r a t i o n o f TDM i n m i c e . These 
macrophages produced l a rge q u a n t i t i e s o f H2O2 f o l l o w i n g 
t r i g g e r i n g by phorbol my r i s ta te aceta te (Leoo ivre et al., 
1982). On the basis of var ious repo r t s t he re are s u f f i c i e n t 
evidences to be l ieve t h a t the n o n - s p e c i f i c p r o t e c t i o n in mice 
f o l l o w i n g TDM a d m i n i s t r a t i o n , i s m a i n l y ach ieved due t o 
macrophage a c t i v a t i o n a few days a f t e r i t s i n t r a - p e r i t o n e a l 
i n o c u l a t i o n of TDM in mouse. In our l abo ra to r y , Pathak 
(1987) had c a r r i e d ou t i m m u n i z a t i o n s t u d i e s i n go lden 
hamsters by i n o c u l a t i n g p u r i f i e d le ishmania ant igen w i th TDM. 
The use of drug and an immuno modulator combination has 
opened a new e ra in the f i e l d o f chemotherapy and immuno 
t h e r a p h y . The work of H a i d a r i s and B o n v e n t r e (1983) as 
c l a i m e d i s t h e f i r s t documented r e p o r t t h a t t h e two 
t h e r a p e u t i c m o d a l i t i e s c o n c u r r e n t l y employed can be o f 
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advantage in the treatment of experimental L. donovani 
infection. In an in-vitro experiment, macrophages from C^ y B 
L/6 mice were infected with L. donovani amastigotes. Partial 
or complete activation of macrophages was found as pitting of 
tumor cells significantly enhanced the efficacy of sodium 
stibogluconate (Pentostam). It should be appreciated that the 
problem of therapeutic control of leishmaniasis is not only 
confined to the discovery of a drug with anti 1 eishmanial 
effect, but also that of the delivery or targeting of other 
drugs to the actual site in the macrophages where parasites 
are lodged. 
The quantity of drug required for elimination of 
parasites from immunostimulated cells was considerably lower 
than that required to achieve comparable amastigote killing 
in thioglycol1 ate cultured macrophages (Haidarais and 
Bonventre, 1983). In an in vivo study C5-7 BL/6 mice infected 
with L. donovani were treated alone and in combination with 
C. parvum and sodium stibogluconate at 60 or 120 mg/kg body 
weight. The combined therapy was significantly more effective 
than the immunotherapy or chemotherapy alone (Haidaris and 
Bonventre, 1983, Berger and Fairlamb, 1992). 
It is well known that cellular, rather than the humoral 
immunity, is responsible for acquired resistance against 
visceral leishmaniasis^ Garham and Humphrey, 1969; Zuckerman, 
1975). In the active state of visceral leishmaniasis, the 
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cell mediated immunity is generally depressed; usually the 
skin test (delayed hypersensitivity) becomes positive only 
after 6-8 weeks of treatment. It is usually such cases which 
later become immune to a subsequent infection. Generally 
speaking, antibodies in leishmaniasis are not of much 
critical value in the immune protection of host (Garnham and 
Humphrey, 1969; Neal et al., 1969, Stauber 1970). 
In this thesis the humoral immune response against 
leishmaniasis in golden hamsters was estimated by using IHA 
and ELISA tests. ELISA has been found more useful and more 
sensitive than IHA and immuno electrophoresis, etc. which 
were used for the diagnosis of kala-azar. (Gupta et al. , 
1993). ELISA technique was first used by Hommel (1976) and 
subsequently by Voller et al., (1976) for the detection of 
antileishmanial antibodies showing promising results. ELISA 
has also been used by Arora et al. , (1985) in large scale 
seroepidimiological surveys for kala-azar and found it to be 
more practical than IFA. Jalees et al. , (1982, 1983) used IHA 
and ELISA for the detection of leishmanial antibodies. Obaid 
et al., (1989) used ELISA for the detection of humoral immune 
responses during immunization studies against visceral 
leishmaniasis. In this study, elevated levels of antibody 
titres were found in infected animals and the level was found 
to be normal in the drug treated; and more effectively by 
using the combined therapy of drug and TDM. 
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In vitro, the CMI responses were detected by the 
development of delayed type hypersensitivity response (DTH) 
following intradermal antigen inoculation. The test has been 
widely used in studies on the epidemiology of kala-azar in 
Kenya and of mucocutanous leishmaniasis in South African 
countries (Pessoa and Barretto, 1948). The leishmanian test 
was found slightly more specific (Manson Bahr, 1961). Dacost 
et al., (1988) reported DTH to have a similar relationship to 
leishmaniasis, since this test measures the delayed 
hypersensitivity of cell mediated immunity. In this study, 
foot pad swelling in response to animal challenge by phenol 
suspension of promastigotes was taken as a measure of DTH 
responsiveness. The skin test was found to be less positive 
in only drug treated animal groups and negative in the group 
which were treated with a combination of drug and TDM. The 
experiment on maximum macrophage miigration inhibition (MMI) 
was also done. It was found to be positive in infected 
animals. The inhibition was less in the drug treated group 
and negative in the group in which a combination of lower 
drug and TDM was used. 
The results from DTH and MMI tests were reproducible 
and in agreement with one another. The main immunological 
feature of visceral leishmaniasis is the total suppression of 
cellular hypersensivity to leishmanias antigens. This is 
associated with high parasite multiplication accompanied by 
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high levels of specific antibodies and polyclonal IgM and IgG 
(Report of WHO Expert Committee, 1990). Earlier workers have 
suggested from the in vitro experiments that the activi-y may 
result from interactions with several cell types (Parant, 
1980). Haider et al., (1983) reported the absence of 
lymphocyte blastogenesis to leishmaniasis antigen in an in 
vitro test. Such impairment in cell mediated immunity is 
attributed to the development of suppressor T cells. However, 
these cells do not interfere with the activity of he':::er T-
cells which along with B-cells help in the production o- nigh 
antibody levels (Preston, 1987). 
Generally speaking, antibodies in leishmaniasis are not 
usually of much critical value in the immune protection of 
host (Garham and Humprey 1969; Stauber 1970). While Zukerman 
and Lainson (1977) suggested that antibodies in leishmaniasis 
have a limited role in providing immune resistance. Our data 
showed that infected animals which received drug in 
combination with TDM were found to have raised antibody 
titres than only drug treated animal groups. 
These results are more or less in agreement witn other 
workers, who have used BOG, glucan, aluminium hydroxice and 
HES as adjuvant to enhance the immune resistance in mice and 
hamsters against L. donovani infection. (Smrkovski and 
Larson, 1977, Jarecki Black et al.. 1984, 1986, 1988, Obaid 
et al.. 1989; Cook and Holbrook, 1983 and White and McMohan 
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Pratt; 1990). The histopathological changes in total 
infections of L. donovani are characterized by hyperplasia 
of the reticulo-endothelial tissues particularly in kupffer 
cells of the liver and macrophages of the spleen and bone 
marrow. This condition results in the enlargement of liver 
and spleen tissues accompanied by some circulatory changes 
(Melency 1925, WHO Tech Rep. Scr. 1984, 1990, Guitirrez et 
aJ. , 1984, Oleveira et al. , 1985). Under laboratory 
conditions in L. donovani infection, some animals respond in 
a manner similar to that in fatal human infection with marked 
macrophage proliferation and in the formation of granulomas 
in the liver and spleen (Melency 1925; Reiner and Mahmood 
1985, Gutierrez et al., 1984). The liver of the infected 
controls showed hyperplasia in Kupffer cells with the 
accumulation of macrophages forming granuloma foci. The 
granuloma formation increased with the progress of infection, 
leading to an atrophy of the heptic cells and distortion of 
the normal liver architecture. 
A large number of L.D. bodies were seen in the 
hyperplastic macrophages. The results were found to be in 
agreement with those of Melency (1925) and Gutierrez (1984). 
In the lower drug treated animal groups, there is a marked 
proliferation of kupffer cells and alteration in the pattern 
of hepatic lobules. Large number of parasitized reticulo 
endothelial cells were seen. The combination of TDM and lower 
concentrations of drug caused significant effects. There was 
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o n l y ve ry l i t t l e i n f l a m m a t i o n o f t h e macrophages bu t t he 
c e l l s d id not conta in LD bod ies . With a h igh drug dose, the 
l i v e r appeared to be more or less normal. 
The purpose of t he p r e s e n t work was t o e x t e n d the 
p r e v i o u s s t u d i e s and t o see t h e s y n e r g e s t i c e f f e c t o f an 
es tab l i shed drug given a t reduced doses along w i th TDM and to 
assess and evaluate the a n t i p a r a s i t i c a c t i v i t y / e f f i c a c y of 
DM a lone and i n comb ina t ion w i t h a n t i 1 e i shmani a l d r u g . 
A l t h o u g h t h e r e a re s e v e r a l s t u d i e s c o n f i r m i n g t h e 
a n t i p a r a s i t i c , . a n t i b a c t e r i a l , a n t i v i r a l and a n t i t u m o r 
a c t i v i t i e s o f TDM, b u t t o o u r know ledge t h e r e a r e no 
a v a i l a b l e repor ts i n d i c a t i n g such use of TDM in exper imental 
1 ieshmanias is . 
As f o r chemotherapy, the an t i l e i shman ia l drugs commonly 
i n use appear t o be q u i t e t o x i c , i f given i n adequate doses. 
Cases of drug res is tance are not uncommon e i t h e r . C u r r e n t l y , 
a l o t of research i s going on t o i nves t i ga te the p o s s i b i l i t y 
o f m i n i m i z i n g the s ide e f f e c t s o f t h e r a p y by i n t r o d u c i n g 
newer/ safer drug, or a l t e r n a t i v e l y , drug combinat ions w i th 
some s u i t a b l e immunomodulators. 
Based on a v a i l a b l e i n f o r m a t i o n , two p o s s i b l e 
exp lana t ions can be proposed; F i r s t i t may be q u i t e l i k e l y 
t h a t the mic rob ia l armamentarium of ac t i va ted macrophages 
a c t s i n p a r a s i t e s w i t h i n t h e c e l l s w h i l e h i g h e r 
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concent ra t ions o f drug are requ i red to k i l l organisms in non-
ac t i va ted macrophages. Because m ic rob ia l products such as 
hydrogen peroxide and s i m i l a r products are produced in very 
smal l amounts, w h i l e the t o x i c subs tances a re produced i n 
considerable q u a n t i t i e s by ac t i va ted c e l l s . Thus sub l e t h a l 
d r u g doses i n c o m b i n a t i o n w i t h m i c r o b i c i d a l e f f e c t o r 
mechanisms o f t he immune s t i m u l a t e d macrophages a c t i n g 
independently may prov ide more e f f e c t i v e tnerapy than e i t h e r 
o f t h e above t r e a t m e n t g i v e n a l o n e . The a l t e r n a t i v e 
e x p l a n a t i o n c o u l d be t h a t t h e a c t i v a t e d macrophages 
concentrate a n t i l e i s h m a n i a l drug more e f f e c t i v e l y so t h a t a 
g r e a t c o n c e n t r a t i o n o f d r u g i s d e l i v e r e d t o t h e 
parasi tophorous vaculoes than i n the uns t imu la ted c e l l . There 
i s ample ev idence i n the l i t e r a t u r e t o show a g r e a t e r 
p i n o c y t i c a c t i v i t y by the ac t i va ted macrophages. E f f e c t of 
combined immunost imulat ion and drug therapy has a lso been 
s t u d i e d i n expe r imen ta l b a c t e r i a l {Proteus mi rati lis, E. 
Coli, KlebsiJla pneumonia, Strepto coccus fecal is)infections 
(Lahnborg e t al. , 1982). I t was concluded t h a t glucose ( 1 -
3 l inkage) i n combinat ion w i th a m p i c i l l i n , has a s i g n i f i c a n t 
e f f e c t on the s u r v i v a l ra te of r a t s w i t h induced p e r i t o n i t e s . 
The e f f i c a c y o f t h i s t r e a t m e n t was p r o b a b l y due t o an 
enhanced a c t i v i t y of the R.E. system - an impor tant segment 
of the t o t a l host res i s tance . 
The f i n d i n g s from our s tudy, suggested t h a t TDM when 
used as an immunomodulator was able to s t i m u l a t e the immune 
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S t a t u s of the an ima l . Such a t r e a t m e n t can overcome t h e 
i n f e c t i o n even when t h e a n i m a l s were t r e a t e d w i th l e s s e r 
doses of drug in combination with TDM, Quite e v i d e n t l y , the 
d r u g a l o n e c a n n o t p o s s i b l y have a s i m i l a r e f f e c t on 
l e i s h m a n i a s i s . 
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6. CONCLUSION 
The results of this study suggest that the theraceutic 
modality involving simultaneous administration of drug and an 
immune enhancer can be used to advantage in the treatment of 
experimental L. donovani infections. BHMARB medium was 
satisfactorily used for parasite maintenance to obtain high 
yield of L. donovani promastigotes, which were ultimately 
required for antigen isolation and immunological stuaies. 
During these investigations, biochemical and immunological 
tests, were performed to characterize the protein and 
carbohydrate nature as well as the antigenicity of parasite 
antigens used for immunological studies. The hamsters were 
infected with L. donovani and after ten weeks of inoculation 
the liver and spleen were removed and the assessment of 
infection was carried out by making parasite counts. 
Firstly, the various drug dose responses were 
determined alone. The 10 mg/kg body weight drug dose 
treatment can reduce the parasite load. After that, the 
effect of different doses of TDM alone and in combination 
with various drug concentration was determined. It has been 
found that 10 mg drug dose/ kg body weight combined witn 500 
ug TDM/kg body weight significantly reduced the parasite 
load as compared to the treatment with drug alone. The 
haematological studies showed that the total leukocyte count 
was higher in the infected and lower drug doses. Leukcotosis 
was reversed by giving a combined therapy of drug anc TDM. 
194 
The mean haemoglobin c o n c e n t r a t i o n was a l s o reduced . The 
anaemic c o n d i t i o n was c o n t r o l l e d by us ing a combination of 
drug and TDM. I n the d i f f e r e n t i a l l e u k o c y t e c o u n t , t he 
lymphocytes and monocytes were f o u n d i n c r e a s e d i n the 
i n f e c t e d a n i m a l s . The count was n o r m a l i z e d by g i v i n g a 
combined dosages of drug and TDM. Our s t u d i e s i nd i ca te t h a t 
l e i s h m a n i a s i s causes v a r i o u s s t r u c t u r a l and f u n c t i o n a l 
a l t e r a t i o n s i n d i f f e r e n t organs of host namely, l i v e r , spleen 
and k idney. Our r e s u l t s conclude t h a t h e p a t o t o x i c i t y assumes 
specia l s i g n i f i c a n c e in experimental i n f e c t i o n of rodents. 
The above f i n d i n g s are suppor ted by t h e f a c t t h a t l i v e r 
acts as the pr imary organ fo r hos t ' s homeostasis, and as such 
var ious chemical cons t i t uen t s and enzymes o f l i v e r i nc lud ing , 
t o t a l l i p i d s , phospho l ip ids , c h o l e s t e r o l , l i p i d pe rox ida t i on , 
p r o t e i n s , DNA, RNA, l i v e r t r a n s a m i n a s e s and l i v e r 
p h o s p h a t a s e s a r e i n v a r i a b l y a l t e r e d . S i g n i f i c a n t l y , 
h is tochemical s t ud ies were also h e l p f u l i n conf i rming t h a t 
massive biochemical changes take place du r ing le ishmanial 
i n f e c t i o n . Due t o l i v e r d y s f u n c t i o n , changes were a l s o 
o b s e r v e d i n serum t r a n s a m i n a s e and se rum p h o s p h a t a s e 
contents . The most s t r i k i n g fea tu re observed in our study 
was t h a t i n the i n fec ted animals and i n the lower drug dose 
t r e a t e d animal groups the l e v e l o f serum phosphatase and 
serum transaminase, which were found t o be a l t e r e d due to 
l i v e r d y s f u n c t i o n , normal ize in the combined therapy (drug + 
TDM). These r e s u l t s f u r t h e r i n d i c a t e a good c o r r e l a t i o n 
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between h o s t ' s res is tance to i n f e c t i o n and the a v a i l a b i l i t y 
of these enzymes. 
The les ihmania l i n f e c t i o n adversely a f f e c t e d the h o s t ' s 
v i t a l organs such as l i v e r , spleen and k idney. Pa tho log ica l 
l e s i o n s i n the hams te r ' s l i v e r i n f e c t e d w i t h L. donovani 
showed a l t e r a t i o n in the hepat ic l obu les . Sinusoides were 
d i l a t e d and f i l l e d w i t h h y p e r t r o p h i e d k u p f f e r c e l l s 
con ta in ing phagocytosed L.D. bodies. Contrary t o t h i s , the 
animals which were t r e a t e d w i t h combined therapy of drug and 
TDM showed normal a r c h i t e c t u r e , f r ee from pigment depos i t i on . 
In b r i e f , the var ious experiments performed dur ing t h i s 
work r e v e a l e d t h a t i n f e c t e d a n i m a l s showed m a s s i v e 
biochemical a l t e r a t i o n s i n t i s s u e and serum. S im i l a r t i s s u e 
a l t e r a t i o n s were a l s o o b s e r v e d i n h i s t o p a t h o l o g i c a l 
examinat ion of the i n f e c t e d l i v e r and i n the animals which 
were t r ea ted w i th lesser doses of drug. Such a l t e r a t i o n s were 
not seen when s i m i l a r examinat ions were c a r r i e d out i n the 
a n i m a l g r o u p s w h i c h were r e s p e c t i v e l y t r e a t e d w i t h a 
combination of drug and TDM and higher drug doses a lone. 
I t can t h e r e f o r e be conc luded f rom our r e s u l t s o f 
var ious experiments t h a t combined therapy of drug ( l esse r 
d o s e s ) and TDM can be used e f f e c t i v e l y t o t r e a t 
l e i shman ias is . I t minimizes the s ide e f f e c t s seen in the 
case of t reatment w i th h igher drug dosages a lone. 
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